LayerRx Mapping ID
364
Slot System
Featured Buckets
Featured Buckets Admin

Impact of Preoperative Specialty Consults on Hospitalist Comanagement of Hip Fracture Patients

Article Type
Changed
Fri, 03/19/2021 - 15:34

Hip fractures in the elderly are associated with significant morbidity and mortality.1 These are typically fragility fractures since they are caused by mechanical forces that would ordinarily not result in a serious injury, such as a fall from or below standing level. The incidence of hip fractures in the United States is expected to increase as the population ages; estimates project 512,000 hip fractures with an associated cost of $16 billion annually by the year 2040.2 Timely surgery is recommended for hip fracture patients as delayed surgery beyond 24 to 48 hours of presentation is associated with increased morbidity and mortality.3-6 Time to surgery (TTS) has been shown to be the major potentially modifiable risk factor in the management of a hip fracture.7

Factors that have been noted to influence TTS include the American Society of Anesthesiologists’ (ASA) score, the day of the week of hospital admission, and preoperative testing.8,9 Preoperative cardiology consultation and subsequent cardiac testing, in particular, can increase the TTS and length of stay (LOS) without changing perioperative management.9,10 In our review of literature, we could not identify any studies specifically looking at the impact of preoperative specialty consults on short-term mortality or comparison of care provided by hospitalists alone versus additionally involving subspecialists such as cardiologists. To our knowledge, there are no studies that have categorized recommendations from a preoperative specialty consult as minor, moderate, or major.

Our study evaluated whether preoperative specialty consults meaningfully change management and influence outcomes for hip fracture patients. At our institution, all hip fracture patients are admitted to the hospitalist service and comanaged with the orthopedic team. The hospitalist physician performs the preoperative evaluation as part of the admission history and physical exam. Preoperative specialty consult(s), if needed, are requested only by the hospitalist team. A consultant such as a cardiologist provides input; however, final management decisions are coordinated by the hospitalist physician.

METHODS

Study Design

We performed a retrospective cohort study of patients aged 50 years and older who underwent surgery for an isolated fragility fracture of the hip at Hartford Hospital, a level one trauma and tertiary care medical center, within the 24-month period from April 2015 to March 2017. Fragility hip fracture is defined as one occurring from a fall of a height of standing or less. A consult referred to a specialty or subspecialty consultation, other than hospital medicine, obtained prior to surgery. Patients with additional skeletal trauma and periprosthetic fractures were excluded. A total of 491 unique patients met the inclusion criteria, and data were obtained from chart review and an orthopedic surgery registry. The Hartford Hospital Institutional Review Board approved this study.

 

 

Our primary predictor was the presence or absence of a preoperative specialty consultation requested by the hospitalist. We also analyzed the following: covariates of demographics (age, sex, race), the ASA score, and severity of comorbidities using the Charlson comorbidity index (CCI) with a Quan modification;11 “R program package, International Classification of Disease (ICD)”12 was used to calculate the CCI using ICD-9 and ICD-10 diagnostic codes.

The primary outcome measures were TTS (measured in hours), LOS (measured in days), complications, and preoperative specialty consult resulting in a change in perioperative management. TTS was defined as the time elapsed from the presentation at the emergency department (ED) to surgery start. For transfer or direct admission patients, the time of admission was used in place of time of presentation. The measured complications included postoperative venous thromboembolic events, surgical site infection, myocardial infarction, stroke, and sepsis. Secondary outcome measures included 30-day mortality, readmission rate, and rate of return to OR. There were no elective or planned readmissions postoperatively on review of our institution’s orthopedic surgery registry.

Our team performed an extensive chart review including reviewing the admission note, consulting physician notes, and relevant test results. Our senior investigator (MK) then rated each preoperative specialty consult on appropriateness, the relative strength of the consultant’s recommendation, and resulting change in perioperative management. Cardiology consultations were deemed reasonable if a patient’s cardiac risk was considered elevated by the admitting physician or an active cardiac condition was present (suggestion of or clear evidence for acute coronary syndrome, acute congestive heart failure, uncontrolled arrhythmia, or symptomatic valvular disease). The determination of “elevated cardiac risk” was made, if admit note contained verbiage expressing concern for further evaluation for cardiac issues or words such as “high risk” or “elevated risk”. A specific guideline-based score such as the revised cardiac risk index was not consistently available in this retrospective chart review. A noncardiology consult was deemed reasonable only if it would have been warranted for the specific clinical situation­—for example, a neurology consult for an acute stroke or a pulmonary consult for acute respiratory failure. Consult recommendations or outcomes were rated as minor, moderate, or major (see Table 1 for detailed criteria). Some consults may generate more than one recommendation, in these cases, we determined that a major recommendation supersedes a moderate or minor recommendation and only one was counted in the final analysis. Next we determined if a consult recommendation led to a change in perioperative or therapeutic management, defined as a medication or dosage change, need to delay surgery to stabilize an unstable medical condition, invasive procedures (such as thoracentesis or cardiac catheterization) or change in postoperative monitoring. As a way of clarification, a consult may have a minor recommendation such as an EKG but if no other recommendations were given and there was no change in therapeutic management such as a medication change, this would be considered as a “no change”.



An independent rating of the entire dataset was subsequently performed by another hospitalist (KM) to establish interrater reliability. This reviewer was blinded to the initial rating and not involved in the initial design of the study or the data collection process. Because of the labor-intensive task of reviewing full charts, we followed a nonstandard process for interrater reliability. This rating was performed with the same dataset that was extracted by three members of our team (NB, SS, and MK); consequently, this does not account for variability in chart extraction as reiterated in the discussion.

 

 

Statistical Analysis

The main analyses compared the two patient subgroups (with or without preoperative specialty consults) around outcome measures. Primary outcome measures were TTS, LOS, complications, and consult resulting in a change in perioperative management. Secondary outcome measures were 30-day readmit, return to OR, and mortality. A preliminary analysis was conducted to explore distributions for TTS and LOS. As expected, none met the assumptions of normality and were thus analyzed with Wilcoxon ranked-sum tests. The other outcomes were dichotomous and analyzed with chi-square tests of proportion or Fisher’s exact test when the expected cell frequencies were too low. Dichotomized variables for TTS (within 24 hours and 48 hours) and LOS (within five days, the median LOS for this cohort) were calculated and subsequently analyzed with additional chi-square tests of proportion or Fisher’s exact test13. To explore the effect of preoperative specialty consults independent of potential confounders, logistic regression analyses predicting each of the dichotomous outcomes were conducted with age and CCI used as predictors in addition to the main variable of whether or not there was a preoperative specialty consult. Since the CCI and ASA scores were highly intercorrelated, only the former was chosen for the multivariate analyses based on the consistent algorithm used to calculate CCI.

Additional analyses with the subgroup of patients with a preoperative specialty consult explored whether the consult was reasonable, the relative strength of resulting recommendation and whether it resulted in a change in management. The statistical approach used was the same as for the other dichotomous outcomes. All analyses used 0.05 as the level of statistical significance; SPSSv21 (IBM, Armonk, New York) was the statistical software used.

The sample size for this retrospective analysis was determined by the available number of patients meeting the inclusion criteria. An a priori power calculation was done to determine if the expected volume would be sufficient for the multivariate analysis; the presence of a complication was selected for calculation. Based on an expected volume of approximately 500 and an estimate of a 10% serious complication rate, it was determined that the sample could support the analysis of up to five predictor variables, sufficient for the main variable and four potential confounders; this was considered adequate.14 Propensity scoring was considered but did not offer any advantages to logistic regression because we only had two observed covariates: CCI and age.

RESULTS

A total of 491 unique patients met our inclusion criteria, 177 patients had a preoperative specialty consult. Of these 177 patients, 24 patients had more than one consult; hence, the total number of consults was 201. Most of the consults were cardiology (159). Others were Infectious disease (11), Pulmonology (10), Neurology (7), and Miscellaneous (14, which included Nephrology, Gastroenterology, Hematology, and Oncology).

No significant differences were found between the consult and no-consult groups with respect to gender, race, body mass index, type of anesthesia, and day of the week of surgery. We did note that patients with a consult were older and had a significantly higher CCI and ASA score (Table 2).



Initial analyses compared those with and without consults unadjusted for other factors with respect to TTS, LOS, 30-day readmission rate, 30-day return to OR rate, and 30-day mortality rate. The median TTS was 22.1 hours for the no-consult group compared with 34.3 hours for the consult group. The percentage of patients with TTS within 24 hours was higher (58.6% compared with 23.7%) and TTS within 48 hours was higher (90.1% compared to 76.8%) if there was no consult. The median LOS was five days for the no-consult group compared with six days for the consult group. There was no difference in complications between the two groups. Patients with consults were more likely to have a readmission (Table 3). No association was found between the type of consult (cardiology, pulmonary, etc.) and outcomes.


In the main analyses adjusted for potential confounders of age and CCI, consults were more likely to be independently associated with TTS beyond 24 hours, TTS beyond 48 hours, an extended LOS, and a higher 30-day readmission rate. CCI independently predicted a higher LOS, 30-day mortality rate, and serious complication rate. Similarly, age predicted 30-day mortality. Consults were not independently associated with 30-day mortality (Table 4).


Of the 177 patients with one or more consults, 163 (92%) were deemed reasonable. Of the patients, 129 (72.8%) had minor, 40 (22.6%) moderate, and 8 (4.5%) major recommendations as a result of the consultation. There was an identifiable change in perioperative management for 66 (37%) patients with consults. The independent review done for interrater reliability examined the entire dataset. This review demonstrated the following percent agreements: 99.4% for if the consult was indicated (kappa = 0.962), 97.7% for the consult outcome classification (minor, moderate, or major; kappa = 0.947), and 94.4% for if the intervention resulted in a change in management (kappa = 0.878).

While reviewing our subset of cardiology consults, we noted moderate or major recommendations from a cardiologist only in cases where an active cardiac condition was suspected by the hospitalist requesting the consult. Only eight patients in our study had major recommendations from a consult, of which, three underwent aortic valvuloplasty and one patient each underwent the following: pericardial window for tamponade, cholecystostomy tube placement to treat acute cholecystitis, thoracentesis, endoscopic retrograde cholangiopancreatography for obstructive jaundice, and inferior vena cava filter placement for acute pulmonary embolism. All these procedures were done prior to hip fracture repair. Interestingly, 42 out of the 177 patients in our consult group had a preoperative echocardiogram performed, with only three patients with critical aortic stenosis undergoing valvuloplasty preoperatively.

 

 

DISCUSSION

Patients with preoperative specialty consults were older and had more comorbidities than patients without consults. Our findings suggest that consults contribute to delays to surgery and may lead to higher LOS and higher risk of 30-day readmission after controlling for age and comorbidities in a multivariate analysis. This observation is significant considering that consults were requested more frequently on patients with a higher comorbidity burden and included patients who did not get additional preoperative testing, suggesting that a delay from waiting for a consult alone may be deleterious. This was a unique observation in our study; prior studies examining this subject have attributed delays to additional testing and not consults alone. Even though most consult requests appear to be reasonable according to our criteria, the majority of recommendations were minor (72.9%), and 62.7% of consults resulted in no change in perioperative management. Major changes in perioperative management were noted in only 4.5% of patients.

Our finding that a majority of patients in the consult group had no significant change in perioperative management raises an important area of potential improvement in the care of hip fracture patients. We believe that narrowing indications for preoperative specialty consults may result in shorter TTS and LOS for this group of frail elderly patients without sacrificing the quality of care. Since all patients in our study were comanaged by hospitalists and patients without additional consults had similar or better outcomes, we believe that hospitalist physicians are well positioned to provide standardized comanagement to this patient group without additional consultation unless absolutely necessary.

The primary limitation of our study was that this was a retrospective case analysis. The designation of minor, moderate, or major recommendation was done after the consults were already completed, and it may not be possible to predict that a consult results in no change without it being actually performed. Additionally, our classification of recommendations is somewhat arbitrary and subjective; for example, some readers might argue that a medication change counts as a moderate recommendation. We rated a medication change to be minor as we believe that an experienced hospitalist may likely make such management decisions on their own, and if this is the only recommendation from a consult, it is not additional information critical to patient care. There may also be an “unmeasured complexity” noted by the admitting physician, which was not necessarily accounted for by multivariate analysis of age and CCI but one that led to higher mortality and readmissions. However, we feel that this “unmeasured complexity” is likely inconsequential as the vast majority of consults did not result in any change in management. We did adjust for covariates as noted, but some confounding by indication is likely to remain. Additionally, categorization of consult recommendations and consequent changes by one physician could be considered subjective. We did control for this by having another physician review the entire dataset and rate it independently for interrater reliability with excellent correlation and kappa, although these may be inflated to some degree because our chart review did not account for variability among chart extractors.

A prospective evaluation of a clinical protocol that delineates reasonable indications for a preoperative consult would be helpful to validate our findings. In our study, we noted moderate or major recommendations from a cardiologist only in cases where an active cardiac condition was suspected by the hospitalist requesting the consult; hence, limiting preoperative cardiology consults to active cardiac conditions may be a reasonable approach to evaluate in a prospective study.

In conclusion, a majority of preoperative specialty consults do not appear to meaningfully influence management and may indirectly increase morbidity by delaying surgery and extending hospital stays. Our data suggest that unless the patient is clinically unstable and likely to require active management by a consultant prior to hip fracture repair, consults may offer limited benefit. Appropriately standardized perioperative management of this patient group by hospitalist physicians appears to manage most hip fracture patients as effectively with faster TTS and shorter hospital LOS.

 

 

Acknowledgments

The authors would like to thank John Corradi, PhD (Research Department at Hartford Hospital) for his input in calculating the Charlson comorbidity index.12,13

References

1. Youm T, Koval KJ, Zuckerman JD. The economic impact of geriatric hip fractures. Am J Orthop. 1999;28(7):423-428.
2. Cummings SR, Rubin SM, Black D. The future of hip fractures in the United States: numbers, costs, and potential effects of post-menopausal estrogen. Clin Orthop Relat Res. 1990;(252):163-166.z
3. Mitchell SM, Chung AS, Walker JB, Hustedt JW, Russell GV, Jones CB. Delay in hip fracture surgery prolongs postoperative hospital length of stay but does not adversely affect outcomes at 30 days. J Orthop Trauma. 2018;32(12):629-633. https://doi.org/10.1097/BOT.0000000000001306.
4. Sobolev B, Guy P, Sheehan KJ, et al. Mortality effects of timing alternatives for hip fracture surgery. CMAJ. 2018;190(31):E923-E932. https://doi.org/10.1503/cmaj.171512.
5. Pincus D, Ravi B, Wasserstein D, et al. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA. 2017;318(20):1994-2003. https://doi.org/10.1001/jama.2017.17606.
6. Fu MC, Boddapati V, Gausden EB, Samuel AM, Russell LA, Lane JM. Surgery for a fracture of the hip within 24 hours of admission is independently associated with reduced short-term post-operative complications. Bone Joint J. 2017;99-B(9):1216-1222. https://doi.org/10.1302/0301-620X.99B9.BJJ-2017-0101.R1.
7. Belmont PJ Jr, Garcia EJ, Romano D, Bader JO, Nelso KJ, Schoenfeld AJ. Risk factors for complications and in-hospital mortality following hip fractures: a study using the National Trauma Data Bank. Arch Orthop Trauma Surg. 2014;134(5):597-604. https://doi.org/10.1007/s00402-014-1959-y.
8. Ricci WM, Brandt A, McAndrew C, Gardner MJ. Factors affecting delay to surgery and length of stay for patients with hip fracture. J Orthop Trauma. 2015;29(3):e109-e114. https://doi.org/10.1097/BOT.0000000000000221.
9. Bernstein J, Roberts FO, Wiesel BB, Ahn J. Preoperative testing for hip fracture patients delays surgery, prolongs hospital stays, and rarely dictates care. J Orthop Trauma. 2016;30(2):78-80. https://doi.org/10.1097/BOT.0000000000000444.
10. Ricci WM, Della Rocca GJ, Combs C, Borrelli J. The medical and economic impact of preoperative cardiac testing in elderly patients with hip fractures. Injury. 2007;38(suppl 3):S49-S52. https://doi.org/10.1016/j.injury.2007.08.011.
11. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676-682. https://doi.org/10.1093/aje/kwq433.
12. Wasey JO. icd: Tools for working with ICD-9 and ICD-10 codes, and finding comorbidities. R package version 3.2.0. https://CRAN.R-project.org/package=icd. Published 2018. Accessed November 13, 2018.
13. Uitenbroek D. The Fisher exact test for 2*5 or smaller crosstable. Quantitativeskills.com. https://www.quantitativeskills.com/sisa/statistics/fiveby2.htm. Published 2019. Accessed November 13, 2018.
14. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373-1379. https://doi.org/10.1016/S0895-4356(96)00236-3.

Article PDF
Author and Disclosure Information

1University of Connecticut School of Medicine, Farmington, Connecticut; 2Hartford Healthcare Bone and Joint Institute, Hartford Hospital, Hartford, Connecticut; 3Department of Research Administration, Hartford Hospital, Hartford, Connecticut.

Disclosures

The ICMJE COI form was reviewed by all authors and they have nothing to disclose.

Issue
Journal of Hospital Medicine 15(1)
Topics
Page Number
16-21. Published online first August 21, 2019
Sections
Author and Disclosure Information

1University of Connecticut School of Medicine, Farmington, Connecticut; 2Hartford Healthcare Bone and Joint Institute, Hartford Hospital, Hartford, Connecticut; 3Department of Research Administration, Hartford Hospital, Hartford, Connecticut.

Disclosures

The ICMJE COI form was reviewed by all authors and they have nothing to disclose.

Author and Disclosure Information

1University of Connecticut School of Medicine, Farmington, Connecticut; 2Hartford Healthcare Bone and Joint Institute, Hartford Hospital, Hartford, Connecticut; 3Department of Research Administration, Hartford Hospital, Hartford, Connecticut.

Disclosures

The ICMJE COI form was reviewed by all authors and they have nothing to disclose.

Article PDF
Article PDF
Related Articles

Hip fractures in the elderly are associated with significant morbidity and mortality.1 These are typically fragility fractures since they are caused by mechanical forces that would ordinarily not result in a serious injury, such as a fall from or below standing level. The incidence of hip fractures in the United States is expected to increase as the population ages; estimates project 512,000 hip fractures with an associated cost of $16 billion annually by the year 2040.2 Timely surgery is recommended for hip fracture patients as delayed surgery beyond 24 to 48 hours of presentation is associated with increased morbidity and mortality.3-6 Time to surgery (TTS) has been shown to be the major potentially modifiable risk factor in the management of a hip fracture.7

Factors that have been noted to influence TTS include the American Society of Anesthesiologists’ (ASA) score, the day of the week of hospital admission, and preoperative testing.8,9 Preoperative cardiology consultation and subsequent cardiac testing, in particular, can increase the TTS and length of stay (LOS) without changing perioperative management.9,10 In our review of literature, we could not identify any studies specifically looking at the impact of preoperative specialty consults on short-term mortality or comparison of care provided by hospitalists alone versus additionally involving subspecialists such as cardiologists. To our knowledge, there are no studies that have categorized recommendations from a preoperative specialty consult as minor, moderate, or major.

Our study evaluated whether preoperative specialty consults meaningfully change management and influence outcomes for hip fracture patients. At our institution, all hip fracture patients are admitted to the hospitalist service and comanaged with the orthopedic team. The hospitalist physician performs the preoperative evaluation as part of the admission history and physical exam. Preoperative specialty consult(s), if needed, are requested only by the hospitalist team. A consultant such as a cardiologist provides input; however, final management decisions are coordinated by the hospitalist physician.

METHODS

Study Design

We performed a retrospective cohort study of patients aged 50 years and older who underwent surgery for an isolated fragility fracture of the hip at Hartford Hospital, a level one trauma and tertiary care medical center, within the 24-month period from April 2015 to March 2017. Fragility hip fracture is defined as one occurring from a fall of a height of standing or less. A consult referred to a specialty or subspecialty consultation, other than hospital medicine, obtained prior to surgery. Patients with additional skeletal trauma and periprosthetic fractures were excluded. A total of 491 unique patients met the inclusion criteria, and data were obtained from chart review and an orthopedic surgery registry. The Hartford Hospital Institutional Review Board approved this study.

 

 

Our primary predictor was the presence or absence of a preoperative specialty consultation requested by the hospitalist. We also analyzed the following: covariates of demographics (age, sex, race), the ASA score, and severity of comorbidities using the Charlson comorbidity index (CCI) with a Quan modification;11 “R program package, International Classification of Disease (ICD)”12 was used to calculate the CCI using ICD-9 and ICD-10 diagnostic codes.

The primary outcome measures were TTS (measured in hours), LOS (measured in days), complications, and preoperative specialty consult resulting in a change in perioperative management. TTS was defined as the time elapsed from the presentation at the emergency department (ED) to surgery start. For transfer or direct admission patients, the time of admission was used in place of time of presentation. The measured complications included postoperative venous thromboembolic events, surgical site infection, myocardial infarction, stroke, and sepsis. Secondary outcome measures included 30-day mortality, readmission rate, and rate of return to OR. There were no elective or planned readmissions postoperatively on review of our institution’s orthopedic surgery registry.

Our team performed an extensive chart review including reviewing the admission note, consulting physician notes, and relevant test results. Our senior investigator (MK) then rated each preoperative specialty consult on appropriateness, the relative strength of the consultant’s recommendation, and resulting change in perioperative management. Cardiology consultations were deemed reasonable if a patient’s cardiac risk was considered elevated by the admitting physician or an active cardiac condition was present (suggestion of or clear evidence for acute coronary syndrome, acute congestive heart failure, uncontrolled arrhythmia, or symptomatic valvular disease). The determination of “elevated cardiac risk” was made, if admit note contained verbiage expressing concern for further evaluation for cardiac issues or words such as “high risk” or “elevated risk”. A specific guideline-based score such as the revised cardiac risk index was not consistently available in this retrospective chart review. A noncardiology consult was deemed reasonable only if it would have been warranted for the specific clinical situation­—for example, a neurology consult for an acute stroke or a pulmonary consult for acute respiratory failure. Consult recommendations or outcomes were rated as minor, moderate, or major (see Table 1 for detailed criteria). Some consults may generate more than one recommendation, in these cases, we determined that a major recommendation supersedes a moderate or minor recommendation and only one was counted in the final analysis. Next we determined if a consult recommendation led to a change in perioperative or therapeutic management, defined as a medication or dosage change, need to delay surgery to stabilize an unstable medical condition, invasive procedures (such as thoracentesis or cardiac catheterization) or change in postoperative monitoring. As a way of clarification, a consult may have a minor recommendation such as an EKG but if no other recommendations were given and there was no change in therapeutic management such as a medication change, this would be considered as a “no change”.



An independent rating of the entire dataset was subsequently performed by another hospitalist (KM) to establish interrater reliability. This reviewer was blinded to the initial rating and not involved in the initial design of the study or the data collection process. Because of the labor-intensive task of reviewing full charts, we followed a nonstandard process for interrater reliability. This rating was performed with the same dataset that was extracted by three members of our team (NB, SS, and MK); consequently, this does not account for variability in chart extraction as reiterated in the discussion.

 

 

Statistical Analysis

The main analyses compared the two patient subgroups (with or without preoperative specialty consults) around outcome measures. Primary outcome measures were TTS, LOS, complications, and consult resulting in a change in perioperative management. Secondary outcome measures were 30-day readmit, return to OR, and mortality. A preliminary analysis was conducted to explore distributions for TTS and LOS. As expected, none met the assumptions of normality and were thus analyzed with Wilcoxon ranked-sum tests. The other outcomes were dichotomous and analyzed with chi-square tests of proportion or Fisher’s exact test when the expected cell frequencies were too low. Dichotomized variables for TTS (within 24 hours and 48 hours) and LOS (within five days, the median LOS for this cohort) were calculated and subsequently analyzed with additional chi-square tests of proportion or Fisher’s exact test13. To explore the effect of preoperative specialty consults independent of potential confounders, logistic regression analyses predicting each of the dichotomous outcomes were conducted with age and CCI used as predictors in addition to the main variable of whether or not there was a preoperative specialty consult. Since the CCI and ASA scores were highly intercorrelated, only the former was chosen for the multivariate analyses based on the consistent algorithm used to calculate CCI.

Additional analyses with the subgroup of patients with a preoperative specialty consult explored whether the consult was reasonable, the relative strength of resulting recommendation and whether it resulted in a change in management. The statistical approach used was the same as for the other dichotomous outcomes. All analyses used 0.05 as the level of statistical significance; SPSSv21 (IBM, Armonk, New York) was the statistical software used.

The sample size for this retrospective analysis was determined by the available number of patients meeting the inclusion criteria. An a priori power calculation was done to determine if the expected volume would be sufficient for the multivariate analysis; the presence of a complication was selected for calculation. Based on an expected volume of approximately 500 and an estimate of a 10% serious complication rate, it was determined that the sample could support the analysis of up to five predictor variables, sufficient for the main variable and four potential confounders; this was considered adequate.14 Propensity scoring was considered but did not offer any advantages to logistic regression because we only had two observed covariates: CCI and age.

RESULTS

A total of 491 unique patients met our inclusion criteria, 177 patients had a preoperative specialty consult. Of these 177 patients, 24 patients had more than one consult; hence, the total number of consults was 201. Most of the consults were cardiology (159). Others were Infectious disease (11), Pulmonology (10), Neurology (7), and Miscellaneous (14, which included Nephrology, Gastroenterology, Hematology, and Oncology).

No significant differences were found between the consult and no-consult groups with respect to gender, race, body mass index, type of anesthesia, and day of the week of surgery. We did note that patients with a consult were older and had a significantly higher CCI and ASA score (Table 2).



Initial analyses compared those with and without consults unadjusted for other factors with respect to TTS, LOS, 30-day readmission rate, 30-day return to OR rate, and 30-day mortality rate. The median TTS was 22.1 hours for the no-consult group compared with 34.3 hours for the consult group. The percentage of patients with TTS within 24 hours was higher (58.6% compared with 23.7%) and TTS within 48 hours was higher (90.1% compared to 76.8%) if there was no consult. The median LOS was five days for the no-consult group compared with six days for the consult group. There was no difference in complications between the two groups. Patients with consults were more likely to have a readmission (Table 3). No association was found between the type of consult (cardiology, pulmonary, etc.) and outcomes.


In the main analyses adjusted for potential confounders of age and CCI, consults were more likely to be independently associated with TTS beyond 24 hours, TTS beyond 48 hours, an extended LOS, and a higher 30-day readmission rate. CCI independently predicted a higher LOS, 30-day mortality rate, and serious complication rate. Similarly, age predicted 30-day mortality. Consults were not independently associated with 30-day mortality (Table 4).


Of the 177 patients with one or more consults, 163 (92%) were deemed reasonable. Of the patients, 129 (72.8%) had minor, 40 (22.6%) moderate, and 8 (4.5%) major recommendations as a result of the consultation. There was an identifiable change in perioperative management for 66 (37%) patients with consults. The independent review done for interrater reliability examined the entire dataset. This review demonstrated the following percent agreements: 99.4% for if the consult was indicated (kappa = 0.962), 97.7% for the consult outcome classification (minor, moderate, or major; kappa = 0.947), and 94.4% for if the intervention resulted in a change in management (kappa = 0.878).

While reviewing our subset of cardiology consults, we noted moderate or major recommendations from a cardiologist only in cases where an active cardiac condition was suspected by the hospitalist requesting the consult. Only eight patients in our study had major recommendations from a consult, of which, three underwent aortic valvuloplasty and one patient each underwent the following: pericardial window for tamponade, cholecystostomy tube placement to treat acute cholecystitis, thoracentesis, endoscopic retrograde cholangiopancreatography for obstructive jaundice, and inferior vena cava filter placement for acute pulmonary embolism. All these procedures were done prior to hip fracture repair. Interestingly, 42 out of the 177 patients in our consult group had a preoperative echocardiogram performed, with only three patients with critical aortic stenosis undergoing valvuloplasty preoperatively.

 

 

DISCUSSION

Patients with preoperative specialty consults were older and had more comorbidities than patients without consults. Our findings suggest that consults contribute to delays to surgery and may lead to higher LOS and higher risk of 30-day readmission after controlling for age and comorbidities in a multivariate analysis. This observation is significant considering that consults were requested more frequently on patients with a higher comorbidity burden and included patients who did not get additional preoperative testing, suggesting that a delay from waiting for a consult alone may be deleterious. This was a unique observation in our study; prior studies examining this subject have attributed delays to additional testing and not consults alone. Even though most consult requests appear to be reasonable according to our criteria, the majority of recommendations were minor (72.9%), and 62.7% of consults resulted in no change in perioperative management. Major changes in perioperative management were noted in only 4.5% of patients.

Our finding that a majority of patients in the consult group had no significant change in perioperative management raises an important area of potential improvement in the care of hip fracture patients. We believe that narrowing indications for preoperative specialty consults may result in shorter TTS and LOS for this group of frail elderly patients without sacrificing the quality of care. Since all patients in our study were comanaged by hospitalists and patients without additional consults had similar or better outcomes, we believe that hospitalist physicians are well positioned to provide standardized comanagement to this patient group without additional consultation unless absolutely necessary.

The primary limitation of our study was that this was a retrospective case analysis. The designation of minor, moderate, or major recommendation was done after the consults were already completed, and it may not be possible to predict that a consult results in no change without it being actually performed. Additionally, our classification of recommendations is somewhat arbitrary and subjective; for example, some readers might argue that a medication change counts as a moderate recommendation. We rated a medication change to be minor as we believe that an experienced hospitalist may likely make such management decisions on their own, and if this is the only recommendation from a consult, it is not additional information critical to patient care. There may also be an “unmeasured complexity” noted by the admitting physician, which was not necessarily accounted for by multivariate analysis of age and CCI but one that led to higher mortality and readmissions. However, we feel that this “unmeasured complexity” is likely inconsequential as the vast majority of consults did not result in any change in management. We did adjust for covariates as noted, but some confounding by indication is likely to remain. Additionally, categorization of consult recommendations and consequent changes by one physician could be considered subjective. We did control for this by having another physician review the entire dataset and rate it independently for interrater reliability with excellent correlation and kappa, although these may be inflated to some degree because our chart review did not account for variability among chart extractors.

A prospective evaluation of a clinical protocol that delineates reasonable indications for a preoperative consult would be helpful to validate our findings. In our study, we noted moderate or major recommendations from a cardiologist only in cases where an active cardiac condition was suspected by the hospitalist requesting the consult; hence, limiting preoperative cardiology consults to active cardiac conditions may be a reasonable approach to evaluate in a prospective study.

In conclusion, a majority of preoperative specialty consults do not appear to meaningfully influence management and may indirectly increase morbidity by delaying surgery and extending hospital stays. Our data suggest that unless the patient is clinically unstable and likely to require active management by a consultant prior to hip fracture repair, consults may offer limited benefit. Appropriately standardized perioperative management of this patient group by hospitalist physicians appears to manage most hip fracture patients as effectively with faster TTS and shorter hospital LOS.

 

 

Acknowledgments

The authors would like to thank John Corradi, PhD (Research Department at Hartford Hospital) for his input in calculating the Charlson comorbidity index.12,13

Hip fractures in the elderly are associated with significant morbidity and mortality.1 These are typically fragility fractures since they are caused by mechanical forces that would ordinarily not result in a serious injury, such as a fall from or below standing level. The incidence of hip fractures in the United States is expected to increase as the population ages; estimates project 512,000 hip fractures with an associated cost of $16 billion annually by the year 2040.2 Timely surgery is recommended for hip fracture patients as delayed surgery beyond 24 to 48 hours of presentation is associated with increased morbidity and mortality.3-6 Time to surgery (TTS) has been shown to be the major potentially modifiable risk factor in the management of a hip fracture.7

Factors that have been noted to influence TTS include the American Society of Anesthesiologists’ (ASA) score, the day of the week of hospital admission, and preoperative testing.8,9 Preoperative cardiology consultation and subsequent cardiac testing, in particular, can increase the TTS and length of stay (LOS) without changing perioperative management.9,10 In our review of literature, we could not identify any studies specifically looking at the impact of preoperative specialty consults on short-term mortality or comparison of care provided by hospitalists alone versus additionally involving subspecialists such as cardiologists. To our knowledge, there are no studies that have categorized recommendations from a preoperative specialty consult as minor, moderate, or major.

Our study evaluated whether preoperative specialty consults meaningfully change management and influence outcomes for hip fracture patients. At our institution, all hip fracture patients are admitted to the hospitalist service and comanaged with the orthopedic team. The hospitalist physician performs the preoperative evaluation as part of the admission history and physical exam. Preoperative specialty consult(s), if needed, are requested only by the hospitalist team. A consultant such as a cardiologist provides input; however, final management decisions are coordinated by the hospitalist physician.

METHODS

Study Design

We performed a retrospective cohort study of patients aged 50 years and older who underwent surgery for an isolated fragility fracture of the hip at Hartford Hospital, a level one trauma and tertiary care medical center, within the 24-month period from April 2015 to March 2017. Fragility hip fracture is defined as one occurring from a fall of a height of standing or less. A consult referred to a specialty or subspecialty consultation, other than hospital medicine, obtained prior to surgery. Patients with additional skeletal trauma and periprosthetic fractures were excluded. A total of 491 unique patients met the inclusion criteria, and data were obtained from chart review and an orthopedic surgery registry. The Hartford Hospital Institutional Review Board approved this study.

 

 

Our primary predictor was the presence or absence of a preoperative specialty consultation requested by the hospitalist. We also analyzed the following: covariates of demographics (age, sex, race), the ASA score, and severity of comorbidities using the Charlson comorbidity index (CCI) with a Quan modification;11 “R program package, International Classification of Disease (ICD)”12 was used to calculate the CCI using ICD-9 and ICD-10 diagnostic codes.

The primary outcome measures were TTS (measured in hours), LOS (measured in days), complications, and preoperative specialty consult resulting in a change in perioperative management. TTS was defined as the time elapsed from the presentation at the emergency department (ED) to surgery start. For transfer or direct admission patients, the time of admission was used in place of time of presentation. The measured complications included postoperative venous thromboembolic events, surgical site infection, myocardial infarction, stroke, and sepsis. Secondary outcome measures included 30-day mortality, readmission rate, and rate of return to OR. There were no elective or planned readmissions postoperatively on review of our institution’s orthopedic surgery registry.

Our team performed an extensive chart review including reviewing the admission note, consulting physician notes, and relevant test results. Our senior investigator (MK) then rated each preoperative specialty consult on appropriateness, the relative strength of the consultant’s recommendation, and resulting change in perioperative management. Cardiology consultations were deemed reasonable if a patient’s cardiac risk was considered elevated by the admitting physician or an active cardiac condition was present (suggestion of or clear evidence for acute coronary syndrome, acute congestive heart failure, uncontrolled arrhythmia, or symptomatic valvular disease). The determination of “elevated cardiac risk” was made, if admit note contained verbiage expressing concern for further evaluation for cardiac issues or words such as “high risk” or “elevated risk”. A specific guideline-based score such as the revised cardiac risk index was not consistently available in this retrospective chart review. A noncardiology consult was deemed reasonable only if it would have been warranted for the specific clinical situation­—for example, a neurology consult for an acute stroke or a pulmonary consult for acute respiratory failure. Consult recommendations or outcomes were rated as minor, moderate, or major (see Table 1 for detailed criteria). Some consults may generate more than one recommendation, in these cases, we determined that a major recommendation supersedes a moderate or minor recommendation and only one was counted in the final analysis. Next we determined if a consult recommendation led to a change in perioperative or therapeutic management, defined as a medication or dosage change, need to delay surgery to stabilize an unstable medical condition, invasive procedures (such as thoracentesis or cardiac catheterization) or change in postoperative monitoring. As a way of clarification, a consult may have a minor recommendation such as an EKG but if no other recommendations were given and there was no change in therapeutic management such as a medication change, this would be considered as a “no change”.



An independent rating of the entire dataset was subsequently performed by another hospitalist (KM) to establish interrater reliability. This reviewer was blinded to the initial rating and not involved in the initial design of the study or the data collection process. Because of the labor-intensive task of reviewing full charts, we followed a nonstandard process for interrater reliability. This rating was performed with the same dataset that was extracted by three members of our team (NB, SS, and MK); consequently, this does not account for variability in chart extraction as reiterated in the discussion.

 

 

Statistical Analysis

The main analyses compared the two patient subgroups (with or without preoperative specialty consults) around outcome measures. Primary outcome measures were TTS, LOS, complications, and consult resulting in a change in perioperative management. Secondary outcome measures were 30-day readmit, return to OR, and mortality. A preliminary analysis was conducted to explore distributions for TTS and LOS. As expected, none met the assumptions of normality and were thus analyzed with Wilcoxon ranked-sum tests. The other outcomes were dichotomous and analyzed with chi-square tests of proportion or Fisher’s exact test when the expected cell frequencies were too low. Dichotomized variables for TTS (within 24 hours and 48 hours) and LOS (within five days, the median LOS for this cohort) were calculated and subsequently analyzed with additional chi-square tests of proportion or Fisher’s exact test13. To explore the effect of preoperative specialty consults independent of potential confounders, logistic regression analyses predicting each of the dichotomous outcomes were conducted with age and CCI used as predictors in addition to the main variable of whether or not there was a preoperative specialty consult. Since the CCI and ASA scores were highly intercorrelated, only the former was chosen for the multivariate analyses based on the consistent algorithm used to calculate CCI.

Additional analyses with the subgroup of patients with a preoperative specialty consult explored whether the consult was reasonable, the relative strength of resulting recommendation and whether it resulted in a change in management. The statistical approach used was the same as for the other dichotomous outcomes. All analyses used 0.05 as the level of statistical significance; SPSSv21 (IBM, Armonk, New York) was the statistical software used.

The sample size for this retrospective analysis was determined by the available number of patients meeting the inclusion criteria. An a priori power calculation was done to determine if the expected volume would be sufficient for the multivariate analysis; the presence of a complication was selected for calculation. Based on an expected volume of approximately 500 and an estimate of a 10% serious complication rate, it was determined that the sample could support the analysis of up to five predictor variables, sufficient for the main variable and four potential confounders; this was considered adequate.14 Propensity scoring was considered but did not offer any advantages to logistic regression because we only had two observed covariates: CCI and age.

RESULTS

A total of 491 unique patients met our inclusion criteria, 177 patients had a preoperative specialty consult. Of these 177 patients, 24 patients had more than one consult; hence, the total number of consults was 201. Most of the consults were cardiology (159). Others were Infectious disease (11), Pulmonology (10), Neurology (7), and Miscellaneous (14, which included Nephrology, Gastroenterology, Hematology, and Oncology).

No significant differences were found between the consult and no-consult groups with respect to gender, race, body mass index, type of anesthesia, and day of the week of surgery. We did note that patients with a consult were older and had a significantly higher CCI and ASA score (Table 2).



Initial analyses compared those with and without consults unadjusted for other factors with respect to TTS, LOS, 30-day readmission rate, 30-day return to OR rate, and 30-day mortality rate. The median TTS was 22.1 hours for the no-consult group compared with 34.3 hours for the consult group. The percentage of patients with TTS within 24 hours was higher (58.6% compared with 23.7%) and TTS within 48 hours was higher (90.1% compared to 76.8%) if there was no consult. The median LOS was five days for the no-consult group compared with six days for the consult group. There was no difference in complications between the two groups. Patients with consults were more likely to have a readmission (Table 3). No association was found between the type of consult (cardiology, pulmonary, etc.) and outcomes.


In the main analyses adjusted for potential confounders of age and CCI, consults were more likely to be independently associated with TTS beyond 24 hours, TTS beyond 48 hours, an extended LOS, and a higher 30-day readmission rate. CCI independently predicted a higher LOS, 30-day mortality rate, and serious complication rate. Similarly, age predicted 30-day mortality. Consults were not independently associated with 30-day mortality (Table 4).


Of the 177 patients with one or more consults, 163 (92%) were deemed reasonable. Of the patients, 129 (72.8%) had minor, 40 (22.6%) moderate, and 8 (4.5%) major recommendations as a result of the consultation. There was an identifiable change in perioperative management for 66 (37%) patients with consults. The independent review done for interrater reliability examined the entire dataset. This review demonstrated the following percent agreements: 99.4% for if the consult was indicated (kappa = 0.962), 97.7% for the consult outcome classification (minor, moderate, or major; kappa = 0.947), and 94.4% for if the intervention resulted in a change in management (kappa = 0.878).

While reviewing our subset of cardiology consults, we noted moderate or major recommendations from a cardiologist only in cases where an active cardiac condition was suspected by the hospitalist requesting the consult. Only eight patients in our study had major recommendations from a consult, of which, three underwent aortic valvuloplasty and one patient each underwent the following: pericardial window for tamponade, cholecystostomy tube placement to treat acute cholecystitis, thoracentesis, endoscopic retrograde cholangiopancreatography for obstructive jaundice, and inferior vena cava filter placement for acute pulmonary embolism. All these procedures were done prior to hip fracture repair. Interestingly, 42 out of the 177 patients in our consult group had a preoperative echocardiogram performed, with only three patients with critical aortic stenosis undergoing valvuloplasty preoperatively.

 

 

DISCUSSION

Patients with preoperative specialty consults were older and had more comorbidities than patients without consults. Our findings suggest that consults contribute to delays to surgery and may lead to higher LOS and higher risk of 30-day readmission after controlling for age and comorbidities in a multivariate analysis. This observation is significant considering that consults were requested more frequently on patients with a higher comorbidity burden and included patients who did not get additional preoperative testing, suggesting that a delay from waiting for a consult alone may be deleterious. This was a unique observation in our study; prior studies examining this subject have attributed delays to additional testing and not consults alone. Even though most consult requests appear to be reasonable according to our criteria, the majority of recommendations were minor (72.9%), and 62.7% of consults resulted in no change in perioperative management. Major changes in perioperative management were noted in only 4.5% of patients.

Our finding that a majority of patients in the consult group had no significant change in perioperative management raises an important area of potential improvement in the care of hip fracture patients. We believe that narrowing indications for preoperative specialty consults may result in shorter TTS and LOS for this group of frail elderly patients without sacrificing the quality of care. Since all patients in our study were comanaged by hospitalists and patients without additional consults had similar or better outcomes, we believe that hospitalist physicians are well positioned to provide standardized comanagement to this patient group without additional consultation unless absolutely necessary.

The primary limitation of our study was that this was a retrospective case analysis. The designation of minor, moderate, or major recommendation was done after the consults were already completed, and it may not be possible to predict that a consult results in no change without it being actually performed. Additionally, our classification of recommendations is somewhat arbitrary and subjective; for example, some readers might argue that a medication change counts as a moderate recommendation. We rated a medication change to be minor as we believe that an experienced hospitalist may likely make such management decisions on their own, and if this is the only recommendation from a consult, it is not additional information critical to patient care. There may also be an “unmeasured complexity” noted by the admitting physician, which was not necessarily accounted for by multivariate analysis of age and CCI but one that led to higher mortality and readmissions. However, we feel that this “unmeasured complexity” is likely inconsequential as the vast majority of consults did not result in any change in management. We did adjust for covariates as noted, but some confounding by indication is likely to remain. Additionally, categorization of consult recommendations and consequent changes by one physician could be considered subjective. We did control for this by having another physician review the entire dataset and rate it independently for interrater reliability with excellent correlation and kappa, although these may be inflated to some degree because our chart review did not account for variability among chart extractors.

A prospective evaluation of a clinical protocol that delineates reasonable indications for a preoperative consult would be helpful to validate our findings. In our study, we noted moderate or major recommendations from a cardiologist only in cases where an active cardiac condition was suspected by the hospitalist requesting the consult; hence, limiting preoperative cardiology consults to active cardiac conditions may be a reasonable approach to evaluate in a prospective study.

In conclusion, a majority of preoperative specialty consults do not appear to meaningfully influence management and may indirectly increase morbidity by delaying surgery and extending hospital stays. Our data suggest that unless the patient is clinically unstable and likely to require active management by a consultant prior to hip fracture repair, consults may offer limited benefit. Appropriately standardized perioperative management of this patient group by hospitalist physicians appears to manage most hip fracture patients as effectively with faster TTS and shorter hospital LOS.

 

 

Acknowledgments

The authors would like to thank John Corradi, PhD (Research Department at Hartford Hospital) for his input in calculating the Charlson comorbidity index.12,13

References

1. Youm T, Koval KJ, Zuckerman JD. The economic impact of geriatric hip fractures. Am J Orthop. 1999;28(7):423-428.
2. Cummings SR, Rubin SM, Black D. The future of hip fractures in the United States: numbers, costs, and potential effects of post-menopausal estrogen. Clin Orthop Relat Res. 1990;(252):163-166.z
3. Mitchell SM, Chung AS, Walker JB, Hustedt JW, Russell GV, Jones CB. Delay in hip fracture surgery prolongs postoperative hospital length of stay but does not adversely affect outcomes at 30 days. J Orthop Trauma. 2018;32(12):629-633. https://doi.org/10.1097/BOT.0000000000001306.
4. Sobolev B, Guy P, Sheehan KJ, et al. Mortality effects of timing alternatives for hip fracture surgery. CMAJ. 2018;190(31):E923-E932. https://doi.org/10.1503/cmaj.171512.
5. Pincus D, Ravi B, Wasserstein D, et al. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA. 2017;318(20):1994-2003. https://doi.org/10.1001/jama.2017.17606.
6. Fu MC, Boddapati V, Gausden EB, Samuel AM, Russell LA, Lane JM. Surgery for a fracture of the hip within 24 hours of admission is independently associated with reduced short-term post-operative complications. Bone Joint J. 2017;99-B(9):1216-1222. https://doi.org/10.1302/0301-620X.99B9.BJJ-2017-0101.R1.
7. Belmont PJ Jr, Garcia EJ, Romano D, Bader JO, Nelso KJ, Schoenfeld AJ. Risk factors for complications and in-hospital mortality following hip fractures: a study using the National Trauma Data Bank. Arch Orthop Trauma Surg. 2014;134(5):597-604. https://doi.org/10.1007/s00402-014-1959-y.
8. Ricci WM, Brandt A, McAndrew C, Gardner MJ. Factors affecting delay to surgery and length of stay for patients with hip fracture. J Orthop Trauma. 2015;29(3):e109-e114. https://doi.org/10.1097/BOT.0000000000000221.
9. Bernstein J, Roberts FO, Wiesel BB, Ahn J. Preoperative testing for hip fracture patients delays surgery, prolongs hospital stays, and rarely dictates care. J Orthop Trauma. 2016;30(2):78-80. https://doi.org/10.1097/BOT.0000000000000444.
10. Ricci WM, Della Rocca GJ, Combs C, Borrelli J. The medical and economic impact of preoperative cardiac testing in elderly patients with hip fractures. Injury. 2007;38(suppl 3):S49-S52. https://doi.org/10.1016/j.injury.2007.08.011.
11. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676-682. https://doi.org/10.1093/aje/kwq433.
12. Wasey JO. icd: Tools for working with ICD-9 and ICD-10 codes, and finding comorbidities. R package version 3.2.0. https://CRAN.R-project.org/package=icd. Published 2018. Accessed November 13, 2018.
13. Uitenbroek D. The Fisher exact test for 2*5 or smaller crosstable. Quantitativeskills.com. https://www.quantitativeskills.com/sisa/statistics/fiveby2.htm. Published 2019. Accessed November 13, 2018.
14. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373-1379. https://doi.org/10.1016/S0895-4356(96)00236-3.

References

1. Youm T, Koval KJ, Zuckerman JD. The economic impact of geriatric hip fractures. Am J Orthop. 1999;28(7):423-428.
2. Cummings SR, Rubin SM, Black D. The future of hip fractures in the United States: numbers, costs, and potential effects of post-menopausal estrogen. Clin Orthop Relat Res. 1990;(252):163-166.z
3. Mitchell SM, Chung AS, Walker JB, Hustedt JW, Russell GV, Jones CB. Delay in hip fracture surgery prolongs postoperative hospital length of stay but does not adversely affect outcomes at 30 days. J Orthop Trauma. 2018;32(12):629-633. https://doi.org/10.1097/BOT.0000000000001306.
4. Sobolev B, Guy P, Sheehan KJ, et al. Mortality effects of timing alternatives for hip fracture surgery. CMAJ. 2018;190(31):E923-E932. https://doi.org/10.1503/cmaj.171512.
5. Pincus D, Ravi B, Wasserstein D, et al. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA. 2017;318(20):1994-2003. https://doi.org/10.1001/jama.2017.17606.
6. Fu MC, Boddapati V, Gausden EB, Samuel AM, Russell LA, Lane JM. Surgery for a fracture of the hip within 24 hours of admission is independently associated with reduced short-term post-operative complications. Bone Joint J. 2017;99-B(9):1216-1222. https://doi.org/10.1302/0301-620X.99B9.BJJ-2017-0101.R1.
7. Belmont PJ Jr, Garcia EJ, Romano D, Bader JO, Nelso KJ, Schoenfeld AJ. Risk factors for complications and in-hospital mortality following hip fractures: a study using the National Trauma Data Bank. Arch Orthop Trauma Surg. 2014;134(5):597-604. https://doi.org/10.1007/s00402-014-1959-y.
8. Ricci WM, Brandt A, McAndrew C, Gardner MJ. Factors affecting delay to surgery and length of stay for patients with hip fracture. J Orthop Trauma. 2015;29(3):e109-e114. https://doi.org/10.1097/BOT.0000000000000221.
9. Bernstein J, Roberts FO, Wiesel BB, Ahn J. Preoperative testing for hip fracture patients delays surgery, prolongs hospital stays, and rarely dictates care. J Orthop Trauma. 2016;30(2):78-80. https://doi.org/10.1097/BOT.0000000000000444.
10. Ricci WM, Della Rocca GJ, Combs C, Borrelli J. The medical and economic impact of preoperative cardiac testing in elderly patients with hip fractures. Injury. 2007;38(suppl 3):S49-S52. https://doi.org/10.1016/j.injury.2007.08.011.
11. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676-682. https://doi.org/10.1093/aje/kwq433.
12. Wasey JO. icd: Tools for working with ICD-9 and ICD-10 codes, and finding comorbidities. R package version 3.2.0. https://CRAN.R-project.org/package=icd. Published 2018. Accessed November 13, 2018.
13. Uitenbroek D. The Fisher exact test for 2*5 or smaller crosstable. Quantitativeskills.com. https://www.quantitativeskills.com/sisa/statistics/fiveby2.htm. Published 2019. Accessed November 13, 2018.
14. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373-1379. https://doi.org/10.1016/S0895-4356(96)00236-3.

Issue
Journal of Hospital Medicine 15(1)
Issue
Journal of Hospital Medicine 15(1)
Page Number
16-21. Published online first August 21, 2019
Page Number
16-21. Published online first August 21, 2019
Topics
Article Type
Sections
Article Source

© 2020 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Mandeep Kumar, MD; E-mail: [email protected]; Telephone: 860-972-0549
Content Gating
Gated (full article locked unless allowed per User)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Gating Strategy
First Peek Free
Medscape Article
Display survey writer
Reuters content
Article PDF Media

Community Pediatric Hospitalist Workload: Results from a National Survey

Article Type
Changed
Wed, 10/30/2019 - 13:52

As a newly recognized specialty, pediatric hospital medicine (PHM) continues to expand and diversify.1 Pediatric hospitalists care for children in hospitals ranging from small, rural community hospitals to large, free-standing quaternary children’s hospitals.2-4 In addition, more than 10% of graduating pediatric residents are seeking future careers within PHM.5

In 2018, Fromme et al. published a study describing clinical workload for pediatric hospitalists within university-based settings.6 They characterized the diversity of work models and programmatic sustainability but limited the study to university-based programs. With over half of children receiving care within community hospitals,7 workforce patterns for community-based pediatric hospitalists should be characterized to maximize sustainability and minimize attrition across the field.

In this study, we describe programmatic variability in clinical work expectations of 70 community-based PHM programs. We aimed to describe existing work models and expectations of community-based program leaders as they relate to their unique clinical setting.

METHODS

We conducted a cross-sectional survey of community-based PHM site directors through structured interviews. Community hospital programs were self-defined by the study participants, although typically defined as general hospitals that admit pediatric patients and are not free-standing or children’s hospitals within a general hospital. Survey respondents were asked to answer questions only reflecting expectations at their community hospital.

Survey Design and Content

Building from a tool used by Fromme et al.6 we created a 12-question structured interview questionnaire focused on three areas: (1) full-time employment (FTE) metrics including definitions of a 1.0 FTE, “typical” shifts, and weekend responsibilities; (2) work volume including census parameters, service-line coverage expectations, back-up systems, and overnight call responsibilities; and (3) programmatic model including sense of sustainability (eg, minimizing burnout and attrition), support for activities such as administrative or research time, and employer model (Appendix).

We modified the survey through research team consensus. After pilot-testing by research team members at their own sites, the survey was refined for item clarity, structural design, and length. We chose to administer surveys through phone interviews over a traditional distribution due to anticipated variability in work models. The research team discussed how each question should be asked, and responses were clarified to maintain consistency.

 

 

Survey Administration

Given the absence of a national registry or database for community-based PHM programs, study participation was solicited through an invitation posted on the American Academy of Pediatrics Section on Hospital Medicine (AAP SOHM) Listserv and the AAP SOHM Community Hospitalist Listserv in May 2018. Invitations were posted twice at two weeks apart. Each research team member completed 6-19 interviews. Responses to survey questions were recorded in REDCap, a secure, web-based data capture instrument.8

Participating in the study was considered implied consent, and participants did not receive a monetary incentive, although respondents were offered deidentified survey data for participation. The study was exempted through the University of Chicago Institutional Review Board.

Data Analysis

Employers were dichotomized as community hospital employer (including primary community hospital employment/private organization) or noncommunity hospital employer (including children’s/university hospital employment or school of medicine). Descriptive statistics were reported to compare the demographics of two employer groups. P values were calculated using two-sample t-tests for the continuous variables and chi-square or Fisher-exact tests for the categorical variables. Mann–Whitney U-test was performed for continuous variables without normality. Analyses were performed using the R Statistical Programming Language (R Foundation for Statistical Computing, Vienna, Austria), version 3.4.3.

RESULTS

Participation and Program Characteristics

We interviewed 70 community-based PHM site directors representing programs across 29 states (Table 1) and five geographic regions: Midwest (34.3%), Northeast (11.4%), Southeast (15.7%), Southwest (4.3%), and West (34.3%). Employer models varied across groups, with more noncommunity hospital employers (57%) than community hospital employers (43%). The top three services covered by pediatric hospitalists were pediatric inpatient or observation bed admissions (97%), emergency department consults (89%), and general newborns (67%). PHM programs also provided coverage for other services, including newborn deliveries (43%), Special Care Nursery/Level II Neonatal Intensive Care Unit (41%), step-down unit (20%), and mental health units (13%). About 59% of programs provided education for family medicine residents, 36% were for pediatric residents, and 70% worked with advanced practice providers. The majority of programs (70%) provided in-house coverage overnight.

Clinical Work Expectations and Employer Model

Clinical work expectations varied broadly across programs (Table 2). The median expected hours for a 1.0 FTE was 1,882 hours per year (interquartile range [IQR] 1,805, 2,016), and the median expected weekend coverage/year (defined as covering two days or two nights of the weekend) was 21 (IQR 14, 24). Most programs did not expand staff coverage based on seasonality (73%), and less than 20% of programs operated with a census cap. Median support for nondirect patient care activities was 4% (IQR 0,10) of a program’s total FTE (ie, a 5.0 FTE program would have 0.20 FTE support). Programs with community hospital employers had an 8% higher expectation of 1.0 FTE hours/year (P = .01) and viewed an appropriate pediatric morning census as 20% higher (P = .01; Table 2).

Program Sustainability

Twenty-six (37%) site directors described their program as unsustainable. When programmatic characteristics and clinical work expectations were analyzed by perception of sustainability, we observed no difference between programs that were perceived as unsustainable in the number of 1.0 FTE hours/year (P = .16), weekends/year (P = .65), in-house call (P = .36), or the presence of a back-up system (P = .61).

 

 

DISCUSSION

To our knowledge, this study is the first to describe clinical work models exclusively for pediatric community hospitalist programs. We found that expectations for clinical FTE hours, weekend coverage, appropriate morning census, support for nondirect patient care activities, and perception of sustainability varied broadly across programs. The only variable affecting some of these differences was employer model, with those employed by a community hospital employer having a higher expectation for hours/year and appropriate morning pediatric census than those employed by noncommunity hospital employers.

With a growing emphasis on physician burnout and career satisfaction,9-11 understanding the characteristics of community hospital work settings is critical for identifying and building sustainable employment models. Previous studies have identified that the balance of clinical and nonclinical responsibilities and the setting of community versus university-based programs are major contributors to burnout and career satisfaction.9,11 Interestingly, although community hospital-based programs have limited FTE for nondirect patient care activities, we found that a higher percentage of program site directors perceived their program models as sustainable when compared with university-based programs in prior research (63% versus 50%).6 Elucidating why community hospital PHM programs are perceived as more sustainable provides an opportunity for future research. Potential reasons may include fewer academic requirements for promotion or an increased connection to a local community.

We also found that the employer model had a statistically significant impact on expected FTE hours per year but not on perception of sustainability. Programs employed by community hospitals worked 8% more hours per year than those employed by noncommunity hospital employers and accepted a higher morning pediatric census. This variation in hours and census level appropriateness is likely multifactorial, potentially from higher nonclinical expectations for promotion (eg, academic or scholarly production) at school of medicine or children’s hospital employed programs versus limited reimbursement for administrative responsibilities within community hospital employment models.

There are several potential next steps for our findings. As our data are the first attempt (to our knowledge) at describing the current practice and expectations exclusively within community hospital programs, this study can be used as a starting point for the development of workload expectation standards. Increasing transparency nationally for individual community programs potentially promotes discussions around burnout and attrition. Having objective data to compare program models may assist in advocating with local hospital leadership for restructuring that better aligns with national norms.

Our study has several limitations. First, our sampling frame was based upon a self-selection of program directors. This may have led to a biased representation of programs with higher workloads motivated to develop a standard to compare with other programs, which may have potentially led to an overestimation of hours. Second, without a registry or database for community-based pediatric hospitalist programs, we do not know the percentage of community-based programs that our sample represents. Although our results cannot speak for all community PHM programs, we attempted to mitigate nonresponse bias through the breadth of programs represented, which spanned 29 states, five geographic regions, and teaching and nonteaching programs. The interview-based method for data collection allowed the research team to clarify questions and responses across sites, thereby improving the quality and consistency of the data for the represented study sample. Finally, other factors possibly contributed to sustainability that we did not address in this study, such as programs that are dependent on billable encounters as part of their salary support.

 

 

CONCLUSION

As a newly recognized subspecialty, creating a reference for community-based program leaders to determine and discuss individual models and expectations with hospital administrators may help address programmatic sustainability. It may also allow for the analysis of long-term career satisfaction and longevity within community PHM programs based on workload. Future studies should further explore root causes for workload discrepancies between community and university employed programs along with establishing potential standards for PHM program development.

Acknowledgments

We would like to thank the Stanford School of Medicine Quantitative Sciences Unit staff for their assistance in statistical analysis.

Disclosure

The authors have nothing to disclose.

Files
References

1. Robert MW, Lee G. Zero to 50,000—The 20th anniversary of the hospitalist. N Engl J Med. 2016;375(11):1009-1011. https://doi.org/10.1056/NEJMp1607958.
2. Gosdin C, Simmons J, Yau C, Sucharew H, Carlson D, Paciorkowski N. Survey of academic pediatric hospitalist programs in the US: organizational, administrative, and financial factors. J Hosp Med. 2013;8(6):285-291. https://doi.org/10.1002/jhm.2020.
3. Paul DH, Jennifer D, Elizabeth R, et al. Proposed dashboard for pediatric hospital medicine groups. Hosp Pediatr. 2012;2(2):59-68. https://doi.org/10.1542/hpeds.2012-0004
4. Gary LF, Kathryn B, Kamilah N, Indu L. Characteristics of the pediatric hospitalist workforce: its roles and work environment. Pediatrics 2007;120(1):33-39. https://doi.org/10.1542/peds.2007-0304
5. Leyenaar JK, Frintner MP. Graduating pediatric residents entering the hospital medicine workforce. 2006-2015. Acad Pediatr. 2018;18(2):200-207. https://doi.org/10.1016/j.acap.2017.05.001.
6. Fromme HB, Chen CO, Fine BR, Gosdin C, Shaughnessy EE. Pediatric hospitalist workload and sustainability in university-based programs: results from a national interview-based survey. J Hosp Med. 2018;13(10):702-705. https://doi.org/10.12788/jhm.2977.
7. Leyenaar JK, Ralston SL, Shieh MS, Pekow PS, Mangione-Smith R, Lindenauer PK. Epidemiology of pediatric hospitalizations at general hospitals and freestanding children’s hospitals in the United States. J Hosp Med. 2016;11(11):743-749. https://doi.org/10.1002/jhm.2624.
8. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010.
9. Laurie AP, Aisha BD, Mary CO. Association between practice setting and pediatric hospitalist career satisfaction. Hosp Pediatr. 2013;3(3):285-291. https://doi.org/10.1542/hpeds.2012-0085
10. Hinami K, Whelan CT, Wolosin RJ, Miller JA, Wetterneck TB. Worklife and satisfaction of hospitalists: toward flourishing careers. J Gen Intern Med. 2011;27(1):28-36. https://doi.org/10.1007/s11606-011-1780-z.
11. Hinami K, Whelan CT, Miller JA, Wolosin RJ, Wetterneck TB. Job characteristics, satisfaction, and burnout across hospitalist practice models. J Hosp Med. 2012;7(5):402-410. https://doi.org/10.1002/jhm.1907

Article PDF
Issue
Journal of Hospital Medicine 14(11)
Topics
Page Number
682-685. Published online first August 21, 2019
Sections
Files
Files
Article PDF
Article PDF
Related Articles

As a newly recognized specialty, pediatric hospital medicine (PHM) continues to expand and diversify.1 Pediatric hospitalists care for children in hospitals ranging from small, rural community hospitals to large, free-standing quaternary children’s hospitals.2-4 In addition, more than 10% of graduating pediatric residents are seeking future careers within PHM.5

In 2018, Fromme et al. published a study describing clinical workload for pediatric hospitalists within university-based settings.6 They characterized the diversity of work models and programmatic sustainability but limited the study to university-based programs. With over half of children receiving care within community hospitals,7 workforce patterns for community-based pediatric hospitalists should be characterized to maximize sustainability and minimize attrition across the field.

In this study, we describe programmatic variability in clinical work expectations of 70 community-based PHM programs. We aimed to describe existing work models and expectations of community-based program leaders as they relate to their unique clinical setting.

METHODS

We conducted a cross-sectional survey of community-based PHM site directors through structured interviews. Community hospital programs were self-defined by the study participants, although typically defined as general hospitals that admit pediatric patients and are not free-standing or children’s hospitals within a general hospital. Survey respondents were asked to answer questions only reflecting expectations at their community hospital.

Survey Design and Content

Building from a tool used by Fromme et al.6 we created a 12-question structured interview questionnaire focused on three areas: (1) full-time employment (FTE) metrics including definitions of a 1.0 FTE, “typical” shifts, and weekend responsibilities; (2) work volume including census parameters, service-line coverage expectations, back-up systems, and overnight call responsibilities; and (3) programmatic model including sense of sustainability (eg, minimizing burnout and attrition), support for activities such as administrative or research time, and employer model (Appendix).

We modified the survey through research team consensus. After pilot-testing by research team members at their own sites, the survey was refined for item clarity, structural design, and length. We chose to administer surveys through phone interviews over a traditional distribution due to anticipated variability in work models. The research team discussed how each question should be asked, and responses were clarified to maintain consistency.

 

 

Survey Administration

Given the absence of a national registry or database for community-based PHM programs, study participation was solicited through an invitation posted on the American Academy of Pediatrics Section on Hospital Medicine (AAP SOHM) Listserv and the AAP SOHM Community Hospitalist Listserv in May 2018. Invitations were posted twice at two weeks apart. Each research team member completed 6-19 interviews. Responses to survey questions were recorded in REDCap, a secure, web-based data capture instrument.8

Participating in the study was considered implied consent, and participants did not receive a monetary incentive, although respondents were offered deidentified survey data for participation. The study was exempted through the University of Chicago Institutional Review Board.

Data Analysis

Employers were dichotomized as community hospital employer (including primary community hospital employment/private organization) or noncommunity hospital employer (including children’s/university hospital employment or school of medicine). Descriptive statistics were reported to compare the demographics of two employer groups. P values were calculated using two-sample t-tests for the continuous variables and chi-square or Fisher-exact tests for the categorical variables. Mann–Whitney U-test was performed for continuous variables without normality. Analyses were performed using the R Statistical Programming Language (R Foundation for Statistical Computing, Vienna, Austria), version 3.4.3.

RESULTS

Participation and Program Characteristics

We interviewed 70 community-based PHM site directors representing programs across 29 states (Table 1) and five geographic regions: Midwest (34.3%), Northeast (11.4%), Southeast (15.7%), Southwest (4.3%), and West (34.3%). Employer models varied across groups, with more noncommunity hospital employers (57%) than community hospital employers (43%). The top three services covered by pediatric hospitalists were pediatric inpatient or observation bed admissions (97%), emergency department consults (89%), and general newborns (67%). PHM programs also provided coverage for other services, including newborn deliveries (43%), Special Care Nursery/Level II Neonatal Intensive Care Unit (41%), step-down unit (20%), and mental health units (13%). About 59% of programs provided education for family medicine residents, 36% were for pediatric residents, and 70% worked with advanced practice providers. The majority of programs (70%) provided in-house coverage overnight.

Clinical Work Expectations and Employer Model

Clinical work expectations varied broadly across programs (Table 2). The median expected hours for a 1.0 FTE was 1,882 hours per year (interquartile range [IQR] 1,805, 2,016), and the median expected weekend coverage/year (defined as covering two days or two nights of the weekend) was 21 (IQR 14, 24). Most programs did not expand staff coverage based on seasonality (73%), and less than 20% of programs operated with a census cap. Median support for nondirect patient care activities was 4% (IQR 0,10) of a program’s total FTE (ie, a 5.0 FTE program would have 0.20 FTE support). Programs with community hospital employers had an 8% higher expectation of 1.0 FTE hours/year (P = .01) and viewed an appropriate pediatric morning census as 20% higher (P = .01; Table 2).

Program Sustainability

Twenty-six (37%) site directors described their program as unsustainable. When programmatic characteristics and clinical work expectations were analyzed by perception of sustainability, we observed no difference between programs that were perceived as unsustainable in the number of 1.0 FTE hours/year (P = .16), weekends/year (P = .65), in-house call (P = .36), or the presence of a back-up system (P = .61).

 

 

DISCUSSION

To our knowledge, this study is the first to describe clinical work models exclusively for pediatric community hospitalist programs. We found that expectations for clinical FTE hours, weekend coverage, appropriate morning census, support for nondirect patient care activities, and perception of sustainability varied broadly across programs. The only variable affecting some of these differences was employer model, with those employed by a community hospital employer having a higher expectation for hours/year and appropriate morning pediatric census than those employed by noncommunity hospital employers.

With a growing emphasis on physician burnout and career satisfaction,9-11 understanding the characteristics of community hospital work settings is critical for identifying and building sustainable employment models. Previous studies have identified that the balance of clinical and nonclinical responsibilities and the setting of community versus university-based programs are major contributors to burnout and career satisfaction.9,11 Interestingly, although community hospital-based programs have limited FTE for nondirect patient care activities, we found that a higher percentage of program site directors perceived their program models as sustainable when compared with university-based programs in prior research (63% versus 50%).6 Elucidating why community hospital PHM programs are perceived as more sustainable provides an opportunity for future research. Potential reasons may include fewer academic requirements for promotion or an increased connection to a local community.

We also found that the employer model had a statistically significant impact on expected FTE hours per year but not on perception of sustainability. Programs employed by community hospitals worked 8% more hours per year than those employed by noncommunity hospital employers and accepted a higher morning pediatric census. This variation in hours and census level appropriateness is likely multifactorial, potentially from higher nonclinical expectations for promotion (eg, academic or scholarly production) at school of medicine or children’s hospital employed programs versus limited reimbursement for administrative responsibilities within community hospital employment models.

There are several potential next steps for our findings. As our data are the first attempt (to our knowledge) at describing the current practice and expectations exclusively within community hospital programs, this study can be used as a starting point for the development of workload expectation standards. Increasing transparency nationally for individual community programs potentially promotes discussions around burnout and attrition. Having objective data to compare program models may assist in advocating with local hospital leadership for restructuring that better aligns with national norms.

Our study has several limitations. First, our sampling frame was based upon a self-selection of program directors. This may have led to a biased representation of programs with higher workloads motivated to develop a standard to compare with other programs, which may have potentially led to an overestimation of hours. Second, without a registry or database for community-based pediatric hospitalist programs, we do not know the percentage of community-based programs that our sample represents. Although our results cannot speak for all community PHM programs, we attempted to mitigate nonresponse bias through the breadth of programs represented, which spanned 29 states, five geographic regions, and teaching and nonteaching programs. The interview-based method for data collection allowed the research team to clarify questions and responses across sites, thereby improving the quality and consistency of the data for the represented study sample. Finally, other factors possibly contributed to sustainability that we did not address in this study, such as programs that are dependent on billable encounters as part of their salary support.

 

 

CONCLUSION

As a newly recognized subspecialty, creating a reference for community-based program leaders to determine and discuss individual models and expectations with hospital administrators may help address programmatic sustainability. It may also allow for the analysis of long-term career satisfaction and longevity within community PHM programs based on workload. Future studies should further explore root causes for workload discrepancies between community and university employed programs along with establishing potential standards for PHM program development.

Acknowledgments

We would like to thank the Stanford School of Medicine Quantitative Sciences Unit staff for their assistance in statistical analysis.

Disclosure

The authors have nothing to disclose.

As a newly recognized specialty, pediatric hospital medicine (PHM) continues to expand and diversify.1 Pediatric hospitalists care for children in hospitals ranging from small, rural community hospitals to large, free-standing quaternary children’s hospitals.2-4 In addition, more than 10% of graduating pediatric residents are seeking future careers within PHM.5

In 2018, Fromme et al. published a study describing clinical workload for pediatric hospitalists within university-based settings.6 They characterized the diversity of work models and programmatic sustainability but limited the study to university-based programs. With over half of children receiving care within community hospitals,7 workforce patterns for community-based pediatric hospitalists should be characterized to maximize sustainability and minimize attrition across the field.

In this study, we describe programmatic variability in clinical work expectations of 70 community-based PHM programs. We aimed to describe existing work models and expectations of community-based program leaders as they relate to their unique clinical setting.

METHODS

We conducted a cross-sectional survey of community-based PHM site directors through structured interviews. Community hospital programs were self-defined by the study participants, although typically defined as general hospitals that admit pediatric patients and are not free-standing or children’s hospitals within a general hospital. Survey respondents were asked to answer questions only reflecting expectations at their community hospital.

Survey Design and Content

Building from a tool used by Fromme et al.6 we created a 12-question structured interview questionnaire focused on three areas: (1) full-time employment (FTE) metrics including definitions of a 1.0 FTE, “typical” shifts, and weekend responsibilities; (2) work volume including census parameters, service-line coverage expectations, back-up systems, and overnight call responsibilities; and (3) programmatic model including sense of sustainability (eg, minimizing burnout and attrition), support for activities such as administrative or research time, and employer model (Appendix).

We modified the survey through research team consensus. After pilot-testing by research team members at their own sites, the survey was refined for item clarity, structural design, and length. We chose to administer surveys through phone interviews over a traditional distribution due to anticipated variability in work models. The research team discussed how each question should be asked, and responses were clarified to maintain consistency.

 

 

Survey Administration

Given the absence of a national registry or database for community-based PHM programs, study participation was solicited through an invitation posted on the American Academy of Pediatrics Section on Hospital Medicine (AAP SOHM) Listserv and the AAP SOHM Community Hospitalist Listserv in May 2018. Invitations were posted twice at two weeks apart. Each research team member completed 6-19 interviews. Responses to survey questions were recorded in REDCap, a secure, web-based data capture instrument.8

Participating in the study was considered implied consent, and participants did not receive a monetary incentive, although respondents were offered deidentified survey data for participation. The study was exempted through the University of Chicago Institutional Review Board.

Data Analysis

Employers were dichotomized as community hospital employer (including primary community hospital employment/private organization) or noncommunity hospital employer (including children’s/university hospital employment or school of medicine). Descriptive statistics were reported to compare the demographics of two employer groups. P values were calculated using two-sample t-tests for the continuous variables and chi-square or Fisher-exact tests for the categorical variables. Mann–Whitney U-test was performed for continuous variables without normality. Analyses were performed using the R Statistical Programming Language (R Foundation for Statistical Computing, Vienna, Austria), version 3.4.3.

RESULTS

Participation and Program Characteristics

We interviewed 70 community-based PHM site directors representing programs across 29 states (Table 1) and five geographic regions: Midwest (34.3%), Northeast (11.4%), Southeast (15.7%), Southwest (4.3%), and West (34.3%). Employer models varied across groups, with more noncommunity hospital employers (57%) than community hospital employers (43%). The top three services covered by pediatric hospitalists were pediatric inpatient or observation bed admissions (97%), emergency department consults (89%), and general newborns (67%). PHM programs also provided coverage for other services, including newborn deliveries (43%), Special Care Nursery/Level II Neonatal Intensive Care Unit (41%), step-down unit (20%), and mental health units (13%). About 59% of programs provided education for family medicine residents, 36% were for pediatric residents, and 70% worked with advanced practice providers. The majority of programs (70%) provided in-house coverage overnight.

Clinical Work Expectations and Employer Model

Clinical work expectations varied broadly across programs (Table 2). The median expected hours for a 1.0 FTE was 1,882 hours per year (interquartile range [IQR] 1,805, 2,016), and the median expected weekend coverage/year (defined as covering two days or two nights of the weekend) was 21 (IQR 14, 24). Most programs did not expand staff coverage based on seasonality (73%), and less than 20% of programs operated with a census cap. Median support for nondirect patient care activities was 4% (IQR 0,10) of a program’s total FTE (ie, a 5.0 FTE program would have 0.20 FTE support). Programs with community hospital employers had an 8% higher expectation of 1.0 FTE hours/year (P = .01) and viewed an appropriate pediatric morning census as 20% higher (P = .01; Table 2).

Program Sustainability

Twenty-six (37%) site directors described their program as unsustainable. When programmatic characteristics and clinical work expectations were analyzed by perception of sustainability, we observed no difference between programs that were perceived as unsustainable in the number of 1.0 FTE hours/year (P = .16), weekends/year (P = .65), in-house call (P = .36), or the presence of a back-up system (P = .61).

 

 

DISCUSSION

To our knowledge, this study is the first to describe clinical work models exclusively for pediatric community hospitalist programs. We found that expectations for clinical FTE hours, weekend coverage, appropriate morning census, support for nondirect patient care activities, and perception of sustainability varied broadly across programs. The only variable affecting some of these differences was employer model, with those employed by a community hospital employer having a higher expectation for hours/year and appropriate morning pediatric census than those employed by noncommunity hospital employers.

With a growing emphasis on physician burnout and career satisfaction,9-11 understanding the characteristics of community hospital work settings is critical for identifying and building sustainable employment models. Previous studies have identified that the balance of clinical and nonclinical responsibilities and the setting of community versus university-based programs are major contributors to burnout and career satisfaction.9,11 Interestingly, although community hospital-based programs have limited FTE for nondirect patient care activities, we found that a higher percentage of program site directors perceived their program models as sustainable when compared with university-based programs in prior research (63% versus 50%).6 Elucidating why community hospital PHM programs are perceived as more sustainable provides an opportunity for future research. Potential reasons may include fewer academic requirements for promotion or an increased connection to a local community.

We also found that the employer model had a statistically significant impact on expected FTE hours per year but not on perception of sustainability. Programs employed by community hospitals worked 8% more hours per year than those employed by noncommunity hospital employers and accepted a higher morning pediatric census. This variation in hours and census level appropriateness is likely multifactorial, potentially from higher nonclinical expectations for promotion (eg, academic or scholarly production) at school of medicine or children’s hospital employed programs versus limited reimbursement for administrative responsibilities within community hospital employment models.

There are several potential next steps for our findings. As our data are the first attempt (to our knowledge) at describing the current practice and expectations exclusively within community hospital programs, this study can be used as a starting point for the development of workload expectation standards. Increasing transparency nationally for individual community programs potentially promotes discussions around burnout and attrition. Having objective data to compare program models may assist in advocating with local hospital leadership for restructuring that better aligns with national norms.

Our study has several limitations. First, our sampling frame was based upon a self-selection of program directors. This may have led to a biased representation of programs with higher workloads motivated to develop a standard to compare with other programs, which may have potentially led to an overestimation of hours. Second, without a registry or database for community-based pediatric hospitalist programs, we do not know the percentage of community-based programs that our sample represents. Although our results cannot speak for all community PHM programs, we attempted to mitigate nonresponse bias through the breadth of programs represented, which spanned 29 states, five geographic regions, and teaching and nonteaching programs. The interview-based method for data collection allowed the research team to clarify questions and responses across sites, thereby improving the quality and consistency of the data for the represented study sample. Finally, other factors possibly contributed to sustainability that we did not address in this study, such as programs that are dependent on billable encounters as part of their salary support.

 

 

CONCLUSION

As a newly recognized subspecialty, creating a reference for community-based program leaders to determine and discuss individual models and expectations with hospital administrators may help address programmatic sustainability. It may also allow for the analysis of long-term career satisfaction and longevity within community PHM programs based on workload. Future studies should further explore root causes for workload discrepancies between community and university employed programs along with establishing potential standards for PHM program development.

Acknowledgments

We would like to thank the Stanford School of Medicine Quantitative Sciences Unit staff for their assistance in statistical analysis.

Disclosure

The authors have nothing to disclose.

References

1. Robert MW, Lee G. Zero to 50,000—The 20th anniversary of the hospitalist. N Engl J Med. 2016;375(11):1009-1011. https://doi.org/10.1056/NEJMp1607958.
2. Gosdin C, Simmons J, Yau C, Sucharew H, Carlson D, Paciorkowski N. Survey of academic pediatric hospitalist programs in the US: organizational, administrative, and financial factors. J Hosp Med. 2013;8(6):285-291. https://doi.org/10.1002/jhm.2020.
3. Paul DH, Jennifer D, Elizabeth R, et al. Proposed dashboard for pediatric hospital medicine groups. Hosp Pediatr. 2012;2(2):59-68. https://doi.org/10.1542/hpeds.2012-0004
4. Gary LF, Kathryn B, Kamilah N, Indu L. Characteristics of the pediatric hospitalist workforce: its roles and work environment. Pediatrics 2007;120(1):33-39. https://doi.org/10.1542/peds.2007-0304
5. Leyenaar JK, Frintner MP. Graduating pediatric residents entering the hospital medicine workforce. 2006-2015. Acad Pediatr. 2018;18(2):200-207. https://doi.org/10.1016/j.acap.2017.05.001.
6. Fromme HB, Chen CO, Fine BR, Gosdin C, Shaughnessy EE. Pediatric hospitalist workload and sustainability in university-based programs: results from a national interview-based survey. J Hosp Med. 2018;13(10):702-705. https://doi.org/10.12788/jhm.2977.
7. Leyenaar JK, Ralston SL, Shieh MS, Pekow PS, Mangione-Smith R, Lindenauer PK. Epidemiology of pediatric hospitalizations at general hospitals and freestanding children’s hospitals in the United States. J Hosp Med. 2016;11(11):743-749. https://doi.org/10.1002/jhm.2624.
8. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010.
9. Laurie AP, Aisha BD, Mary CO. Association between practice setting and pediatric hospitalist career satisfaction. Hosp Pediatr. 2013;3(3):285-291. https://doi.org/10.1542/hpeds.2012-0085
10. Hinami K, Whelan CT, Wolosin RJ, Miller JA, Wetterneck TB. Worklife and satisfaction of hospitalists: toward flourishing careers. J Gen Intern Med. 2011;27(1):28-36. https://doi.org/10.1007/s11606-011-1780-z.
11. Hinami K, Whelan CT, Miller JA, Wolosin RJ, Wetterneck TB. Job characteristics, satisfaction, and burnout across hospitalist practice models. J Hosp Med. 2012;7(5):402-410. https://doi.org/10.1002/jhm.1907

References

1. Robert MW, Lee G. Zero to 50,000—The 20th anniversary of the hospitalist. N Engl J Med. 2016;375(11):1009-1011. https://doi.org/10.1056/NEJMp1607958.
2. Gosdin C, Simmons J, Yau C, Sucharew H, Carlson D, Paciorkowski N. Survey of academic pediatric hospitalist programs in the US: organizational, administrative, and financial factors. J Hosp Med. 2013;8(6):285-291. https://doi.org/10.1002/jhm.2020.
3. Paul DH, Jennifer D, Elizabeth R, et al. Proposed dashboard for pediatric hospital medicine groups. Hosp Pediatr. 2012;2(2):59-68. https://doi.org/10.1542/hpeds.2012-0004
4. Gary LF, Kathryn B, Kamilah N, Indu L. Characteristics of the pediatric hospitalist workforce: its roles and work environment. Pediatrics 2007;120(1):33-39. https://doi.org/10.1542/peds.2007-0304
5. Leyenaar JK, Frintner MP. Graduating pediatric residents entering the hospital medicine workforce. 2006-2015. Acad Pediatr. 2018;18(2):200-207. https://doi.org/10.1016/j.acap.2017.05.001.
6. Fromme HB, Chen CO, Fine BR, Gosdin C, Shaughnessy EE. Pediatric hospitalist workload and sustainability in university-based programs: results from a national interview-based survey. J Hosp Med. 2018;13(10):702-705. https://doi.org/10.12788/jhm.2977.
7. Leyenaar JK, Ralston SL, Shieh MS, Pekow PS, Mangione-Smith R, Lindenauer PK. Epidemiology of pediatric hospitalizations at general hospitals and freestanding children’s hospitals in the United States. J Hosp Med. 2016;11(11):743-749. https://doi.org/10.1002/jhm.2624.
8. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010.
9. Laurie AP, Aisha BD, Mary CO. Association between practice setting and pediatric hospitalist career satisfaction. Hosp Pediatr. 2013;3(3):285-291. https://doi.org/10.1542/hpeds.2012-0085
10. Hinami K, Whelan CT, Wolosin RJ, Miller JA, Wetterneck TB. Worklife and satisfaction of hospitalists: toward flourishing careers. J Gen Intern Med. 2011;27(1):28-36. https://doi.org/10.1007/s11606-011-1780-z.
11. Hinami K, Whelan CT, Miller JA, Wolosin RJ, Wetterneck TB. Job characteristics, satisfaction, and burnout across hospitalist practice models. J Hosp Med. 2012;7(5):402-410. https://doi.org/10.1002/jhm.1907

Issue
Journal of Hospital Medicine 14(11)
Issue
Journal of Hospital Medicine 14(11)
Page Number
682-685. Published online first August 21, 2019
Page Number
682-685. Published online first August 21, 2019
Topics
Article Type
Sections
Article Source

© 2019 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Francisco Alvarez, MD; E-mail: [email protected]; Telephone: 650-736-4421
Content Gating
Gated (full article locked unless allowed per User)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Gating Strategy
First Peek Free
Article PDF Media
Media Files

Improving Resident Feedback on Diagnostic Reasoning after Handovers: The LOOP Project

Article Type
Changed
Sun, 10/13/2019 - 21:49

One of the most promising methods for improving medical decision-making is learning from the outcomes of one’s decisions and either maintaining or modifying future decision-making based on those outcomes.1-3 This process of iterative improvement over time based on feedback is called calibration and is one of the most important drivers of lifelong learning and improvement.1

Despite the importance of knowing the outcomes of one’s decisions, this seldom occurs in modern medical education.4 Learners do not often obtain specific feedback about the decisions they make within a short enough time frame to intentionally reflect upon and modify that decision-making process.3,5 In addition, almost every patient admitted to a teaching hospital will be cared for by multiple physicians over the course of a hospitalization. These care transitions may be seen as barriers to high-quality care and education, but we suggest a different paradigm: transitions of care present opportunities for trainees to be teammates in each other’s calibration. Peers can provide specific feedback about the diagnostic process and inform one another about patient outcomes. Transitions of care allow for built-in “second opinions,” and trainees can intentionally learn by comparing the clinical reasoning involved at different points in a patient’s course. The diagnostic process is dynamic and complex; it is fundamental that trainees have the opportunity to reflect on the process to identify how and why the diagnostic process evolved throughout a patient’s hospitalization. Most inpatient diagnoses are “working diagnoses” that are likely to change. Thus, identifying the twists and turns in a patient’s diagnostic journey provides invaluable learning for future practice.

Herein, we describe the implementation and impact of a multisite initiative to engage residents in delivering feedback to their peers about medical decisions around transitions of care.

METHODS

The LOOP Project is a prospective clinical educational study that aimed to engage resident physicians to deliver feedback and updates about their colleagues’ diagnostic decision-making around care transitions. This study was deemed exempt from review by the University of Minnesota Institutional Review Board and either approved or deemed exempt by the corresponding Institutional Review Boards at all participating institutions. The study was conducted by seven programs at six institutions and included Internal Medicine, Pediatrics, and Internal Medicine–Pediatrics (PGY 1-4) residents from February 2017 to June 2017. Residents rotating through participating clinical services during the study period were invited to participate and given further information by site leads via informational presentations, written handouts, and/or emails.

 

 

The intervention entailed residents delivering structured feedback to their colleagues regarding their patients’ diagnoses after transitions of care. The predominant setting was the inpatient hospital medicine day-shift team providing feedback to the night-shift team regarding overnight admissions. Feedback about patients (usually chosen by the day-shift team) was delivered through completion of a standard templated form (Figure) usually sent within 24 hours after hospital admission through secure messaging (ie, EPIC In-Basket message utilizing a Smartphrase of the LOOP feedback form). A 24-hour time period was chosen to allow for rapid cycling of feedback focusing on initial diagnostic assessment. Site leads and resident champions promoted the project through presentations, informal discussions, and prizes for high completion rates of forms and surveys (ie, coffee cards and pizza).



Feedback forms were collected by site leads. A categorization rubric was developed during a pilot phase. Diagnoses before and after the transition of care were categorized as no change, diagnostic refinement (ie, the initial diagnosis was modified to be more specific), disease evolution (ie, the patient’s physiology or disease course changed), or major diagnostic change (ie, the initial and subsequent diagnoses differed substantially). Site leads acted as single-coders and conference calls were held to discuss coding and build consensus regarding the taxonomy. Diagnoses were not labeled as “right” or “wrong”; instead, categorization focused on differences between diagnoses before and after transitions of care.

Residents were invited to complete surveys before and after the rotation during which they had the opportunity to give or receive feedback. A unique identifier was entered by each participant to allow pairing of pre- and postsurveys. The survey (Appendix 1) was developed and refined during the initial pilot phase at the University of Minnesota. Surveys were collected using RedCap and analyzed using SAS version 9.3 (SAS Institute Inc., Cary, North Carolina). Differences between pre- and postsurveys were calculated using paired t-tests for continuous variables, and descriptive statistics were used for demographic and other items. Only surveys completed by individuals who completed both pre- and postsurveys were included in the analysis.

RESULTS

Overall, there were 716 current residents in the training programs that participated in this study; one site planned on participating but did not complete any forms. A total of 405 residents were eligible to participate during the study period. Overall, 221 (54.5%) presurveys and 90 postsurveys were completed (22.2%); 54 residents (13.3%) completed both pre- and postsurveys and were included in the analysis. Of the 54 survey respondents, 26 (48.15%) were female.

Survey results (Table) indicated significantly improved self-efficacy in identifying cognitive errors in residents’ own practice, identifying why those errors occurred, and identifying strategies to decrease future diagnostic errors. Participants noted increased frequency of discussions within teams regarding differential diagnoses, diagnostic errors, and why diagnoses changed over time. The feedback process was viewed positively by participants, who were also generally satisfied with the overall quality, frequency, and value of the feedback received. After the intervention, participants reported an increase in the amount of feedback received for night admissions and an overall increase in the perception that nighttime admissions were as “educational” as daytime admissions.



Of 544 collected forms, 238 (43.7%) showed some diagnostic change. These changes were further categorized into disease evolution (60 forms, 11.0%), diagnostic refinement (109 forms, 20.0%), and major diagnostic change (69 forms, 12.7%).

 

 

CONCLUSION

This study suggests that an intervention to operationalize standardized, structured feedback about diagnostic decision-making around transitions of care is a promising approach to improve residents’ understanding of changes in, and evolution of, the diagnostic process, as well as improve the perceived educational value of overnight admissions. In our results, over 40% of the patients admitted by residents had some change in their diagnoses after a transition of care during their early hospitalization. This finding highlights the importance of ensuring that trainees have the opportunity to know the outcomes of their decisions. Indeed, residents should be encouraged to follow-up on their own patients without prompting; however, studies show that this practice is uncommon and interventions beyond admonition are necessary.4

The diagnostic change rate observed in this study confirms that diagnosis is an iterative process and that the concept of a working diagnosis is key—a diagnosis made at admission will very likely be modified by time, the natural history of the disease, and new clinical information. When diagnoses are viewed as working diagnoses, trainees may be empowered to better understand the diagnostic process. As learners and teachers adopt this perspective, training programs are more likely to be successful in helping learners calibrate toward expertise.

Previous studies have questioned whether resident physicians view overnight admissions as valuable.6 After our intervention, we found an increase in both the amount of feedback received and the proportion of participants who agreed that night and day admissions were equally educational, suggesting that targeted diagnostic reasoning feedback can bolster educational value of nighttime admissions.

This study presents a number of limitations. First, the survey response rate was low, which could potentially lead to biased results. We excluded those respondents who did not respond to both the pre- and postsurveys from the analysis. Second, we did not measure actual change in diagnostic performance. While learners did report learning and saw feedback as valuable, self-identified learning points may not always translate to improved patient care. Additionally, residents chose the patients for whom feedback was provided, and the diagnostic change rate described may be overestimated. We did not track the total number of admissions for which feedback could have been delivered during the study. We did not include a control group, and the intervention may not be responsible for changing learners’ perceptions. However, the included programs were not implementing other new protocols focused on diagnostic reasoning during the study period. In addition, we addressed diagnostic changes early in a hospital course; a comprehensive program should address more feedback loops (eg, discharging team to admitting team).

This work is a pilot study; for future interventions focused on improving calibration to be sustainable, they should be congruent with existing clinical workflows and avoid adding to the stress and/or cognitive load of an already-busy clinical experience. The most optimal strategies for delivering feedback about clinical reasoning remain unclear.

In summary, a program to deliver structured feedback among resident physicians about diagnostic reasoning across care transitions for selected hospitalized patients is viewed positively by trainees, is feasible, and leads to changes in resident perception and self-efficacy. Future studies and interventions should aim to provide feedback more systematically, rather than just for selected patients, and objectively track diagnostic changes over time in hospitalized patients. While truly objective diagnostic information is challenging to obtain, comparing admission and other inpatient diagnoses to discharge diagnoses or diagnoses from primary care follow-up visits may be helpful. In addition, studies should aim to track trainees’ clinical decision-making over time and determine the effectiveness of feedback at improving diagnostic performance through calibration.

 

 

 

Acknowledgments

The authors thank the trainees who participated in this study, as well as the residency leadership at participating institutions. The authors also thank Qi Wang, PhD, for providing statistical analysis.

Disclosures

The authors have nothing to disclose.

Funding

The study was funded by an AAIM Innovation Grant and local support at each participating institution.

Files
References

1. Croskerry P. The feedback sanction. Acad Emerg Med. 2000;7(11):1232-1238. https://doi.org/10.1111/j.1553-2712.2000.tb00468.x.
2. Trowbridge RL, Dhaliwal G, Cosby KS. Educational agenda for diagnostic error reduction. BMJ Qual Saf. 2013;22(Suppl 2):ii28-ii32. https://doi.org/10.1136/bmjqs-2012-001622.
3. Dhaliwal G. Clinical excellence: make it a habit. Acad Med. 2012;87(11):1473. https://doi.org/10.1097/ACM.0b013e31826d68d9.
4. Shenvi EC, Feupe SF, Yang H, El-Kareh R. Closing the loop: a mixed-methods study about resident learning from outcome feedback after patient handoffs. Diagnosis. 2018;5(4):235-242. https://doi.org/10.1515/dx-2018-0013.
5. Rencic J. Twelve tips for teaching expertise in clinical reasoning. Med Teach. 2011;33(11):887-892. https://doi.org/10.3109/0142159X.2011.558142.
6. Bump GM, Zimmer SM, McNeil MA, Elnicki DM. Hold-over admissions: are they educational for residents? J Gen Intern Med. 2014;29(3):463-467. https://doi.org/10.1007/s11606-013-2667-y.

Article PDF
Issue
Journal of Hospital Medicine 14(10)
Topics
Page Number
622-625. Published online first August 21, 2019
Sections
Files
Files
Article PDF
Article PDF

One of the most promising methods for improving medical decision-making is learning from the outcomes of one’s decisions and either maintaining or modifying future decision-making based on those outcomes.1-3 This process of iterative improvement over time based on feedback is called calibration and is one of the most important drivers of lifelong learning and improvement.1

Despite the importance of knowing the outcomes of one’s decisions, this seldom occurs in modern medical education.4 Learners do not often obtain specific feedback about the decisions they make within a short enough time frame to intentionally reflect upon and modify that decision-making process.3,5 In addition, almost every patient admitted to a teaching hospital will be cared for by multiple physicians over the course of a hospitalization. These care transitions may be seen as barriers to high-quality care and education, but we suggest a different paradigm: transitions of care present opportunities for trainees to be teammates in each other’s calibration. Peers can provide specific feedback about the diagnostic process and inform one another about patient outcomes. Transitions of care allow for built-in “second opinions,” and trainees can intentionally learn by comparing the clinical reasoning involved at different points in a patient’s course. The diagnostic process is dynamic and complex; it is fundamental that trainees have the opportunity to reflect on the process to identify how and why the diagnostic process evolved throughout a patient’s hospitalization. Most inpatient diagnoses are “working diagnoses” that are likely to change. Thus, identifying the twists and turns in a patient’s diagnostic journey provides invaluable learning for future practice.

Herein, we describe the implementation and impact of a multisite initiative to engage residents in delivering feedback to their peers about medical decisions around transitions of care.

METHODS

The LOOP Project is a prospective clinical educational study that aimed to engage resident physicians to deliver feedback and updates about their colleagues’ diagnostic decision-making around care transitions. This study was deemed exempt from review by the University of Minnesota Institutional Review Board and either approved or deemed exempt by the corresponding Institutional Review Boards at all participating institutions. The study was conducted by seven programs at six institutions and included Internal Medicine, Pediatrics, and Internal Medicine–Pediatrics (PGY 1-4) residents from February 2017 to June 2017. Residents rotating through participating clinical services during the study period were invited to participate and given further information by site leads via informational presentations, written handouts, and/or emails.

 

 

The intervention entailed residents delivering structured feedback to their colleagues regarding their patients’ diagnoses after transitions of care. The predominant setting was the inpatient hospital medicine day-shift team providing feedback to the night-shift team regarding overnight admissions. Feedback about patients (usually chosen by the day-shift team) was delivered through completion of a standard templated form (Figure) usually sent within 24 hours after hospital admission through secure messaging (ie, EPIC In-Basket message utilizing a Smartphrase of the LOOP feedback form). A 24-hour time period was chosen to allow for rapid cycling of feedback focusing on initial diagnostic assessment. Site leads and resident champions promoted the project through presentations, informal discussions, and prizes for high completion rates of forms and surveys (ie, coffee cards and pizza).



Feedback forms were collected by site leads. A categorization rubric was developed during a pilot phase. Diagnoses before and after the transition of care were categorized as no change, diagnostic refinement (ie, the initial diagnosis was modified to be more specific), disease evolution (ie, the patient’s physiology or disease course changed), or major diagnostic change (ie, the initial and subsequent diagnoses differed substantially). Site leads acted as single-coders and conference calls were held to discuss coding and build consensus regarding the taxonomy. Diagnoses were not labeled as “right” or “wrong”; instead, categorization focused on differences between diagnoses before and after transitions of care.

Residents were invited to complete surveys before and after the rotation during which they had the opportunity to give or receive feedback. A unique identifier was entered by each participant to allow pairing of pre- and postsurveys. The survey (Appendix 1) was developed and refined during the initial pilot phase at the University of Minnesota. Surveys were collected using RedCap and analyzed using SAS version 9.3 (SAS Institute Inc., Cary, North Carolina). Differences between pre- and postsurveys were calculated using paired t-tests for continuous variables, and descriptive statistics were used for demographic and other items. Only surveys completed by individuals who completed both pre- and postsurveys were included in the analysis.

RESULTS

Overall, there were 716 current residents in the training programs that participated in this study; one site planned on participating but did not complete any forms. A total of 405 residents were eligible to participate during the study period. Overall, 221 (54.5%) presurveys and 90 postsurveys were completed (22.2%); 54 residents (13.3%) completed both pre- and postsurveys and were included in the analysis. Of the 54 survey respondents, 26 (48.15%) were female.

Survey results (Table) indicated significantly improved self-efficacy in identifying cognitive errors in residents’ own practice, identifying why those errors occurred, and identifying strategies to decrease future diagnostic errors. Participants noted increased frequency of discussions within teams regarding differential diagnoses, diagnostic errors, and why diagnoses changed over time. The feedback process was viewed positively by participants, who were also generally satisfied with the overall quality, frequency, and value of the feedback received. After the intervention, participants reported an increase in the amount of feedback received for night admissions and an overall increase in the perception that nighttime admissions were as “educational” as daytime admissions.



Of 544 collected forms, 238 (43.7%) showed some diagnostic change. These changes were further categorized into disease evolution (60 forms, 11.0%), diagnostic refinement (109 forms, 20.0%), and major diagnostic change (69 forms, 12.7%).

 

 

CONCLUSION

This study suggests that an intervention to operationalize standardized, structured feedback about diagnostic decision-making around transitions of care is a promising approach to improve residents’ understanding of changes in, and evolution of, the diagnostic process, as well as improve the perceived educational value of overnight admissions. In our results, over 40% of the patients admitted by residents had some change in their diagnoses after a transition of care during their early hospitalization. This finding highlights the importance of ensuring that trainees have the opportunity to know the outcomes of their decisions. Indeed, residents should be encouraged to follow-up on their own patients without prompting; however, studies show that this practice is uncommon and interventions beyond admonition are necessary.4

The diagnostic change rate observed in this study confirms that diagnosis is an iterative process and that the concept of a working diagnosis is key—a diagnosis made at admission will very likely be modified by time, the natural history of the disease, and new clinical information. When diagnoses are viewed as working diagnoses, trainees may be empowered to better understand the diagnostic process. As learners and teachers adopt this perspective, training programs are more likely to be successful in helping learners calibrate toward expertise.

Previous studies have questioned whether resident physicians view overnight admissions as valuable.6 After our intervention, we found an increase in both the amount of feedback received and the proportion of participants who agreed that night and day admissions were equally educational, suggesting that targeted diagnostic reasoning feedback can bolster educational value of nighttime admissions.

This study presents a number of limitations. First, the survey response rate was low, which could potentially lead to biased results. We excluded those respondents who did not respond to both the pre- and postsurveys from the analysis. Second, we did not measure actual change in diagnostic performance. While learners did report learning and saw feedback as valuable, self-identified learning points may not always translate to improved patient care. Additionally, residents chose the patients for whom feedback was provided, and the diagnostic change rate described may be overestimated. We did not track the total number of admissions for which feedback could have been delivered during the study. We did not include a control group, and the intervention may not be responsible for changing learners’ perceptions. However, the included programs were not implementing other new protocols focused on diagnostic reasoning during the study period. In addition, we addressed diagnostic changes early in a hospital course; a comprehensive program should address more feedback loops (eg, discharging team to admitting team).

This work is a pilot study; for future interventions focused on improving calibration to be sustainable, they should be congruent with existing clinical workflows and avoid adding to the stress and/or cognitive load of an already-busy clinical experience. The most optimal strategies for delivering feedback about clinical reasoning remain unclear.

In summary, a program to deliver structured feedback among resident physicians about diagnostic reasoning across care transitions for selected hospitalized patients is viewed positively by trainees, is feasible, and leads to changes in resident perception and self-efficacy. Future studies and interventions should aim to provide feedback more systematically, rather than just for selected patients, and objectively track diagnostic changes over time in hospitalized patients. While truly objective diagnostic information is challenging to obtain, comparing admission and other inpatient diagnoses to discharge diagnoses or diagnoses from primary care follow-up visits may be helpful. In addition, studies should aim to track trainees’ clinical decision-making over time and determine the effectiveness of feedback at improving diagnostic performance through calibration.

 

 

 

Acknowledgments

The authors thank the trainees who participated in this study, as well as the residency leadership at participating institutions. The authors also thank Qi Wang, PhD, for providing statistical analysis.

Disclosures

The authors have nothing to disclose.

Funding

The study was funded by an AAIM Innovation Grant and local support at each participating institution.

One of the most promising methods for improving medical decision-making is learning from the outcomes of one’s decisions and either maintaining or modifying future decision-making based on those outcomes.1-3 This process of iterative improvement over time based on feedback is called calibration and is one of the most important drivers of lifelong learning and improvement.1

Despite the importance of knowing the outcomes of one’s decisions, this seldom occurs in modern medical education.4 Learners do not often obtain specific feedback about the decisions they make within a short enough time frame to intentionally reflect upon and modify that decision-making process.3,5 In addition, almost every patient admitted to a teaching hospital will be cared for by multiple physicians over the course of a hospitalization. These care transitions may be seen as barriers to high-quality care and education, but we suggest a different paradigm: transitions of care present opportunities for trainees to be teammates in each other’s calibration. Peers can provide specific feedback about the diagnostic process and inform one another about patient outcomes. Transitions of care allow for built-in “second opinions,” and trainees can intentionally learn by comparing the clinical reasoning involved at different points in a patient’s course. The diagnostic process is dynamic and complex; it is fundamental that trainees have the opportunity to reflect on the process to identify how and why the diagnostic process evolved throughout a patient’s hospitalization. Most inpatient diagnoses are “working diagnoses” that are likely to change. Thus, identifying the twists and turns in a patient’s diagnostic journey provides invaluable learning for future practice.

Herein, we describe the implementation and impact of a multisite initiative to engage residents in delivering feedback to their peers about medical decisions around transitions of care.

METHODS

The LOOP Project is a prospective clinical educational study that aimed to engage resident physicians to deliver feedback and updates about their colleagues’ diagnostic decision-making around care transitions. This study was deemed exempt from review by the University of Minnesota Institutional Review Board and either approved or deemed exempt by the corresponding Institutional Review Boards at all participating institutions. The study was conducted by seven programs at six institutions and included Internal Medicine, Pediatrics, and Internal Medicine–Pediatrics (PGY 1-4) residents from February 2017 to June 2017. Residents rotating through participating clinical services during the study period were invited to participate and given further information by site leads via informational presentations, written handouts, and/or emails.

 

 

The intervention entailed residents delivering structured feedback to their colleagues regarding their patients’ diagnoses after transitions of care. The predominant setting was the inpatient hospital medicine day-shift team providing feedback to the night-shift team regarding overnight admissions. Feedback about patients (usually chosen by the day-shift team) was delivered through completion of a standard templated form (Figure) usually sent within 24 hours after hospital admission through secure messaging (ie, EPIC In-Basket message utilizing a Smartphrase of the LOOP feedback form). A 24-hour time period was chosen to allow for rapid cycling of feedback focusing on initial diagnostic assessment. Site leads and resident champions promoted the project through presentations, informal discussions, and prizes for high completion rates of forms and surveys (ie, coffee cards and pizza).



Feedback forms were collected by site leads. A categorization rubric was developed during a pilot phase. Diagnoses before and after the transition of care were categorized as no change, diagnostic refinement (ie, the initial diagnosis was modified to be more specific), disease evolution (ie, the patient’s physiology or disease course changed), or major diagnostic change (ie, the initial and subsequent diagnoses differed substantially). Site leads acted as single-coders and conference calls were held to discuss coding and build consensus regarding the taxonomy. Diagnoses were not labeled as “right” or “wrong”; instead, categorization focused on differences between diagnoses before and after transitions of care.

Residents were invited to complete surveys before and after the rotation during which they had the opportunity to give or receive feedback. A unique identifier was entered by each participant to allow pairing of pre- and postsurveys. The survey (Appendix 1) was developed and refined during the initial pilot phase at the University of Minnesota. Surveys were collected using RedCap and analyzed using SAS version 9.3 (SAS Institute Inc., Cary, North Carolina). Differences between pre- and postsurveys were calculated using paired t-tests for continuous variables, and descriptive statistics were used for demographic and other items. Only surveys completed by individuals who completed both pre- and postsurveys were included in the analysis.

RESULTS

Overall, there were 716 current residents in the training programs that participated in this study; one site planned on participating but did not complete any forms. A total of 405 residents were eligible to participate during the study period. Overall, 221 (54.5%) presurveys and 90 postsurveys were completed (22.2%); 54 residents (13.3%) completed both pre- and postsurveys and were included in the analysis. Of the 54 survey respondents, 26 (48.15%) were female.

Survey results (Table) indicated significantly improved self-efficacy in identifying cognitive errors in residents’ own practice, identifying why those errors occurred, and identifying strategies to decrease future diagnostic errors. Participants noted increased frequency of discussions within teams regarding differential diagnoses, diagnostic errors, and why diagnoses changed over time. The feedback process was viewed positively by participants, who were also generally satisfied with the overall quality, frequency, and value of the feedback received. After the intervention, participants reported an increase in the amount of feedback received for night admissions and an overall increase in the perception that nighttime admissions were as “educational” as daytime admissions.



Of 544 collected forms, 238 (43.7%) showed some diagnostic change. These changes were further categorized into disease evolution (60 forms, 11.0%), diagnostic refinement (109 forms, 20.0%), and major diagnostic change (69 forms, 12.7%).

 

 

CONCLUSION

This study suggests that an intervention to operationalize standardized, structured feedback about diagnostic decision-making around transitions of care is a promising approach to improve residents’ understanding of changes in, and evolution of, the diagnostic process, as well as improve the perceived educational value of overnight admissions. In our results, over 40% of the patients admitted by residents had some change in their diagnoses after a transition of care during their early hospitalization. This finding highlights the importance of ensuring that trainees have the opportunity to know the outcomes of their decisions. Indeed, residents should be encouraged to follow-up on their own patients without prompting; however, studies show that this practice is uncommon and interventions beyond admonition are necessary.4

The diagnostic change rate observed in this study confirms that diagnosis is an iterative process and that the concept of a working diagnosis is key—a diagnosis made at admission will very likely be modified by time, the natural history of the disease, and new clinical information. When diagnoses are viewed as working diagnoses, trainees may be empowered to better understand the diagnostic process. As learners and teachers adopt this perspective, training programs are more likely to be successful in helping learners calibrate toward expertise.

Previous studies have questioned whether resident physicians view overnight admissions as valuable.6 After our intervention, we found an increase in both the amount of feedback received and the proportion of participants who agreed that night and day admissions were equally educational, suggesting that targeted diagnostic reasoning feedback can bolster educational value of nighttime admissions.

This study presents a number of limitations. First, the survey response rate was low, which could potentially lead to biased results. We excluded those respondents who did not respond to both the pre- and postsurveys from the analysis. Second, we did not measure actual change in diagnostic performance. While learners did report learning and saw feedback as valuable, self-identified learning points may not always translate to improved patient care. Additionally, residents chose the patients for whom feedback was provided, and the diagnostic change rate described may be overestimated. We did not track the total number of admissions for which feedback could have been delivered during the study. We did not include a control group, and the intervention may not be responsible for changing learners’ perceptions. However, the included programs were not implementing other new protocols focused on diagnostic reasoning during the study period. In addition, we addressed diagnostic changes early in a hospital course; a comprehensive program should address more feedback loops (eg, discharging team to admitting team).

This work is a pilot study; for future interventions focused on improving calibration to be sustainable, they should be congruent with existing clinical workflows and avoid adding to the stress and/or cognitive load of an already-busy clinical experience. The most optimal strategies for delivering feedback about clinical reasoning remain unclear.

In summary, a program to deliver structured feedback among resident physicians about diagnostic reasoning across care transitions for selected hospitalized patients is viewed positively by trainees, is feasible, and leads to changes in resident perception and self-efficacy. Future studies and interventions should aim to provide feedback more systematically, rather than just for selected patients, and objectively track diagnostic changes over time in hospitalized patients. While truly objective diagnostic information is challenging to obtain, comparing admission and other inpatient diagnoses to discharge diagnoses or diagnoses from primary care follow-up visits may be helpful. In addition, studies should aim to track trainees’ clinical decision-making over time and determine the effectiveness of feedback at improving diagnostic performance through calibration.

 

 

 

Acknowledgments

The authors thank the trainees who participated in this study, as well as the residency leadership at participating institutions. The authors also thank Qi Wang, PhD, for providing statistical analysis.

Disclosures

The authors have nothing to disclose.

Funding

The study was funded by an AAIM Innovation Grant and local support at each participating institution.

References

1. Croskerry P. The feedback sanction. Acad Emerg Med. 2000;7(11):1232-1238. https://doi.org/10.1111/j.1553-2712.2000.tb00468.x.
2. Trowbridge RL, Dhaliwal G, Cosby KS. Educational agenda for diagnostic error reduction. BMJ Qual Saf. 2013;22(Suppl 2):ii28-ii32. https://doi.org/10.1136/bmjqs-2012-001622.
3. Dhaliwal G. Clinical excellence: make it a habit. Acad Med. 2012;87(11):1473. https://doi.org/10.1097/ACM.0b013e31826d68d9.
4. Shenvi EC, Feupe SF, Yang H, El-Kareh R. Closing the loop: a mixed-methods study about resident learning from outcome feedback after patient handoffs. Diagnosis. 2018;5(4):235-242. https://doi.org/10.1515/dx-2018-0013.
5. Rencic J. Twelve tips for teaching expertise in clinical reasoning. Med Teach. 2011;33(11):887-892. https://doi.org/10.3109/0142159X.2011.558142.
6. Bump GM, Zimmer SM, McNeil MA, Elnicki DM. Hold-over admissions: are they educational for residents? J Gen Intern Med. 2014;29(3):463-467. https://doi.org/10.1007/s11606-013-2667-y.

References

1. Croskerry P. The feedback sanction. Acad Emerg Med. 2000;7(11):1232-1238. https://doi.org/10.1111/j.1553-2712.2000.tb00468.x.
2. Trowbridge RL, Dhaliwal G, Cosby KS. Educational agenda for diagnostic error reduction. BMJ Qual Saf. 2013;22(Suppl 2):ii28-ii32. https://doi.org/10.1136/bmjqs-2012-001622.
3. Dhaliwal G. Clinical excellence: make it a habit. Acad Med. 2012;87(11):1473. https://doi.org/10.1097/ACM.0b013e31826d68d9.
4. Shenvi EC, Feupe SF, Yang H, El-Kareh R. Closing the loop: a mixed-methods study about resident learning from outcome feedback after patient handoffs. Diagnosis. 2018;5(4):235-242. https://doi.org/10.1515/dx-2018-0013.
5. Rencic J. Twelve tips for teaching expertise in clinical reasoning. Med Teach. 2011;33(11):887-892. https://doi.org/10.3109/0142159X.2011.558142.
6. Bump GM, Zimmer SM, McNeil MA, Elnicki DM. Hold-over admissions: are they educational for residents? J Gen Intern Med. 2014;29(3):463-467. https://doi.org/10.1007/s11606-013-2667-y.

Issue
Journal of Hospital Medicine 14(10)
Issue
Journal of Hospital Medicine 14(10)
Page Number
622-625. Published online first August 21, 2019
Page Number
622-625. Published online first August 21, 2019
Topics
Article Type
Sections
Article Source

© 2019 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Kathleen P. Lane, MD; E-mail: [email protected]; Telephone: 612-624-8984
Content Gating
Gated (full article locked unless allowed per User)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Gating Strategy
First Peek Free
Article PDF Media
Media Files

An On-Treatment Analysis of the MARQUIS Study: Interventions to Improve Inpatient Medication Reconciliation

Article Type
Changed
Sun, 10/13/2019 - 21:47

Unintentional medication discrepancies in the hospital setting are common and contribute to adverse drug events, resulting in patient harm.1 Discrepancies can be resolved by implementing high-quality medication reconciliation, but there are insufficient data to guide hospitals as to which interventions are most effective at improving medication reconciliation processes and reducing harm.2 We recently reported that implementation of a best practices toolkit reduced total medication discrepancies in the Multi-Center Medication Reconciliation Quality Improvement Study (MARQUIS).3 This report describes the effect of individual toolkit components on rates of medication discrepancies with the potential for patient harm.

METHODS

Detailed descriptions of the intervention toolkit and study design of MARQUIS are published.4,5 Briefly, MARQUIS was a pragmatic, mentored, quality improvement (QI) study in which five hospitals in the United States implemented interventions from a best practices toolkit to improve medication reconciliation on noncritical care medical and surgical units from September 2011 to July 2014. We used a mentored implementation approach, in which each site identified the leaders of their local quality improvement team (ie, mentees) who received mentorship from a trained physician with QI and medication safety experience.6 Mentors conducted monthly calls with their mentees and two site visits. Sites adapted and implemented one or more components from the MARQUIS toolkit, a compilation of evidence-based best practices in medication reconciliation.5,7

The primary outcome was unintentional medication discrepancies in admission and discharge orders with the potential for causing harm, as previously described.4 Trained study pharmacists at each site took “gold standard” medication histories on a random sample of up to 22 patients per month. These medications were then compared with admission and discharge medication orders, and all unintentional discrepancies were identified. The discrepancies were then adjudicated by physicians blinded to the treatment arm, who confirmed whether discrepancies were unintentional and carried the potential for patient harm.

We employed a modification of a stepped wedge methodology to measure the incremental effect of implementing nine different intervention components, introduced at different sites over the course of the study, on the number of potentially harmful discrepancies per patient. These analyses were restricted to the postimplementation period on hospital units that implemented at least one intervention. All interventions conducted at each site were categorized by component, including dates of implementation. Each intervention component could be applied more than once per site (eg, when involving a new group of providers) or implemented on a new hospital unit or service, in which case, all dates were included in the analysis. We conducted a multivariable Poisson regression (with time divided into months) adjusted for patient factors, season, and site, with the number of potentially harmful discrepancies as the dependent variable, and the total number of gold standard medications as a model offset. The model was designed to analyze changes in the y-intercept each time an intervention component was either implemented or spread and assumed the change in the y-intercept was the same for each of these events for any given component. The model also assumes that combinations of interventions had independent additive effects.

 

 

RESULTS

Across the five participating sites, 1,648 patients were enrolled from September 2011 to July 2014. This number included 613 patients during the preimplementation period and 1,035 patients during the postimplementation period, of which 791 were on intervention units and comprised the study population. Table 1 displays the intervention components implemented by site. Sites implemented between one and seven components. The most frequently implemented intervention component was training existing staff to take the best possible medication histories (BPMHs), implemented at four sites. The regression results are displayed in Table 2. Three interventions were associated with significant decreases in potentially harmful discrepancy rates: (1) clearly defining roles and responsibilities and communicating this with clinical staff (hazard ratio [HR] 0.53, 95% CI: 0.32–0.87); (2) training existing staff to perform discharge medication reconciliation and patient counseling (HR 0.64, 95% CI: 0.46–0.89); and (3) hiring additional staff to perform discharge medication reconciliation and patient counseling (HR 0.48, 95% CI: 0.31–0.77). Two interventions were associated with significant increases in potentially harmful discrepancy rates: training existing staff to take BPMHs (HR 1.38, 95% CI: 1.21–1.57) and implementing a new electronic health record (EHR; HR 2.21, 95% CI: 1.64–2.97).

DISCUSSION

We noted that three intervention components were associated with decreased rates of unintentional medication discrepancies with potential for harm, whereas two were associated with increased rates. The components with a beneficial effect were not surprising. A prior qualitative study demonstrated the confusion related to clinicians’ roles and responsibilities during medication reconciliation; therefore, clear delineations should reduce rework and improve the medication reconciliation process.8 Other studies have shown the benefits of pharmacist involvement in the inpatient setting, particularly in reducing errors at discharge.9 However, we did not anticipate that training staff to take BPMHs would be detrimental. Possible reasons for this finding that are based on direct observations by mentors at site visits or noted during monthly calls include (1) training personnel on this task without certification of competency may not sufficiently improve their skills, leading instead to diffusion of responsibility; (2) training personnel without sufficient time to perform the task well (eg, frontline nurses with many other responsibilities) may be counterproductive compared with training a few personnel with time dedicated to this task; and (3) training existing personnel in history-taking may have been used to delay the necessary hiring of more staff to take BPMHs. Future studies could address several of these shortcomings in both the design and implementation of medication history-training intervention components.

Several reasons may explain the association we found between implementing a new EHR and increased rates of discrepancies. Based on mentors’ experiences, we suspect it is because sitewide EHR implementation requires significant resources, time, and effort. Therefore, sitewide EHR implementation pulls attention away from a focus on medication safety. Most large vendor EHRs have design flaws in their medication reconciliation modules, with the overarching problem being that their systems are not designed for an interdisciplinary team approach to medication reconciliation (unpublished material). In addition, problems may also exist with the local implementation of these modules and the way they are used by clinicians (eg, bypassing critical steps in the medication reconciliation process that lead to new medication errors). We have updated the MARQUIS toolkit to include pros and cons of EHR software and ideal features and functions of medication reconciliation information technology. We should note that this finding contrasts with previous studies that showed beneficial effects of dedicated medication reconciliation applications, which used proprietary technology, often combined with process redesign, in a focused QI effort.10-13 These findings suggest the need for improvements in the design, local customization, and use of medication reconciliation modules in vendor EHRs.

Our study has several limitations. We conducted an on-treatment analysis, which may be confounded by characteristics of sites that chose to implement different intervention components; however, we adjusted for sites in the analysis. Some results are based on a limited number of sites implementing an intervention component (eg, defining roles and responsibilities). Although this was a longitudinal study, and we adjusted for seasonal effects, it is possible that temporal trends and cointerventions confounded our results. The adjudication of discrepancies for the potential for harm was somewhat subjective, although we used a rigorous process to ensure the reliability of adjudication, as in prior studies.3,14 As in the main analysis of the MARQUIS study, this analysis did not measure intervention fidelity.

Based on these analyses and the literature base, we recommend that hospitals focus first on hiring and training dedicated staff (usually pharmacists) to assist with medication reconciliation at discharge.7 Hospitals should also be aware of potential increases in medication discrepancies when implementing a large vendor EHR across their institution. Further work is needed on the best ways to mitigate these adverse effects, at both the design and local site levels. Finally, the effect of medication history training on discrepancies warrants further study.

 

 

Disclosures

SK has served as a consultant to Verustat, a remote health monitoring company. All other authors have no disclosures or conflicts of interests.

Funding

This study was supported by the Agency for Healthcare Research and Quality (grant number: R18 HS019598). JLS has received funding from (1) Mallinckrodt Pharmaceuticals for an investigator-initiated study of opioid-related adverse drug events in postsurgical patients; (2) Horizon Blue Cross Blue Shield for an honorarium and travel expenses for workshop on medication reconciliation; (3) Island Peer Review Organization for honorarium and travel expenses for workshop on medication reconciliation; and, (4) Portola Pharmaceuticals for investigator-initiated study of inpatients who decline subcutaneous medications for venous thromboembolism prophylaxis. ASM was funded by a VA HSR&D Career Development Award (12-168).

Trial Registration

ClinicalTrials.gov NCT01337063

References

1. Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005;165(4):424-429. https://doi.org/10.1001/archinte.165.4.424.
2. Kaboli PJ, Fernandes O. Medication reconciliation: moving forward. Arch Intern Med. 2012;172(14):1069-1070. https://doi.org/10.1001/archinternmed.2012.2667. PubMed
3. Schnipper JL, Mixon A, Stein J, et al. Effects of a multifaceted medication reconciliation quality improvement intervention on patient safety: final results of the MARQUIS study. BMJ Qual Saf. 2018;27(12):954-964. https://doi.org/10.1136/bmjqs-2018-008233.
4. Salanitro AH, Kripalani S, Resnic J, et al. Rational and design of the Multicenter Medication Reconciliation Quality Improvement Study (MARQUIS). BMC Health Serv Res. 2013;13:230. https://doi.org/10.1186/1472-6963-13-230.
5. Mueller SK, Kripalani S, Stein J, et al. Development of a toolkit to disseminate best practices in inpatient medication reconciliation. Jt Comm J Qual Patient Saf. 2013;39(8):371-382. https://10.1016/S1553-7250(13)39051-5.
6. Maynard GA, Budnitz TL, Nickel WK, et al. 2011 John M. Eisenberg patient safety and quality awards. Mentored implementation: building leaders and achieving results through a collaborative improvement model. Innovation in patient safety and quality at the national level. Jt Comm J Qual Patient Saf. 2012;38(7):301-310. https://doi.org/10.1016/S1553-7250(12)38040-9.
7. Mueller SK, Sponsler KC, Kripalani S, Schnipper JL. Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med. 2012;172(14):1057-1069. https://doi.org/10.1001/archinternmed.2012.2246.
8. Vogelsmeier A, Pepper GA, Oderda L, Weir C. Medication reconciliation: a qualitative analysis of clinicians’ perceptions. Res Social Adm Pharm. 2013;9(4):419-430. https://doi.org/10.1016/j.sapharm.2012.08.002.
9. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955-964. https://doi.org/10.1001/archinte.166.9.955.
10. Plaisant C, Wu J, Hettinger AZ, Powsner S, Shneiderman B. Novel user interface design for medication reconciliation: an evaluation of Twinlist. J Am Med Inform Assoc. 2015;22(2):340-349. https://doi.org/10.1093/jamia/ocu021.
11. Bassi J, Lau F, Bardal S. Use of information technology in medication reconciliation: a scoping review. Ann Pharmacother. 2010;44(5):885-897. https://doi.org/10.1345/aph.1M699.
12. Marien S, Krug B, Spinewine A. Electronic tools to support medication reconciliation: a systematic review. J Am Med Inform Assoc. 2017;24(1):227-240. https://doi.org/10.1093/jamia/ocw068.
13. Agrawal A. Medication errors: prevention using information technology systems. Br J Clin Pharmacol. 2009;67(6):681-686. https://doi.org/10.1111/j.1365-2125.2009.03427.x.
14. Pippins JR, Gandhi TK, Hamann C, et al. Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med. 2008;23(9):1414-1422. https://doi.org/10.1007/s11606-008-0687-9.

Article PDF
Issue
Journal of Hospital Medicine 14(10)
Topics
Page Number
614-617. Published online first August 21, 2019
Sections
Article PDF
Article PDF
Related Articles

Unintentional medication discrepancies in the hospital setting are common and contribute to adverse drug events, resulting in patient harm.1 Discrepancies can be resolved by implementing high-quality medication reconciliation, but there are insufficient data to guide hospitals as to which interventions are most effective at improving medication reconciliation processes and reducing harm.2 We recently reported that implementation of a best practices toolkit reduced total medication discrepancies in the Multi-Center Medication Reconciliation Quality Improvement Study (MARQUIS).3 This report describes the effect of individual toolkit components on rates of medication discrepancies with the potential for patient harm.

METHODS

Detailed descriptions of the intervention toolkit and study design of MARQUIS are published.4,5 Briefly, MARQUIS was a pragmatic, mentored, quality improvement (QI) study in which five hospitals in the United States implemented interventions from a best practices toolkit to improve medication reconciliation on noncritical care medical and surgical units from September 2011 to July 2014. We used a mentored implementation approach, in which each site identified the leaders of their local quality improvement team (ie, mentees) who received mentorship from a trained physician with QI and medication safety experience.6 Mentors conducted monthly calls with their mentees and two site visits. Sites adapted and implemented one or more components from the MARQUIS toolkit, a compilation of evidence-based best practices in medication reconciliation.5,7

The primary outcome was unintentional medication discrepancies in admission and discharge orders with the potential for causing harm, as previously described.4 Trained study pharmacists at each site took “gold standard” medication histories on a random sample of up to 22 patients per month. These medications were then compared with admission and discharge medication orders, and all unintentional discrepancies were identified. The discrepancies were then adjudicated by physicians blinded to the treatment arm, who confirmed whether discrepancies were unintentional and carried the potential for patient harm.

We employed a modification of a stepped wedge methodology to measure the incremental effect of implementing nine different intervention components, introduced at different sites over the course of the study, on the number of potentially harmful discrepancies per patient. These analyses were restricted to the postimplementation period on hospital units that implemented at least one intervention. All interventions conducted at each site were categorized by component, including dates of implementation. Each intervention component could be applied more than once per site (eg, when involving a new group of providers) or implemented on a new hospital unit or service, in which case, all dates were included in the analysis. We conducted a multivariable Poisson regression (with time divided into months) adjusted for patient factors, season, and site, with the number of potentially harmful discrepancies as the dependent variable, and the total number of gold standard medications as a model offset. The model was designed to analyze changes in the y-intercept each time an intervention component was either implemented or spread and assumed the change in the y-intercept was the same for each of these events for any given component. The model also assumes that combinations of interventions had independent additive effects.

 

 

RESULTS

Across the five participating sites, 1,648 patients were enrolled from September 2011 to July 2014. This number included 613 patients during the preimplementation period and 1,035 patients during the postimplementation period, of which 791 were on intervention units and comprised the study population. Table 1 displays the intervention components implemented by site. Sites implemented between one and seven components. The most frequently implemented intervention component was training existing staff to take the best possible medication histories (BPMHs), implemented at four sites. The regression results are displayed in Table 2. Three interventions were associated with significant decreases in potentially harmful discrepancy rates: (1) clearly defining roles and responsibilities and communicating this with clinical staff (hazard ratio [HR] 0.53, 95% CI: 0.32–0.87); (2) training existing staff to perform discharge medication reconciliation and patient counseling (HR 0.64, 95% CI: 0.46–0.89); and (3) hiring additional staff to perform discharge medication reconciliation and patient counseling (HR 0.48, 95% CI: 0.31–0.77). Two interventions were associated with significant increases in potentially harmful discrepancy rates: training existing staff to take BPMHs (HR 1.38, 95% CI: 1.21–1.57) and implementing a new electronic health record (EHR; HR 2.21, 95% CI: 1.64–2.97).

DISCUSSION

We noted that three intervention components were associated with decreased rates of unintentional medication discrepancies with potential for harm, whereas two were associated with increased rates. The components with a beneficial effect were not surprising. A prior qualitative study demonstrated the confusion related to clinicians’ roles and responsibilities during medication reconciliation; therefore, clear delineations should reduce rework and improve the medication reconciliation process.8 Other studies have shown the benefits of pharmacist involvement in the inpatient setting, particularly in reducing errors at discharge.9 However, we did not anticipate that training staff to take BPMHs would be detrimental. Possible reasons for this finding that are based on direct observations by mentors at site visits or noted during monthly calls include (1) training personnel on this task without certification of competency may not sufficiently improve their skills, leading instead to diffusion of responsibility; (2) training personnel without sufficient time to perform the task well (eg, frontline nurses with many other responsibilities) may be counterproductive compared with training a few personnel with time dedicated to this task; and (3) training existing personnel in history-taking may have been used to delay the necessary hiring of more staff to take BPMHs. Future studies could address several of these shortcomings in both the design and implementation of medication history-training intervention components.

Several reasons may explain the association we found between implementing a new EHR and increased rates of discrepancies. Based on mentors’ experiences, we suspect it is because sitewide EHR implementation requires significant resources, time, and effort. Therefore, sitewide EHR implementation pulls attention away from a focus on medication safety. Most large vendor EHRs have design flaws in their medication reconciliation modules, with the overarching problem being that their systems are not designed for an interdisciplinary team approach to medication reconciliation (unpublished material). In addition, problems may also exist with the local implementation of these modules and the way they are used by clinicians (eg, bypassing critical steps in the medication reconciliation process that lead to new medication errors). We have updated the MARQUIS toolkit to include pros and cons of EHR software and ideal features and functions of medication reconciliation information technology. We should note that this finding contrasts with previous studies that showed beneficial effects of dedicated medication reconciliation applications, which used proprietary technology, often combined with process redesign, in a focused QI effort.10-13 These findings suggest the need for improvements in the design, local customization, and use of medication reconciliation modules in vendor EHRs.

Our study has several limitations. We conducted an on-treatment analysis, which may be confounded by characteristics of sites that chose to implement different intervention components; however, we adjusted for sites in the analysis. Some results are based on a limited number of sites implementing an intervention component (eg, defining roles and responsibilities). Although this was a longitudinal study, and we adjusted for seasonal effects, it is possible that temporal trends and cointerventions confounded our results. The adjudication of discrepancies for the potential for harm was somewhat subjective, although we used a rigorous process to ensure the reliability of adjudication, as in prior studies.3,14 As in the main analysis of the MARQUIS study, this analysis did not measure intervention fidelity.

Based on these analyses and the literature base, we recommend that hospitals focus first on hiring and training dedicated staff (usually pharmacists) to assist with medication reconciliation at discharge.7 Hospitals should also be aware of potential increases in medication discrepancies when implementing a large vendor EHR across their institution. Further work is needed on the best ways to mitigate these adverse effects, at both the design and local site levels. Finally, the effect of medication history training on discrepancies warrants further study.

 

 

Disclosures

SK has served as a consultant to Verustat, a remote health monitoring company. All other authors have no disclosures or conflicts of interests.

Funding

This study was supported by the Agency for Healthcare Research and Quality (grant number: R18 HS019598). JLS has received funding from (1) Mallinckrodt Pharmaceuticals for an investigator-initiated study of opioid-related adverse drug events in postsurgical patients; (2) Horizon Blue Cross Blue Shield for an honorarium and travel expenses for workshop on medication reconciliation; (3) Island Peer Review Organization for honorarium and travel expenses for workshop on medication reconciliation; and, (4) Portola Pharmaceuticals for investigator-initiated study of inpatients who decline subcutaneous medications for venous thromboembolism prophylaxis. ASM was funded by a VA HSR&D Career Development Award (12-168).

Trial Registration

ClinicalTrials.gov NCT01337063

Unintentional medication discrepancies in the hospital setting are common and contribute to adverse drug events, resulting in patient harm.1 Discrepancies can be resolved by implementing high-quality medication reconciliation, but there are insufficient data to guide hospitals as to which interventions are most effective at improving medication reconciliation processes and reducing harm.2 We recently reported that implementation of a best practices toolkit reduced total medication discrepancies in the Multi-Center Medication Reconciliation Quality Improvement Study (MARQUIS).3 This report describes the effect of individual toolkit components on rates of medication discrepancies with the potential for patient harm.

METHODS

Detailed descriptions of the intervention toolkit and study design of MARQUIS are published.4,5 Briefly, MARQUIS was a pragmatic, mentored, quality improvement (QI) study in which five hospitals in the United States implemented interventions from a best practices toolkit to improve medication reconciliation on noncritical care medical and surgical units from September 2011 to July 2014. We used a mentored implementation approach, in which each site identified the leaders of their local quality improvement team (ie, mentees) who received mentorship from a trained physician with QI and medication safety experience.6 Mentors conducted monthly calls with their mentees and two site visits. Sites adapted and implemented one or more components from the MARQUIS toolkit, a compilation of evidence-based best practices in medication reconciliation.5,7

The primary outcome was unintentional medication discrepancies in admission and discharge orders with the potential for causing harm, as previously described.4 Trained study pharmacists at each site took “gold standard” medication histories on a random sample of up to 22 patients per month. These medications were then compared with admission and discharge medication orders, and all unintentional discrepancies were identified. The discrepancies were then adjudicated by physicians blinded to the treatment arm, who confirmed whether discrepancies were unintentional and carried the potential for patient harm.

We employed a modification of a stepped wedge methodology to measure the incremental effect of implementing nine different intervention components, introduced at different sites over the course of the study, on the number of potentially harmful discrepancies per patient. These analyses were restricted to the postimplementation period on hospital units that implemented at least one intervention. All interventions conducted at each site were categorized by component, including dates of implementation. Each intervention component could be applied more than once per site (eg, when involving a new group of providers) or implemented on a new hospital unit or service, in which case, all dates were included in the analysis. We conducted a multivariable Poisson regression (with time divided into months) adjusted for patient factors, season, and site, with the number of potentially harmful discrepancies as the dependent variable, and the total number of gold standard medications as a model offset. The model was designed to analyze changes in the y-intercept each time an intervention component was either implemented or spread and assumed the change in the y-intercept was the same for each of these events for any given component. The model also assumes that combinations of interventions had independent additive effects.

 

 

RESULTS

Across the five participating sites, 1,648 patients were enrolled from September 2011 to July 2014. This number included 613 patients during the preimplementation period and 1,035 patients during the postimplementation period, of which 791 were on intervention units and comprised the study population. Table 1 displays the intervention components implemented by site. Sites implemented between one and seven components. The most frequently implemented intervention component was training existing staff to take the best possible medication histories (BPMHs), implemented at four sites. The regression results are displayed in Table 2. Three interventions were associated with significant decreases in potentially harmful discrepancy rates: (1) clearly defining roles and responsibilities and communicating this with clinical staff (hazard ratio [HR] 0.53, 95% CI: 0.32–0.87); (2) training existing staff to perform discharge medication reconciliation and patient counseling (HR 0.64, 95% CI: 0.46–0.89); and (3) hiring additional staff to perform discharge medication reconciliation and patient counseling (HR 0.48, 95% CI: 0.31–0.77). Two interventions were associated with significant increases in potentially harmful discrepancy rates: training existing staff to take BPMHs (HR 1.38, 95% CI: 1.21–1.57) and implementing a new electronic health record (EHR; HR 2.21, 95% CI: 1.64–2.97).

DISCUSSION

We noted that three intervention components were associated with decreased rates of unintentional medication discrepancies with potential for harm, whereas two were associated with increased rates. The components with a beneficial effect were not surprising. A prior qualitative study demonstrated the confusion related to clinicians’ roles and responsibilities during medication reconciliation; therefore, clear delineations should reduce rework and improve the medication reconciliation process.8 Other studies have shown the benefits of pharmacist involvement in the inpatient setting, particularly in reducing errors at discharge.9 However, we did not anticipate that training staff to take BPMHs would be detrimental. Possible reasons for this finding that are based on direct observations by mentors at site visits or noted during monthly calls include (1) training personnel on this task without certification of competency may not sufficiently improve their skills, leading instead to diffusion of responsibility; (2) training personnel without sufficient time to perform the task well (eg, frontline nurses with many other responsibilities) may be counterproductive compared with training a few personnel with time dedicated to this task; and (3) training existing personnel in history-taking may have been used to delay the necessary hiring of more staff to take BPMHs. Future studies could address several of these shortcomings in both the design and implementation of medication history-training intervention components.

Several reasons may explain the association we found between implementing a new EHR and increased rates of discrepancies. Based on mentors’ experiences, we suspect it is because sitewide EHR implementation requires significant resources, time, and effort. Therefore, sitewide EHR implementation pulls attention away from a focus on medication safety. Most large vendor EHRs have design flaws in their medication reconciliation modules, with the overarching problem being that their systems are not designed for an interdisciplinary team approach to medication reconciliation (unpublished material). In addition, problems may also exist with the local implementation of these modules and the way they are used by clinicians (eg, bypassing critical steps in the medication reconciliation process that lead to new medication errors). We have updated the MARQUIS toolkit to include pros and cons of EHR software and ideal features and functions of medication reconciliation information technology. We should note that this finding contrasts with previous studies that showed beneficial effects of dedicated medication reconciliation applications, which used proprietary technology, often combined with process redesign, in a focused QI effort.10-13 These findings suggest the need for improvements in the design, local customization, and use of medication reconciliation modules in vendor EHRs.

Our study has several limitations. We conducted an on-treatment analysis, which may be confounded by characteristics of sites that chose to implement different intervention components; however, we adjusted for sites in the analysis. Some results are based on a limited number of sites implementing an intervention component (eg, defining roles and responsibilities). Although this was a longitudinal study, and we adjusted for seasonal effects, it is possible that temporal trends and cointerventions confounded our results. The adjudication of discrepancies for the potential for harm was somewhat subjective, although we used a rigorous process to ensure the reliability of adjudication, as in prior studies.3,14 As in the main analysis of the MARQUIS study, this analysis did not measure intervention fidelity.

Based on these analyses and the literature base, we recommend that hospitals focus first on hiring and training dedicated staff (usually pharmacists) to assist with medication reconciliation at discharge.7 Hospitals should also be aware of potential increases in medication discrepancies when implementing a large vendor EHR across their institution. Further work is needed on the best ways to mitigate these adverse effects, at both the design and local site levels. Finally, the effect of medication history training on discrepancies warrants further study.

 

 

Disclosures

SK has served as a consultant to Verustat, a remote health monitoring company. All other authors have no disclosures or conflicts of interests.

Funding

This study was supported by the Agency for Healthcare Research and Quality (grant number: R18 HS019598). JLS has received funding from (1) Mallinckrodt Pharmaceuticals for an investigator-initiated study of opioid-related adverse drug events in postsurgical patients; (2) Horizon Blue Cross Blue Shield for an honorarium and travel expenses for workshop on medication reconciliation; (3) Island Peer Review Organization for honorarium and travel expenses for workshop on medication reconciliation; and, (4) Portola Pharmaceuticals for investigator-initiated study of inpatients who decline subcutaneous medications for venous thromboembolism prophylaxis. ASM was funded by a VA HSR&D Career Development Award (12-168).

Trial Registration

ClinicalTrials.gov NCT01337063

References

1. Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005;165(4):424-429. https://doi.org/10.1001/archinte.165.4.424.
2. Kaboli PJ, Fernandes O. Medication reconciliation: moving forward. Arch Intern Med. 2012;172(14):1069-1070. https://doi.org/10.1001/archinternmed.2012.2667. PubMed
3. Schnipper JL, Mixon A, Stein J, et al. Effects of a multifaceted medication reconciliation quality improvement intervention on patient safety: final results of the MARQUIS study. BMJ Qual Saf. 2018;27(12):954-964. https://doi.org/10.1136/bmjqs-2018-008233.
4. Salanitro AH, Kripalani S, Resnic J, et al. Rational and design of the Multicenter Medication Reconciliation Quality Improvement Study (MARQUIS). BMC Health Serv Res. 2013;13:230. https://doi.org/10.1186/1472-6963-13-230.
5. Mueller SK, Kripalani S, Stein J, et al. Development of a toolkit to disseminate best practices in inpatient medication reconciliation. Jt Comm J Qual Patient Saf. 2013;39(8):371-382. https://10.1016/S1553-7250(13)39051-5.
6. Maynard GA, Budnitz TL, Nickel WK, et al. 2011 John M. Eisenberg patient safety and quality awards. Mentored implementation: building leaders and achieving results through a collaborative improvement model. Innovation in patient safety and quality at the national level. Jt Comm J Qual Patient Saf. 2012;38(7):301-310. https://doi.org/10.1016/S1553-7250(12)38040-9.
7. Mueller SK, Sponsler KC, Kripalani S, Schnipper JL. Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med. 2012;172(14):1057-1069. https://doi.org/10.1001/archinternmed.2012.2246.
8. Vogelsmeier A, Pepper GA, Oderda L, Weir C. Medication reconciliation: a qualitative analysis of clinicians’ perceptions. Res Social Adm Pharm. 2013;9(4):419-430. https://doi.org/10.1016/j.sapharm.2012.08.002.
9. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955-964. https://doi.org/10.1001/archinte.166.9.955.
10. Plaisant C, Wu J, Hettinger AZ, Powsner S, Shneiderman B. Novel user interface design for medication reconciliation: an evaluation of Twinlist. J Am Med Inform Assoc. 2015;22(2):340-349. https://doi.org/10.1093/jamia/ocu021.
11. Bassi J, Lau F, Bardal S. Use of information technology in medication reconciliation: a scoping review. Ann Pharmacother. 2010;44(5):885-897. https://doi.org/10.1345/aph.1M699.
12. Marien S, Krug B, Spinewine A. Electronic tools to support medication reconciliation: a systematic review. J Am Med Inform Assoc. 2017;24(1):227-240. https://doi.org/10.1093/jamia/ocw068.
13. Agrawal A. Medication errors: prevention using information technology systems. Br J Clin Pharmacol. 2009;67(6):681-686. https://doi.org/10.1111/j.1365-2125.2009.03427.x.
14. Pippins JR, Gandhi TK, Hamann C, et al. Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med. 2008;23(9):1414-1422. https://doi.org/10.1007/s11606-008-0687-9.

References

1. Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005;165(4):424-429. https://doi.org/10.1001/archinte.165.4.424.
2. Kaboli PJ, Fernandes O. Medication reconciliation: moving forward. Arch Intern Med. 2012;172(14):1069-1070. https://doi.org/10.1001/archinternmed.2012.2667. PubMed
3. Schnipper JL, Mixon A, Stein J, et al. Effects of a multifaceted medication reconciliation quality improvement intervention on patient safety: final results of the MARQUIS study. BMJ Qual Saf. 2018;27(12):954-964. https://doi.org/10.1136/bmjqs-2018-008233.
4. Salanitro AH, Kripalani S, Resnic J, et al. Rational and design of the Multicenter Medication Reconciliation Quality Improvement Study (MARQUIS). BMC Health Serv Res. 2013;13:230. https://doi.org/10.1186/1472-6963-13-230.
5. Mueller SK, Kripalani S, Stein J, et al. Development of a toolkit to disseminate best practices in inpatient medication reconciliation. Jt Comm J Qual Patient Saf. 2013;39(8):371-382. https://10.1016/S1553-7250(13)39051-5.
6. Maynard GA, Budnitz TL, Nickel WK, et al. 2011 John M. Eisenberg patient safety and quality awards. Mentored implementation: building leaders and achieving results through a collaborative improvement model. Innovation in patient safety and quality at the national level. Jt Comm J Qual Patient Saf. 2012;38(7):301-310. https://doi.org/10.1016/S1553-7250(12)38040-9.
7. Mueller SK, Sponsler KC, Kripalani S, Schnipper JL. Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med. 2012;172(14):1057-1069. https://doi.org/10.1001/archinternmed.2012.2246.
8. Vogelsmeier A, Pepper GA, Oderda L, Weir C. Medication reconciliation: a qualitative analysis of clinicians’ perceptions. Res Social Adm Pharm. 2013;9(4):419-430. https://doi.org/10.1016/j.sapharm.2012.08.002.
9. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955-964. https://doi.org/10.1001/archinte.166.9.955.
10. Plaisant C, Wu J, Hettinger AZ, Powsner S, Shneiderman B. Novel user interface design for medication reconciliation: an evaluation of Twinlist. J Am Med Inform Assoc. 2015;22(2):340-349. https://doi.org/10.1093/jamia/ocu021.
11. Bassi J, Lau F, Bardal S. Use of information technology in medication reconciliation: a scoping review. Ann Pharmacother. 2010;44(5):885-897. https://doi.org/10.1345/aph.1M699.
12. Marien S, Krug B, Spinewine A. Electronic tools to support medication reconciliation: a systematic review. J Am Med Inform Assoc. 2017;24(1):227-240. https://doi.org/10.1093/jamia/ocw068.
13. Agrawal A. Medication errors: prevention using information technology systems. Br J Clin Pharmacol. 2009;67(6):681-686. https://doi.org/10.1111/j.1365-2125.2009.03427.x.
14. Pippins JR, Gandhi TK, Hamann C, et al. Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med. 2008;23(9):1414-1422. https://doi.org/10.1007/s11606-008-0687-9.

Issue
Journal of Hospital Medicine 14(10)
Issue
Journal of Hospital Medicine 14(10)
Page Number
614-617. Published online first August 21, 2019
Page Number
614-617. Published online first August 21, 2019
Topics
Article Type
Sections
Article Source

© 2019 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
*Corresponding Author: Amanda S. Mixon, MD, MS, MSPH, FHM; E-mail: [email protected]; Telephone: 615-936-3710; Twitter: @mixovida.
Content Gating
Gated (full article locked unless allowed per User)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Gating Strategy
First Peek Free
Article PDF Media

Night Call in a Teaching Hospital: 1979 and 2019

Article Type
Changed
Fri, 11/22/2019 - 13:16

N o matter the era, few aspects of residency are more defining or memorable than overnight call. Nights can be a time of growth and learning but also of fear and uncertainty, as residents take on the responsibility of managing sick patients on their own. One of us (ASD) started his residency in 1978 at the Massachusetts General Hospital in Boston; the other two (ST and BCY) started theirs in 2016 and 2017, respectively, at the University of Toronto. In this essay, we reflect on our experiences of night call separated by 40 years, highlighting what has changed and what has stayed the same.

1979

At 6 pm, a calm overtook the hospital as the daytime staff emptied out of the building. The only remaining residents were those on call for the night. Each team had one resident and one medical student responsible for about 20 inpatients. Teams also admitted new patients from the emergency department (ED). Since there were three teams who rotated the admissions, we were able to spend a part of our night on the inpatient ward. Most of the new patients had been thoroughly evaluated by a medical resident in the ED before we saw them, giving us a head start on eliciting their stories, performing physical examinations, reviewing the laboratory workup, and generating plans to present to the attending physician (who was called “the visit”) the next morning at 10 am .

We carried one pager that was about 7 inches long and 2 inches wide clipped to the waist of our pants. It could only make a beep; we then had to call the page operator to find out who wanted us. However, the pages were relatively few. Nurses called only when a patient was unstable, and other residents called only when a new patient was ready in the emergency department. At 9 pm , the laboratory data for the day were delivered to the ward nursing stations on computer-generated paper. Our job was to separate the pages connected by serrated breaks, review the results, and then file the pages in the charts. The nurses were aware of this routine, so they saved their questions for our presence on the wards, reducing the need to page us. At 10 pm , residents from all services went to the cafeteria for the “10 o’clock meal” when the food was free.We learned early in the year to drop everything at 10 pm ; otherwise, we did not eat. The social aspect of the group meal was comforting, but compared with today, the group was much more homogeneous and therefore less interesting. There were several women medical residents (although almost none in surgery), but very few minorities, and no openly gay residents.

Gathering data about patients prior to the current hospitalization required reviewing the “old chart,” which had to be delivered from patient records but was generally available when the patient was still in the ED. It contained typed discharge summaries and progress notes often handwritten by coresidents whom we knew. The handwriting was often difficult to read, outpatient notes were not included, and information from other hospitals was absent—but despite these deficiencies, we somehow managed just fine.


The patients on the inpatient ward were mostly stable, but more importantly, we had very few medications and tests to order. I recall prescribing fewer than 20 drugs—furosemide, hydrochlorothiazide, penicillins, cephalosporins, gentamicin, isoniazid, lidocaine, nitroglycerin, aminophylline, alpha-methyldopa, clonidine, propranolol, digoxin, hydralazine, indomethacin, steroids, and morphine. Orders for tests and imaging had to be physically written in the chart and could not be inputted remotely, which was a nuisance when we were away from the ward. However, we rarely ordered any imaging beyond plain radiographs at night. We did draw arterial blood gases and venous blood, administer oxygen, insert intravenous and central lines, take electrocardiograms, and perform urinalyses by microscopy. We did all these tasks ourselves for patients on the “ward service” (as opposed to the “private service”, which had to do with the type of insurance the patients possessed). As a result, we became experts in both blood drawing and intravenous line insertion—skills that might be less familiar to today’s residents.

Of course, patients did get acutely ill during the night. I recall intubating, cardioverting, performing phlebotomy to alleviate pulmonary edema, sending patients to surgery, and pronouncing death. Nevertheless, we often got sleep, and sometimes, several hours in a row. I had a rule; I always took a shower the next morning and put on clean clothes (we stayed until 5 pm , making the shifts 33.5 hours long). There was a camaraderie that existed between all of us at night. We were supportive, friendly, and knew each other by name, and more.

We were often frightened by the responsibility of managing sick patients alone. On particularly challenging nights, we would record our fears and feelings in a “night call diary” in one of the conference rooms—generally at 4
am . Some entries became legendary as people read and reread those months and years later. Mornings always brought a sense of relief and accomplishment, because when the sun came up, we knew that the other residents would not be far behind; when they arrived, we could tell our stories and get help.

There was definitely competitiveness to the work. Those who responded quickly to deteriorating patients were applauded; those who did not really know what to do were subtly disdained. However, over time, we all got the hang of it, and this led to a growing confidence that we were indeed doctors. The graded autonomy afforded by night call was a crucial part of that journey.

 

 

2019

At 6 pm , the on-call residents assemble in the ED, where we would spend the remainder of the night and early morning admitting new patients to the hospital. A night team consists of a senior resident, three junior residents, and two medical students, with each resident being responsible for approximately 20 inpatients. Overnight coverage of the ward mostly occurs remotely; since the ED is often so busy, we address most of the issues through a computer or over the phone. Only in rare cases, such as when a patient is unstable or a death has occurred, do we deal with the matter in person.

To enable rapid remote responses, we each carry an assortment of devices on our waists or lanyards and in our pockets, such as a personal pager, ED consult pager, code blue pager, and hospital-issued smartphones capable of receiving pages, text messages, phone calls, and e-mails. Nurses, pharmacists, and other consultants communicate with us through all of these channels. Few of these interactions occur face-to-face. To our frustration, encounters with patients are frequently interrupted by a stream of beeps, rings, and vibrations—irrespective of whether we are having a difficult discussion about goals of care or performing a delicate procedure.

The ED contains a work space dedicated for residents to enter electronic orders, type notes, and review new admissions. Between consults, we try to discuss exciting cases and provide teaching to the medical students and interns, which we enjoy. Dinner is generally devoured while inputting orders. In exceptional circumstances, a brief reprieve from pages may allow the on-call team to share a meal. Depending on our role, sleep may be possible on certain nights but is never guaranteed. Moments spent with the on-call team—all of us learning, commiserating, and growing together—are some of the most memorable of residency, and many of us become close friends by the end of the rotation.

However, apart from these few familiar faces, we rarely get acquainted with the nurses or residents from other services. Many often refer to themselves by specialty rather than name and phone calls that begin with “Are you Medicine?” can end with “You should really call Orthopedics.” Meanwhile, “Medicine” and “Orthopedics” may pass each other in the hallway without recognition beyond a vague familiarity of a voice heard on the phone.

Every 10 minutes spent with a new patient is accompanied by approximately one hour of “electronic” time, which includes reading through previous medical records, reviewing laboratory data and imaging, and creating an admission note. Interns might groan as they pull up a patient’s electronic health record (EHR); irrelevant details often arise with each click of the mouse, and the cursed “copy-paste” function means that new notes often duplicate older ones. However, with time, we learn to look past the EHR’s shortcomings and appreciate several of its advantages. For example, we are now able to access test results performed outside our hospital and thus limit our repetition of investigations. We can also use the EHR to rapidly glean salient information about a patient in time-critical scenarios. This is always a satisfying process, and it makes us wonder how physicians ever practiced in the era before computers.

Today’s patients are older and sicker than ever before. Many are receiving treatments that did not exist even a decade ago. As residents, we must recognize a seemingly endless variety of drugs—a challenging but intellectually satisfying responsibility. We must also decide whether the patient’s current health state permits their continuation, or whether safer alternatives exist. Some of these decisions cannot wait until the morning.

During handover at 8
am , we often recount moments from our call shift with a sense of vigor that is only partly dulled by fatigue. We may share with pride our management of a sick patient. We may relay a touching exchange with a concerned family member. Or we may recall with satisfaction our handling of a tense situation with a colleague. Taking part in these experiences is one of the most character-building aspects of being on call. The absence of our supervisors can be unnerving at first, but we gradually begin to enjoy the sense of independence. Moreover, we feel empowered to make our patients better with the right combination of carefully selected treatments. Nothing makes us feel more like doctors.

No doubt, being on call is difficult. The next day brings a feeling of relief and accomplishment, knowing that we got through it—whether by floundering or flourishing—in one piece.

 

 

CONCLUSION

The two passages described here are personal descriptions of a typical night on-call in two different eras. Readers around the world may have a very different recollection of their own experience. Nevertheless, several aspects of being on call remain constant, such as anxiety about caring for sick patients alone, fond recollections of friends made, and relief when the morning comes. Most important, however, might be the tremendous satisfaction at the opportunity to learn and grow—to become a competent physician by testing one’s physical and intellectual limits through graded autonomy

On the other hand, certain elements of night call have undeniably changed—partly a consequence of the increased number of people involved in patient care and changing communication technology. Residents today encounter a greater number of interruptions to their work flow. Tasks that require long, continuous periods of full attention are now punctuated by texts, e-mails, calls, and pages. The EHR is often clumsy to navigate, but it can also be a veritable mine of information. Finally, although residents from the same specialty may be close friends, duty hour restrictions and remote asynchronous communication may reduce familiarity with residents from other programs.

Do these descriptions resonate with your experience of night call? Keeping in mind that the 1979 vignette is described through the rose-colored lens of nostalgia, both eras have their advantages and disadvantages. We leave it to the reader to decide what has changed (plus ça change) and what has stayed the same (plus c’est la même chose).

Acknowledgments

The authors thank Micheal A. Fifer, MD (Massachusetts General Hospital), and Timothy J. Judson, MD (UCSF), for their comments on an earlier draft of this essay.

Disclosures

The authors have nothing to disclose.

Article PDF
Issue
Journal of Hospital Medicine 14(12)
Topics
Page Number
782-784. Published online first August 21, 2019
Sections
Article PDF
Article PDF
Related Articles

N o matter the era, few aspects of residency are more defining or memorable than overnight call. Nights can be a time of growth and learning but also of fear and uncertainty, as residents take on the responsibility of managing sick patients on their own. One of us (ASD) started his residency in 1978 at the Massachusetts General Hospital in Boston; the other two (ST and BCY) started theirs in 2016 and 2017, respectively, at the University of Toronto. In this essay, we reflect on our experiences of night call separated by 40 years, highlighting what has changed and what has stayed the same.

1979

At 6 pm, a calm overtook the hospital as the daytime staff emptied out of the building. The only remaining residents were those on call for the night. Each team had one resident and one medical student responsible for about 20 inpatients. Teams also admitted new patients from the emergency department (ED). Since there were three teams who rotated the admissions, we were able to spend a part of our night on the inpatient ward. Most of the new patients had been thoroughly evaluated by a medical resident in the ED before we saw them, giving us a head start on eliciting their stories, performing physical examinations, reviewing the laboratory workup, and generating plans to present to the attending physician (who was called “the visit”) the next morning at 10 am .

We carried one pager that was about 7 inches long and 2 inches wide clipped to the waist of our pants. It could only make a beep; we then had to call the page operator to find out who wanted us. However, the pages were relatively few. Nurses called only when a patient was unstable, and other residents called only when a new patient was ready in the emergency department. At 9 pm , the laboratory data for the day were delivered to the ward nursing stations on computer-generated paper. Our job was to separate the pages connected by serrated breaks, review the results, and then file the pages in the charts. The nurses were aware of this routine, so they saved their questions for our presence on the wards, reducing the need to page us. At 10 pm , residents from all services went to the cafeteria for the “10 o’clock meal” when the food was free.We learned early in the year to drop everything at 10 pm ; otherwise, we did not eat. The social aspect of the group meal was comforting, but compared with today, the group was much more homogeneous and therefore less interesting. There were several women medical residents (although almost none in surgery), but very few minorities, and no openly gay residents.

Gathering data about patients prior to the current hospitalization required reviewing the “old chart,” which had to be delivered from patient records but was generally available when the patient was still in the ED. It contained typed discharge summaries and progress notes often handwritten by coresidents whom we knew. The handwriting was often difficult to read, outpatient notes were not included, and information from other hospitals was absent—but despite these deficiencies, we somehow managed just fine.


The patients on the inpatient ward were mostly stable, but more importantly, we had very few medications and tests to order. I recall prescribing fewer than 20 drugs—furosemide, hydrochlorothiazide, penicillins, cephalosporins, gentamicin, isoniazid, lidocaine, nitroglycerin, aminophylline, alpha-methyldopa, clonidine, propranolol, digoxin, hydralazine, indomethacin, steroids, and morphine. Orders for tests and imaging had to be physically written in the chart and could not be inputted remotely, which was a nuisance when we were away from the ward. However, we rarely ordered any imaging beyond plain radiographs at night. We did draw arterial blood gases and venous blood, administer oxygen, insert intravenous and central lines, take electrocardiograms, and perform urinalyses by microscopy. We did all these tasks ourselves for patients on the “ward service” (as opposed to the “private service”, which had to do with the type of insurance the patients possessed). As a result, we became experts in both blood drawing and intravenous line insertion—skills that might be less familiar to today’s residents.

Of course, patients did get acutely ill during the night. I recall intubating, cardioverting, performing phlebotomy to alleviate pulmonary edema, sending patients to surgery, and pronouncing death. Nevertheless, we often got sleep, and sometimes, several hours in a row. I had a rule; I always took a shower the next morning and put on clean clothes (we stayed until 5 pm , making the shifts 33.5 hours long). There was a camaraderie that existed between all of us at night. We were supportive, friendly, and knew each other by name, and more.

We were often frightened by the responsibility of managing sick patients alone. On particularly challenging nights, we would record our fears and feelings in a “night call diary” in one of the conference rooms—generally at 4
am . Some entries became legendary as people read and reread those months and years later. Mornings always brought a sense of relief and accomplishment, because when the sun came up, we knew that the other residents would not be far behind; when they arrived, we could tell our stories and get help.

There was definitely competitiveness to the work. Those who responded quickly to deteriorating patients were applauded; those who did not really know what to do were subtly disdained. However, over time, we all got the hang of it, and this led to a growing confidence that we were indeed doctors. The graded autonomy afforded by night call was a crucial part of that journey.

 

 

2019

At 6 pm , the on-call residents assemble in the ED, where we would spend the remainder of the night and early morning admitting new patients to the hospital. A night team consists of a senior resident, three junior residents, and two medical students, with each resident being responsible for approximately 20 inpatients. Overnight coverage of the ward mostly occurs remotely; since the ED is often so busy, we address most of the issues through a computer or over the phone. Only in rare cases, such as when a patient is unstable or a death has occurred, do we deal with the matter in person.

To enable rapid remote responses, we each carry an assortment of devices on our waists or lanyards and in our pockets, such as a personal pager, ED consult pager, code blue pager, and hospital-issued smartphones capable of receiving pages, text messages, phone calls, and e-mails. Nurses, pharmacists, and other consultants communicate with us through all of these channels. Few of these interactions occur face-to-face. To our frustration, encounters with patients are frequently interrupted by a stream of beeps, rings, and vibrations—irrespective of whether we are having a difficult discussion about goals of care or performing a delicate procedure.

The ED contains a work space dedicated for residents to enter electronic orders, type notes, and review new admissions. Between consults, we try to discuss exciting cases and provide teaching to the medical students and interns, which we enjoy. Dinner is generally devoured while inputting orders. In exceptional circumstances, a brief reprieve from pages may allow the on-call team to share a meal. Depending on our role, sleep may be possible on certain nights but is never guaranteed. Moments spent with the on-call team—all of us learning, commiserating, and growing together—are some of the most memorable of residency, and many of us become close friends by the end of the rotation.

However, apart from these few familiar faces, we rarely get acquainted with the nurses or residents from other services. Many often refer to themselves by specialty rather than name and phone calls that begin with “Are you Medicine?” can end with “You should really call Orthopedics.” Meanwhile, “Medicine” and “Orthopedics” may pass each other in the hallway without recognition beyond a vague familiarity of a voice heard on the phone.

Every 10 minutes spent with a new patient is accompanied by approximately one hour of “electronic” time, which includes reading through previous medical records, reviewing laboratory data and imaging, and creating an admission note. Interns might groan as they pull up a patient’s electronic health record (EHR); irrelevant details often arise with each click of the mouse, and the cursed “copy-paste” function means that new notes often duplicate older ones. However, with time, we learn to look past the EHR’s shortcomings and appreciate several of its advantages. For example, we are now able to access test results performed outside our hospital and thus limit our repetition of investigations. We can also use the EHR to rapidly glean salient information about a patient in time-critical scenarios. This is always a satisfying process, and it makes us wonder how physicians ever practiced in the era before computers.

Today’s patients are older and sicker than ever before. Many are receiving treatments that did not exist even a decade ago. As residents, we must recognize a seemingly endless variety of drugs—a challenging but intellectually satisfying responsibility. We must also decide whether the patient’s current health state permits their continuation, or whether safer alternatives exist. Some of these decisions cannot wait until the morning.

During handover at 8
am , we often recount moments from our call shift with a sense of vigor that is only partly dulled by fatigue. We may share with pride our management of a sick patient. We may relay a touching exchange with a concerned family member. Or we may recall with satisfaction our handling of a tense situation with a colleague. Taking part in these experiences is one of the most character-building aspects of being on call. The absence of our supervisors can be unnerving at first, but we gradually begin to enjoy the sense of independence. Moreover, we feel empowered to make our patients better with the right combination of carefully selected treatments. Nothing makes us feel more like doctors.

No doubt, being on call is difficult. The next day brings a feeling of relief and accomplishment, knowing that we got through it—whether by floundering or flourishing—in one piece.

 

 

CONCLUSION

The two passages described here are personal descriptions of a typical night on-call in two different eras. Readers around the world may have a very different recollection of their own experience. Nevertheless, several aspects of being on call remain constant, such as anxiety about caring for sick patients alone, fond recollections of friends made, and relief when the morning comes. Most important, however, might be the tremendous satisfaction at the opportunity to learn and grow—to become a competent physician by testing one’s physical and intellectual limits through graded autonomy

On the other hand, certain elements of night call have undeniably changed—partly a consequence of the increased number of people involved in patient care and changing communication technology. Residents today encounter a greater number of interruptions to their work flow. Tasks that require long, continuous periods of full attention are now punctuated by texts, e-mails, calls, and pages. The EHR is often clumsy to navigate, but it can also be a veritable mine of information. Finally, although residents from the same specialty may be close friends, duty hour restrictions and remote asynchronous communication may reduce familiarity with residents from other programs.

Do these descriptions resonate with your experience of night call? Keeping in mind that the 1979 vignette is described through the rose-colored lens of nostalgia, both eras have their advantages and disadvantages. We leave it to the reader to decide what has changed (plus ça change) and what has stayed the same (plus c’est la même chose).

Acknowledgments

The authors thank Micheal A. Fifer, MD (Massachusetts General Hospital), and Timothy J. Judson, MD (UCSF), for their comments on an earlier draft of this essay.

Disclosures

The authors have nothing to disclose.

N o matter the era, few aspects of residency are more defining or memorable than overnight call. Nights can be a time of growth and learning but also of fear and uncertainty, as residents take on the responsibility of managing sick patients on their own. One of us (ASD) started his residency in 1978 at the Massachusetts General Hospital in Boston; the other two (ST and BCY) started theirs in 2016 and 2017, respectively, at the University of Toronto. In this essay, we reflect on our experiences of night call separated by 40 years, highlighting what has changed and what has stayed the same.

1979

At 6 pm, a calm overtook the hospital as the daytime staff emptied out of the building. The only remaining residents were those on call for the night. Each team had one resident and one medical student responsible for about 20 inpatients. Teams also admitted new patients from the emergency department (ED). Since there were three teams who rotated the admissions, we were able to spend a part of our night on the inpatient ward. Most of the new patients had been thoroughly evaluated by a medical resident in the ED before we saw them, giving us a head start on eliciting their stories, performing physical examinations, reviewing the laboratory workup, and generating plans to present to the attending physician (who was called “the visit”) the next morning at 10 am .

We carried one pager that was about 7 inches long and 2 inches wide clipped to the waist of our pants. It could only make a beep; we then had to call the page operator to find out who wanted us. However, the pages were relatively few. Nurses called only when a patient was unstable, and other residents called only when a new patient was ready in the emergency department. At 9 pm , the laboratory data for the day were delivered to the ward nursing stations on computer-generated paper. Our job was to separate the pages connected by serrated breaks, review the results, and then file the pages in the charts. The nurses were aware of this routine, so they saved their questions for our presence on the wards, reducing the need to page us. At 10 pm , residents from all services went to the cafeteria for the “10 o’clock meal” when the food was free.We learned early in the year to drop everything at 10 pm ; otherwise, we did not eat. The social aspect of the group meal was comforting, but compared with today, the group was much more homogeneous and therefore less interesting. There were several women medical residents (although almost none in surgery), but very few minorities, and no openly gay residents.

Gathering data about patients prior to the current hospitalization required reviewing the “old chart,” which had to be delivered from patient records but was generally available when the patient was still in the ED. It contained typed discharge summaries and progress notes often handwritten by coresidents whom we knew. The handwriting was often difficult to read, outpatient notes were not included, and information from other hospitals was absent—but despite these deficiencies, we somehow managed just fine.


The patients on the inpatient ward were mostly stable, but more importantly, we had very few medications and tests to order. I recall prescribing fewer than 20 drugs—furosemide, hydrochlorothiazide, penicillins, cephalosporins, gentamicin, isoniazid, lidocaine, nitroglycerin, aminophylline, alpha-methyldopa, clonidine, propranolol, digoxin, hydralazine, indomethacin, steroids, and morphine. Orders for tests and imaging had to be physically written in the chart and could not be inputted remotely, which was a nuisance when we were away from the ward. However, we rarely ordered any imaging beyond plain radiographs at night. We did draw arterial blood gases and venous blood, administer oxygen, insert intravenous and central lines, take electrocardiograms, and perform urinalyses by microscopy. We did all these tasks ourselves for patients on the “ward service” (as opposed to the “private service”, which had to do with the type of insurance the patients possessed). As a result, we became experts in both blood drawing and intravenous line insertion—skills that might be less familiar to today’s residents.

Of course, patients did get acutely ill during the night. I recall intubating, cardioverting, performing phlebotomy to alleviate pulmonary edema, sending patients to surgery, and pronouncing death. Nevertheless, we often got sleep, and sometimes, several hours in a row. I had a rule; I always took a shower the next morning and put on clean clothes (we stayed until 5 pm , making the shifts 33.5 hours long). There was a camaraderie that existed between all of us at night. We were supportive, friendly, and knew each other by name, and more.

We were often frightened by the responsibility of managing sick patients alone. On particularly challenging nights, we would record our fears and feelings in a “night call diary” in one of the conference rooms—generally at 4
am . Some entries became legendary as people read and reread those months and years later. Mornings always brought a sense of relief and accomplishment, because when the sun came up, we knew that the other residents would not be far behind; when they arrived, we could tell our stories and get help.

There was definitely competitiveness to the work. Those who responded quickly to deteriorating patients were applauded; those who did not really know what to do were subtly disdained. However, over time, we all got the hang of it, and this led to a growing confidence that we were indeed doctors. The graded autonomy afforded by night call was a crucial part of that journey.

 

 

2019

At 6 pm , the on-call residents assemble in the ED, where we would spend the remainder of the night and early morning admitting new patients to the hospital. A night team consists of a senior resident, three junior residents, and two medical students, with each resident being responsible for approximately 20 inpatients. Overnight coverage of the ward mostly occurs remotely; since the ED is often so busy, we address most of the issues through a computer or over the phone. Only in rare cases, such as when a patient is unstable or a death has occurred, do we deal with the matter in person.

To enable rapid remote responses, we each carry an assortment of devices on our waists or lanyards and in our pockets, such as a personal pager, ED consult pager, code blue pager, and hospital-issued smartphones capable of receiving pages, text messages, phone calls, and e-mails. Nurses, pharmacists, and other consultants communicate with us through all of these channels. Few of these interactions occur face-to-face. To our frustration, encounters with patients are frequently interrupted by a stream of beeps, rings, and vibrations—irrespective of whether we are having a difficult discussion about goals of care or performing a delicate procedure.

The ED contains a work space dedicated for residents to enter electronic orders, type notes, and review new admissions. Between consults, we try to discuss exciting cases and provide teaching to the medical students and interns, which we enjoy. Dinner is generally devoured while inputting orders. In exceptional circumstances, a brief reprieve from pages may allow the on-call team to share a meal. Depending on our role, sleep may be possible on certain nights but is never guaranteed. Moments spent with the on-call team—all of us learning, commiserating, and growing together—are some of the most memorable of residency, and many of us become close friends by the end of the rotation.

However, apart from these few familiar faces, we rarely get acquainted with the nurses or residents from other services. Many often refer to themselves by specialty rather than name and phone calls that begin with “Are you Medicine?” can end with “You should really call Orthopedics.” Meanwhile, “Medicine” and “Orthopedics” may pass each other in the hallway without recognition beyond a vague familiarity of a voice heard on the phone.

Every 10 minutes spent with a new patient is accompanied by approximately one hour of “electronic” time, which includes reading through previous medical records, reviewing laboratory data and imaging, and creating an admission note. Interns might groan as they pull up a patient’s electronic health record (EHR); irrelevant details often arise with each click of the mouse, and the cursed “copy-paste” function means that new notes often duplicate older ones. However, with time, we learn to look past the EHR’s shortcomings and appreciate several of its advantages. For example, we are now able to access test results performed outside our hospital and thus limit our repetition of investigations. We can also use the EHR to rapidly glean salient information about a patient in time-critical scenarios. This is always a satisfying process, and it makes us wonder how physicians ever practiced in the era before computers.

Today’s patients are older and sicker than ever before. Many are receiving treatments that did not exist even a decade ago. As residents, we must recognize a seemingly endless variety of drugs—a challenging but intellectually satisfying responsibility. We must also decide whether the patient’s current health state permits their continuation, or whether safer alternatives exist. Some of these decisions cannot wait until the morning.

During handover at 8
am , we often recount moments from our call shift with a sense of vigor that is only partly dulled by fatigue. We may share with pride our management of a sick patient. We may relay a touching exchange with a concerned family member. Or we may recall with satisfaction our handling of a tense situation with a colleague. Taking part in these experiences is one of the most character-building aspects of being on call. The absence of our supervisors can be unnerving at first, but we gradually begin to enjoy the sense of independence. Moreover, we feel empowered to make our patients better with the right combination of carefully selected treatments. Nothing makes us feel more like doctors.

No doubt, being on call is difficult. The next day brings a feeling of relief and accomplishment, knowing that we got through it—whether by floundering or flourishing—in one piece.

 

 

CONCLUSION

The two passages described here are personal descriptions of a typical night on-call in two different eras. Readers around the world may have a very different recollection of their own experience. Nevertheless, several aspects of being on call remain constant, such as anxiety about caring for sick patients alone, fond recollections of friends made, and relief when the morning comes. Most important, however, might be the tremendous satisfaction at the opportunity to learn and grow—to become a competent physician by testing one’s physical and intellectual limits through graded autonomy

On the other hand, certain elements of night call have undeniably changed—partly a consequence of the increased number of people involved in patient care and changing communication technology. Residents today encounter a greater number of interruptions to their work flow. Tasks that require long, continuous periods of full attention are now punctuated by texts, e-mails, calls, and pages. The EHR is often clumsy to navigate, but it can also be a veritable mine of information. Finally, although residents from the same specialty may be close friends, duty hour restrictions and remote asynchronous communication may reduce familiarity with residents from other programs.

Do these descriptions resonate with your experience of night call? Keeping in mind that the 1979 vignette is described through the rose-colored lens of nostalgia, both eras have their advantages and disadvantages. We leave it to the reader to decide what has changed (plus ça change) and what has stayed the same (plus c’est la même chose).

Acknowledgments

The authors thank Micheal A. Fifer, MD (Massachusetts General Hospital), and Timothy J. Judson, MD (UCSF), for their comments on an earlier draft of this essay.

Disclosures

The authors have nothing to disclose.

Issue
Journal of Hospital Medicine 14(12)
Issue
Journal of Hospital Medicine 14(12)
Page Number
782-784. Published online first August 21, 2019
Page Number
782-784. Published online first August 21, 2019
Topics
Article Type
Sections
Article Source

© 2019 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Allan S. Detsky, MD, , PhD; E-mail: [email protected]; Telephone: 416-586-8507
Content Gating
Gated (full article locked unless allowed per User)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 09/18/2019 - 05:00
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Gating Strategy
First Peek Free
Article PDF Media

Methodological Progress Note: Group Level Assessment

Article Type
Changed
Sun, 10/13/2019 - 21:54

Group Level Assessment (GLA) is a qualitative research methodology designed to enable groups of stakeholders to generate and evaluate data in participatory sessions.1 It has been used in diverse health-related settings for multiple research purposes, including needs/resource assessment, program evaluation, quality improvement, intervention development, feasibility/acceptability testing, knowledge generation, and prioritization.2-6 Unlike traditional qualitative research methods in which participants provide data and researchers analyze it, GLA uses a seven-step structured process (Table) that actively involves a large group of stakeholders in the generation, interpretation, and synthesis of data and allows salient themes to be identified from stakeholders’ perspectives.7 GLA deliverables include a set of action items that are relevant to the target issue and representative of the collective view of stakeholders. In this issue of the Journal of Hospital Medicine, Choe and colleagues used GLA methodology to identify the perspectives of pediatric medical providers and interpreters with regard to the use of interpreter services for hospitalized children having limited English proficiency (LEP).8

Each individual GLA session is intended for a group of 15-60 stakeholders. Ideally, a GLA session is scheduled for approximately three hours with a skilled facilitator guiding the group through the steps of the session.1 Depending on the study scope and research questions, modifications to GLA can be made when engaging fewer stakeholders, conducting the GLA across several shorter sessions with the same group, or conducting multiple sessions with different stakeholder groups wherein results are integrated across the groups.1

APPLICATION OF GLA

Stakeholder Recruitment

GLAs are designed to bring diverse groups together to be able to generate and evaluate ideas collectively, which in turn helps to reduce potential power differentials between or among participants. Depending on the research question(s), relevant stakeholders may include local community residents, patients, caregivers, community leaders, practitioners, providers, community-based organizations, and even CEOs. The use of purposeful sampling techniques can obtain a diverse group of stakeholders, thus helping ensure a wide range of ideas and perspectives. Choe and colleagues used flyers and announcements at staff meetings to recruit physicians, nursing staff, and interpreters who were subsequently assigned to GLA sessions to ensure engagement from a range of stakeholder roles at each session.8

Session Logistics

Strategies to create an open, equitable atmosphere in GLA sessions include role-based assigning of individuals to specific groups, avoiding introductions that emphasize status, pre-education for any leaders and supervisors about the participatory and equitable nature of GLA, and minimizing cliques and overly dominant voices throughout the session. Stakeholders who take part in activities in a GLA session typically receive an incentive for participating. Additional supports such as food and childcare may be considered. GLA sessions involving children may require providing the young participants assistance in writing their responses and/or the use of additional facilitators to keep the small groups on track.5 Interpreters and facilitators can be incorporated into GLA sessions to assist stakeholders who may need assistance with understanding and responding to prompts, such as language interpretation and translation services.

 

 

Prompt Development

Similar to the development of questions for interview and focus group guides, creating effective prompts is a critical component of data collection in GLA. Prompts are statements worded as incomplete or fill-in-the-blank sentences that should be open ended to allow participants to respond with their own thoughts and experiences. Prompts that resemble the beginning of a sentence (eg, “The biggest challenge we face is…”) encourage honest reflection rather than questions that can make participants feel like they are being evaluated. We recommend varying the number of prompts based on the group size: approximately one chart and prompt per person attending, with a maximum of 35 prompts at one session.1 This allows for sufficient variability in the responses generated without being overwhelming or too time-consuming. For example, Choe et al. developed a pool of 51 unique prompts addressing their research questions and then used 15-32 prompts in each GLA session, depending on the number of participants. 8 Prompts should be written with some purposeful redundancy, targeting the research question from several angles. The emphasis should be on the content’s alignment with the research questions rather than the actual wording of the prompts as a way of ensuring that the generated data is both valid and useful.

Prompts should also vary in format, style (eg, different color markers, pictures, fonts, etc.), and placement on each flip chart page. An individual flip chart can include multiple related prompts: for example, “split-halves” in two columns or rows (ie, the best part/worst part). Taken as a whole, the flip charts and accompanying prompts create different lenses for gathering participant perspectives on the research questions. See Appendix Table for suggested prompt characteristics and examples from a hypothetical study related to pediatric healthcare.

GLA prompt development will ideally occur in collaboration with an advisory team comprised of representative members from each of the stakeholder groups. Using a participatory research approach in the research design and preparation phases ensures that GLA prompts are understandable and relevant to participants and are able to appropriately capture the underlying purpose of the study.

Description of the Seven Steps in GLA

In step one, climate setting, the facilitator provides an overview of the session, including a description of the GLA rationale and process. Typically, an icebreaker or brief introduction activity is conducted. Step two, generating, is a hallmark step of GLA in which participants walk around and respond to prompts prewritten on flip charts hung on walls in a large room. Participants use markers and respond to each prompt by either providing a unique comment and/or corroborating an existing comment by adding a checkmark or star. During this step, organizers typically play music and encourage participants to enjoy food, chat with fellow participants, and leisurely move from prompt to prompt in any order. Step three, appreciating, is a brief interim step where participants take a “gallery walk” and view responses written on the charts.

In step four, reflecting, participants reflect on the data and briefly write down their thoughts about the responses generated in the session. In step five, understanding, smaller groups synthesize responses across a subset of charts and report their findings to the larger group. Depending on the size and composition of the larger group, small groups of four to seven people are formed or assigned. Each small group is assigned a subset of approximately four to six charts. Using thematic analysis, participants look for relationships among the responses on their assigned charts, referring to individual responses as evidence for the main findings. Groups will take notes on the charts, circle key phrases, or draw arrows to show relationships in the data and thereafter develop themes. As each small group reports their findings, the facilitator will keep a running list of generated themes, ideally in the participants’ own words. Step six, selecting, involves participants discussing, further synthesizing, and prioritizing data. Step six can occur as a facilitated large group discussion or in a form in which participants can remain in the same small groups from step five and work together to complete this further step. Themes across all of the small groups are consolidated and developed into overarching themes. Step seven, action, includes planning the next steps to address priorities.

 

 

Data Analysis

Analyzing the data generated through a GLA is an iterative process incorporated into steps three to seven as described above and often continues after the GLA session is complete. Step seven can be scheduled as a separate action-planning session depending on time constraints and the study goals. This final step moves the group toward interpretation and dissemination as themes are prioritized and used to drive action steps toward a programmatic, policy, or community change. In some studies, themes will be aggregated across multiple GLAs to integrate the findings from several sessions. This step is sometimes completed with a smaller group of stakeholders, an advisory board, or the research team.

Complementary Data and Synthesis

Research teams often collect additional sources of data that are later used to analyze and interpret the initial stakeholder-developed findings (ie, demographic surveys) and to identify priority areas. Field notes, photographs of completed charts, and recorded participant quotes can also be incorporated into the thematic analysis. Small and large group discussions could be audio recorded and transcribed to capture participants’ individual comments and interpretations. In Choe et al. the team recorded detailed notes, including quotations from participants, and collected a demographic survey. After each GLA session, Choe and colleagues compiled all of the stakeholder-driven findings to develop an overarching set of themes related to communication with LEP families and priority areas that could inform subsequent action. Similar to the qualitative validation strategy of member checking, the authors shared and revised this overarching set of themes in discussion with stakeholders to ensure that participant ideas were adequately and accurately represented.8

STRENGTHS OF GLA

Compared to traditional qualitative methods such as one-on-one interviews and focus groups, GLA is designed for large groups and is used to promote active engagement of diverse stakeholders in the participatory process. Unlike many other qualitative methods, GLA provides a stakeholder-driven, structured format to elicit diverse stakeholder viewpoints in the moment and build consensus in a participatory manner about priorities and subsequent actions. The progression of the GLA process is collaborative, with stakeholders generating, analyzing, and prioritizing data from their own perspectives. In a focus group or one-on-one interviews, researchers would conduct the analysis after the audio recordings were transcribed. In GLA, stakeholders conduct a thematic analysis in real time, an aspect that adds the stakeholder perspective to analysis of the findings, interpretation, and implications. GLA offers a fun and interactive experience that can build a sense of community among participants (eg, walking around, impromptu conversation, working in small groups, sharing perspectives on the same issue from different vantage points, etc.). GLA is a versatile, flexible methodology that can be used to address different research objectives, be modified for use with various size groups, and be adapted based on the needs and characteristics of stakeholders (eg, children, people with disabilities, etc.).1 When used in recruitment, GLA is designed to include stakeholders representing different roles and levels of a system. GLA can be particularly useful when engaging underserved communities in research because the process is nonthreatening and promotive of shared perspectives and decision-making. Importantly, the final step of GLA provides interested stakeholders with a way to stay involved in the research through prioritization and action.

 

 

LIMITATIONS OF GLA

Like other self-report research methods, GLA relies on stakeholder comfort and willingness to share “public data.”1 Thus, controversial or sensitive issues may not be brought forth. Since the final themes of GLA are consensus based in terms of what the group of stakeholders finds to be most important, nuances and outlier data can be missed. Successfully conducting a GLA requires a skilled, flexible facilitator who can manage group dynamics while also balancing the structure of the seven-step process, promoting an open and equitable environment, and ensuring the research process remains rigorous. Large groups can be more difficult for facilitators to manage especially when there are power differentials, conflict, and hidden agendas among stakeholders. The large group design, multiple steps of GLA, and participatory atmosphere with music and food can be off-putting for some stakeholders who find the process too noisy, overwhelming, or unstructured. In addition, large groups can be challenging to schedule at times and to find locations that are convenient for stakeholders.

WHY DID THE AUTHORS USE GLA?

Compared to researcher-driven qualitative methods that can be resource-intensive and are limited by researcher perspective, GLA emphasizes the contextual, “lived” expertise of stakeholders and relies on them in real time to identify and prioritize matters relevant to the participants. The participatory process of GLA promotes stakeholder buy-in and builds on the collective wisdom of the stakeholder group. This is ideally seen in Choe et al.’s study where GLA offered the researchers a structured qualitative methodology that engaged a large number of medical providers and interpreters to identify effective practices that should ultimately enhance communication with families of hospitalized LEP children.

Disclosures

The authors have nothing to disclose.

 

Files
References

1. Vaughn LM, Lohmueller M. Calling all stakeholders: group-level assessment (GLA)—a qualitative and participatory method for large groups. Eval Rev. 2014;38(4):336-355. https:// doi.org/10.1177/0193841X14544903.
2. Gosdin CH, Vaughn L. Perceptions of physician bedside handoff with nurse and family involvement. Hosp Pediatr. 2012;2(1):34-38. https://doi.org/10.1542/hpeds.2011-0008-2
3. Graham KE, Schellinger AR, Vaughn LM. Developing strategies for positive change: transitioning foster youth to adulthood. Child Youth Serv Rev. 2015;54:71-79. https://doi.org/10.1016/j.childyouth.2015.04.014
4. Schondelmeyer AC, Jenkins AM, Allison B, et al. Factors influencing use of continuous physiologic monitors for hospitalized pediatric patients. Hosp Pediatr. 2019;9(6):423-428. https://doi.org/10.1542/hpeds.2019-0007
5. Vaughn LM, Jacquez F, Zhao J, Lang M. Partnering with students to explore the health needs of an ethnically diverse, low-resource school: an innovative large group assessment approach. Fam Community Health. 2011;34(1):72-84. https://doi.org/10.1097/FCH.0b013e3181fded12
6. Vaughn LM. Group level assessment: a large group method for identifying primary issues and needs within a community. Sage Journals. 2014;38:336-355. https://doi.org/10.4135/978144627305014541626
7. Vaughn LM. Psychology and culture: thinking, feeling and behaving in a global context. 2nd ed. New York, NY: Taylor & Francis; 2019.
8. Choe A, Unaka N, Schondelmeyer AC, Bignall, RW, Vilvens H, Thomson J. Inpatient communication barriers and drivers when caring for children with limited English proficiency [published online ahead of print July 24, 2019]. J Hosp Med. https://doi.org/10.12788/jhm.3240.

Article PDF
Issue
Journal of Hospital Medicine 14(10)
Topics
Page Number
627-629. Published online first August 21, 2019.
Sections
Files
Files
Article PDF
Article PDF

Group Level Assessment (GLA) is a qualitative research methodology designed to enable groups of stakeholders to generate and evaluate data in participatory sessions.1 It has been used in diverse health-related settings for multiple research purposes, including needs/resource assessment, program evaluation, quality improvement, intervention development, feasibility/acceptability testing, knowledge generation, and prioritization.2-6 Unlike traditional qualitative research methods in which participants provide data and researchers analyze it, GLA uses a seven-step structured process (Table) that actively involves a large group of stakeholders in the generation, interpretation, and synthesis of data and allows salient themes to be identified from stakeholders’ perspectives.7 GLA deliverables include a set of action items that are relevant to the target issue and representative of the collective view of stakeholders. In this issue of the Journal of Hospital Medicine, Choe and colleagues used GLA methodology to identify the perspectives of pediatric medical providers and interpreters with regard to the use of interpreter services for hospitalized children having limited English proficiency (LEP).8

Each individual GLA session is intended for a group of 15-60 stakeholders. Ideally, a GLA session is scheduled for approximately three hours with a skilled facilitator guiding the group through the steps of the session.1 Depending on the study scope and research questions, modifications to GLA can be made when engaging fewer stakeholders, conducting the GLA across several shorter sessions with the same group, or conducting multiple sessions with different stakeholder groups wherein results are integrated across the groups.1

APPLICATION OF GLA

Stakeholder Recruitment

GLAs are designed to bring diverse groups together to be able to generate and evaluate ideas collectively, which in turn helps to reduce potential power differentials between or among participants. Depending on the research question(s), relevant stakeholders may include local community residents, patients, caregivers, community leaders, practitioners, providers, community-based organizations, and even CEOs. The use of purposeful sampling techniques can obtain a diverse group of stakeholders, thus helping ensure a wide range of ideas and perspectives. Choe and colleagues used flyers and announcements at staff meetings to recruit physicians, nursing staff, and interpreters who were subsequently assigned to GLA sessions to ensure engagement from a range of stakeholder roles at each session.8

Session Logistics

Strategies to create an open, equitable atmosphere in GLA sessions include role-based assigning of individuals to specific groups, avoiding introductions that emphasize status, pre-education for any leaders and supervisors about the participatory and equitable nature of GLA, and minimizing cliques and overly dominant voices throughout the session. Stakeholders who take part in activities in a GLA session typically receive an incentive for participating. Additional supports such as food and childcare may be considered. GLA sessions involving children may require providing the young participants assistance in writing their responses and/or the use of additional facilitators to keep the small groups on track.5 Interpreters and facilitators can be incorporated into GLA sessions to assist stakeholders who may need assistance with understanding and responding to prompts, such as language interpretation and translation services.

 

 

Prompt Development

Similar to the development of questions for interview and focus group guides, creating effective prompts is a critical component of data collection in GLA. Prompts are statements worded as incomplete or fill-in-the-blank sentences that should be open ended to allow participants to respond with their own thoughts and experiences. Prompts that resemble the beginning of a sentence (eg, “The biggest challenge we face is…”) encourage honest reflection rather than questions that can make participants feel like they are being evaluated. We recommend varying the number of prompts based on the group size: approximately one chart and prompt per person attending, with a maximum of 35 prompts at one session.1 This allows for sufficient variability in the responses generated without being overwhelming or too time-consuming. For example, Choe et al. developed a pool of 51 unique prompts addressing their research questions and then used 15-32 prompts in each GLA session, depending on the number of participants. 8 Prompts should be written with some purposeful redundancy, targeting the research question from several angles. The emphasis should be on the content’s alignment with the research questions rather than the actual wording of the prompts as a way of ensuring that the generated data is both valid and useful.

Prompts should also vary in format, style (eg, different color markers, pictures, fonts, etc.), and placement on each flip chart page. An individual flip chart can include multiple related prompts: for example, “split-halves” in two columns or rows (ie, the best part/worst part). Taken as a whole, the flip charts and accompanying prompts create different lenses for gathering participant perspectives on the research questions. See Appendix Table for suggested prompt characteristics and examples from a hypothetical study related to pediatric healthcare.

GLA prompt development will ideally occur in collaboration with an advisory team comprised of representative members from each of the stakeholder groups. Using a participatory research approach in the research design and preparation phases ensures that GLA prompts are understandable and relevant to participants and are able to appropriately capture the underlying purpose of the study.

Description of the Seven Steps in GLA

In step one, climate setting, the facilitator provides an overview of the session, including a description of the GLA rationale and process. Typically, an icebreaker or brief introduction activity is conducted. Step two, generating, is a hallmark step of GLA in which participants walk around and respond to prompts prewritten on flip charts hung on walls in a large room. Participants use markers and respond to each prompt by either providing a unique comment and/or corroborating an existing comment by adding a checkmark or star. During this step, organizers typically play music and encourage participants to enjoy food, chat with fellow participants, and leisurely move from prompt to prompt in any order. Step three, appreciating, is a brief interim step where participants take a “gallery walk” and view responses written on the charts.

In step four, reflecting, participants reflect on the data and briefly write down their thoughts about the responses generated in the session. In step five, understanding, smaller groups synthesize responses across a subset of charts and report their findings to the larger group. Depending on the size and composition of the larger group, small groups of four to seven people are formed or assigned. Each small group is assigned a subset of approximately four to six charts. Using thematic analysis, participants look for relationships among the responses on their assigned charts, referring to individual responses as evidence for the main findings. Groups will take notes on the charts, circle key phrases, or draw arrows to show relationships in the data and thereafter develop themes. As each small group reports their findings, the facilitator will keep a running list of generated themes, ideally in the participants’ own words. Step six, selecting, involves participants discussing, further synthesizing, and prioritizing data. Step six can occur as a facilitated large group discussion or in a form in which participants can remain in the same small groups from step five and work together to complete this further step. Themes across all of the small groups are consolidated and developed into overarching themes. Step seven, action, includes planning the next steps to address priorities.

 

 

Data Analysis

Analyzing the data generated through a GLA is an iterative process incorporated into steps three to seven as described above and often continues after the GLA session is complete. Step seven can be scheduled as a separate action-planning session depending on time constraints and the study goals. This final step moves the group toward interpretation and dissemination as themes are prioritized and used to drive action steps toward a programmatic, policy, or community change. In some studies, themes will be aggregated across multiple GLAs to integrate the findings from several sessions. This step is sometimes completed with a smaller group of stakeholders, an advisory board, or the research team.

Complementary Data and Synthesis

Research teams often collect additional sources of data that are later used to analyze and interpret the initial stakeholder-developed findings (ie, demographic surveys) and to identify priority areas. Field notes, photographs of completed charts, and recorded participant quotes can also be incorporated into the thematic analysis. Small and large group discussions could be audio recorded and transcribed to capture participants’ individual comments and interpretations. In Choe et al. the team recorded detailed notes, including quotations from participants, and collected a demographic survey. After each GLA session, Choe and colleagues compiled all of the stakeholder-driven findings to develop an overarching set of themes related to communication with LEP families and priority areas that could inform subsequent action. Similar to the qualitative validation strategy of member checking, the authors shared and revised this overarching set of themes in discussion with stakeholders to ensure that participant ideas were adequately and accurately represented.8

STRENGTHS OF GLA

Compared to traditional qualitative methods such as one-on-one interviews and focus groups, GLA is designed for large groups and is used to promote active engagement of diverse stakeholders in the participatory process. Unlike many other qualitative methods, GLA provides a stakeholder-driven, structured format to elicit diverse stakeholder viewpoints in the moment and build consensus in a participatory manner about priorities and subsequent actions. The progression of the GLA process is collaborative, with stakeholders generating, analyzing, and prioritizing data from their own perspectives. In a focus group or one-on-one interviews, researchers would conduct the analysis after the audio recordings were transcribed. In GLA, stakeholders conduct a thematic analysis in real time, an aspect that adds the stakeholder perspective to analysis of the findings, interpretation, and implications. GLA offers a fun and interactive experience that can build a sense of community among participants (eg, walking around, impromptu conversation, working in small groups, sharing perspectives on the same issue from different vantage points, etc.). GLA is a versatile, flexible methodology that can be used to address different research objectives, be modified for use with various size groups, and be adapted based on the needs and characteristics of stakeholders (eg, children, people with disabilities, etc.).1 When used in recruitment, GLA is designed to include stakeholders representing different roles and levels of a system. GLA can be particularly useful when engaging underserved communities in research because the process is nonthreatening and promotive of shared perspectives and decision-making. Importantly, the final step of GLA provides interested stakeholders with a way to stay involved in the research through prioritization and action.

 

 

LIMITATIONS OF GLA

Like other self-report research methods, GLA relies on stakeholder comfort and willingness to share “public data.”1 Thus, controversial or sensitive issues may not be brought forth. Since the final themes of GLA are consensus based in terms of what the group of stakeholders finds to be most important, nuances and outlier data can be missed. Successfully conducting a GLA requires a skilled, flexible facilitator who can manage group dynamics while also balancing the structure of the seven-step process, promoting an open and equitable environment, and ensuring the research process remains rigorous. Large groups can be more difficult for facilitators to manage especially when there are power differentials, conflict, and hidden agendas among stakeholders. The large group design, multiple steps of GLA, and participatory atmosphere with music and food can be off-putting for some stakeholders who find the process too noisy, overwhelming, or unstructured. In addition, large groups can be challenging to schedule at times and to find locations that are convenient for stakeholders.

WHY DID THE AUTHORS USE GLA?

Compared to researcher-driven qualitative methods that can be resource-intensive and are limited by researcher perspective, GLA emphasizes the contextual, “lived” expertise of stakeholders and relies on them in real time to identify and prioritize matters relevant to the participants. The participatory process of GLA promotes stakeholder buy-in and builds on the collective wisdom of the stakeholder group. This is ideally seen in Choe et al.’s study where GLA offered the researchers a structured qualitative methodology that engaged a large number of medical providers and interpreters to identify effective practices that should ultimately enhance communication with families of hospitalized LEP children.

Disclosures

The authors have nothing to disclose.

 

Group Level Assessment (GLA) is a qualitative research methodology designed to enable groups of stakeholders to generate and evaluate data in participatory sessions.1 It has been used in diverse health-related settings for multiple research purposes, including needs/resource assessment, program evaluation, quality improvement, intervention development, feasibility/acceptability testing, knowledge generation, and prioritization.2-6 Unlike traditional qualitative research methods in which participants provide data and researchers analyze it, GLA uses a seven-step structured process (Table) that actively involves a large group of stakeholders in the generation, interpretation, and synthesis of data and allows salient themes to be identified from stakeholders’ perspectives.7 GLA deliverables include a set of action items that are relevant to the target issue and representative of the collective view of stakeholders. In this issue of the Journal of Hospital Medicine, Choe and colleagues used GLA methodology to identify the perspectives of pediatric medical providers and interpreters with regard to the use of interpreter services for hospitalized children having limited English proficiency (LEP).8

Each individual GLA session is intended for a group of 15-60 stakeholders. Ideally, a GLA session is scheduled for approximately three hours with a skilled facilitator guiding the group through the steps of the session.1 Depending on the study scope and research questions, modifications to GLA can be made when engaging fewer stakeholders, conducting the GLA across several shorter sessions with the same group, or conducting multiple sessions with different stakeholder groups wherein results are integrated across the groups.1

APPLICATION OF GLA

Stakeholder Recruitment

GLAs are designed to bring diverse groups together to be able to generate and evaluate ideas collectively, which in turn helps to reduce potential power differentials between or among participants. Depending on the research question(s), relevant stakeholders may include local community residents, patients, caregivers, community leaders, practitioners, providers, community-based organizations, and even CEOs. The use of purposeful sampling techniques can obtain a diverse group of stakeholders, thus helping ensure a wide range of ideas and perspectives. Choe and colleagues used flyers and announcements at staff meetings to recruit physicians, nursing staff, and interpreters who were subsequently assigned to GLA sessions to ensure engagement from a range of stakeholder roles at each session.8

Session Logistics

Strategies to create an open, equitable atmosphere in GLA sessions include role-based assigning of individuals to specific groups, avoiding introductions that emphasize status, pre-education for any leaders and supervisors about the participatory and equitable nature of GLA, and minimizing cliques and overly dominant voices throughout the session. Stakeholders who take part in activities in a GLA session typically receive an incentive for participating. Additional supports such as food and childcare may be considered. GLA sessions involving children may require providing the young participants assistance in writing their responses and/or the use of additional facilitators to keep the small groups on track.5 Interpreters and facilitators can be incorporated into GLA sessions to assist stakeholders who may need assistance with understanding and responding to prompts, such as language interpretation and translation services.

 

 

Prompt Development

Similar to the development of questions for interview and focus group guides, creating effective prompts is a critical component of data collection in GLA. Prompts are statements worded as incomplete or fill-in-the-blank sentences that should be open ended to allow participants to respond with their own thoughts and experiences. Prompts that resemble the beginning of a sentence (eg, “The biggest challenge we face is…”) encourage honest reflection rather than questions that can make participants feel like they are being evaluated. We recommend varying the number of prompts based on the group size: approximately one chart and prompt per person attending, with a maximum of 35 prompts at one session.1 This allows for sufficient variability in the responses generated without being overwhelming or too time-consuming. For example, Choe et al. developed a pool of 51 unique prompts addressing their research questions and then used 15-32 prompts in each GLA session, depending on the number of participants. 8 Prompts should be written with some purposeful redundancy, targeting the research question from several angles. The emphasis should be on the content’s alignment with the research questions rather than the actual wording of the prompts as a way of ensuring that the generated data is both valid and useful.

Prompts should also vary in format, style (eg, different color markers, pictures, fonts, etc.), and placement on each flip chart page. An individual flip chart can include multiple related prompts: for example, “split-halves” in two columns or rows (ie, the best part/worst part). Taken as a whole, the flip charts and accompanying prompts create different lenses for gathering participant perspectives on the research questions. See Appendix Table for suggested prompt characteristics and examples from a hypothetical study related to pediatric healthcare.

GLA prompt development will ideally occur in collaboration with an advisory team comprised of representative members from each of the stakeholder groups. Using a participatory research approach in the research design and preparation phases ensures that GLA prompts are understandable and relevant to participants and are able to appropriately capture the underlying purpose of the study.

Description of the Seven Steps in GLA

In step one, climate setting, the facilitator provides an overview of the session, including a description of the GLA rationale and process. Typically, an icebreaker or brief introduction activity is conducted. Step two, generating, is a hallmark step of GLA in which participants walk around and respond to prompts prewritten on flip charts hung on walls in a large room. Participants use markers and respond to each prompt by either providing a unique comment and/or corroborating an existing comment by adding a checkmark or star. During this step, organizers typically play music and encourage participants to enjoy food, chat with fellow participants, and leisurely move from prompt to prompt in any order. Step three, appreciating, is a brief interim step where participants take a “gallery walk” and view responses written on the charts.

In step four, reflecting, participants reflect on the data and briefly write down their thoughts about the responses generated in the session. In step five, understanding, smaller groups synthesize responses across a subset of charts and report their findings to the larger group. Depending on the size and composition of the larger group, small groups of four to seven people are formed or assigned. Each small group is assigned a subset of approximately four to six charts. Using thematic analysis, participants look for relationships among the responses on their assigned charts, referring to individual responses as evidence for the main findings. Groups will take notes on the charts, circle key phrases, or draw arrows to show relationships in the data and thereafter develop themes. As each small group reports their findings, the facilitator will keep a running list of generated themes, ideally in the participants’ own words. Step six, selecting, involves participants discussing, further synthesizing, and prioritizing data. Step six can occur as a facilitated large group discussion or in a form in which participants can remain in the same small groups from step five and work together to complete this further step. Themes across all of the small groups are consolidated and developed into overarching themes. Step seven, action, includes planning the next steps to address priorities.

 

 

Data Analysis

Analyzing the data generated through a GLA is an iterative process incorporated into steps three to seven as described above and often continues after the GLA session is complete. Step seven can be scheduled as a separate action-planning session depending on time constraints and the study goals. This final step moves the group toward interpretation and dissemination as themes are prioritized and used to drive action steps toward a programmatic, policy, or community change. In some studies, themes will be aggregated across multiple GLAs to integrate the findings from several sessions. This step is sometimes completed with a smaller group of stakeholders, an advisory board, or the research team.

Complementary Data and Synthesis

Research teams often collect additional sources of data that are later used to analyze and interpret the initial stakeholder-developed findings (ie, demographic surveys) and to identify priority areas. Field notes, photographs of completed charts, and recorded participant quotes can also be incorporated into the thematic analysis. Small and large group discussions could be audio recorded and transcribed to capture participants’ individual comments and interpretations. In Choe et al. the team recorded detailed notes, including quotations from participants, and collected a demographic survey. After each GLA session, Choe and colleagues compiled all of the stakeholder-driven findings to develop an overarching set of themes related to communication with LEP families and priority areas that could inform subsequent action. Similar to the qualitative validation strategy of member checking, the authors shared and revised this overarching set of themes in discussion with stakeholders to ensure that participant ideas were adequately and accurately represented.8

STRENGTHS OF GLA

Compared to traditional qualitative methods such as one-on-one interviews and focus groups, GLA is designed for large groups and is used to promote active engagement of diverse stakeholders in the participatory process. Unlike many other qualitative methods, GLA provides a stakeholder-driven, structured format to elicit diverse stakeholder viewpoints in the moment and build consensus in a participatory manner about priorities and subsequent actions. The progression of the GLA process is collaborative, with stakeholders generating, analyzing, and prioritizing data from their own perspectives. In a focus group or one-on-one interviews, researchers would conduct the analysis after the audio recordings were transcribed. In GLA, stakeholders conduct a thematic analysis in real time, an aspect that adds the stakeholder perspective to analysis of the findings, interpretation, and implications. GLA offers a fun and interactive experience that can build a sense of community among participants (eg, walking around, impromptu conversation, working in small groups, sharing perspectives on the same issue from different vantage points, etc.). GLA is a versatile, flexible methodology that can be used to address different research objectives, be modified for use with various size groups, and be adapted based on the needs and characteristics of stakeholders (eg, children, people with disabilities, etc.).1 When used in recruitment, GLA is designed to include stakeholders representing different roles and levels of a system. GLA can be particularly useful when engaging underserved communities in research because the process is nonthreatening and promotive of shared perspectives and decision-making. Importantly, the final step of GLA provides interested stakeholders with a way to stay involved in the research through prioritization and action.

 

 

LIMITATIONS OF GLA

Like other self-report research methods, GLA relies on stakeholder comfort and willingness to share “public data.”1 Thus, controversial or sensitive issues may not be brought forth. Since the final themes of GLA are consensus based in terms of what the group of stakeholders finds to be most important, nuances and outlier data can be missed. Successfully conducting a GLA requires a skilled, flexible facilitator who can manage group dynamics while also balancing the structure of the seven-step process, promoting an open and equitable environment, and ensuring the research process remains rigorous. Large groups can be more difficult for facilitators to manage especially when there are power differentials, conflict, and hidden agendas among stakeholders. The large group design, multiple steps of GLA, and participatory atmosphere with music and food can be off-putting for some stakeholders who find the process too noisy, overwhelming, or unstructured. In addition, large groups can be challenging to schedule at times and to find locations that are convenient for stakeholders.

WHY DID THE AUTHORS USE GLA?

Compared to researcher-driven qualitative methods that can be resource-intensive and are limited by researcher perspective, GLA emphasizes the contextual, “lived” expertise of stakeholders and relies on them in real time to identify and prioritize matters relevant to the participants. The participatory process of GLA promotes stakeholder buy-in and builds on the collective wisdom of the stakeholder group. This is ideally seen in Choe et al.’s study where GLA offered the researchers a structured qualitative methodology that engaged a large number of medical providers and interpreters to identify effective practices that should ultimately enhance communication with families of hospitalized LEP children.

Disclosures

The authors have nothing to disclose.

 

References

1. Vaughn LM, Lohmueller M. Calling all stakeholders: group-level assessment (GLA)—a qualitative and participatory method for large groups. Eval Rev. 2014;38(4):336-355. https:// doi.org/10.1177/0193841X14544903.
2. Gosdin CH, Vaughn L. Perceptions of physician bedside handoff with nurse and family involvement. Hosp Pediatr. 2012;2(1):34-38. https://doi.org/10.1542/hpeds.2011-0008-2
3. Graham KE, Schellinger AR, Vaughn LM. Developing strategies for positive change: transitioning foster youth to adulthood. Child Youth Serv Rev. 2015;54:71-79. https://doi.org/10.1016/j.childyouth.2015.04.014
4. Schondelmeyer AC, Jenkins AM, Allison B, et al. Factors influencing use of continuous physiologic monitors for hospitalized pediatric patients. Hosp Pediatr. 2019;9(6):423-428. https://doi.org/10.1542/hpeds.2019-0007
5. Vaughn LM, Jacquez F, Zhao J, Lang M. Partnering with students to explore the health needs of an ethnically diverse, low-resource school: an innovative large group assessment approach. Fam Community Health. 2011;34(1):72-84. https://doi.org/10.1097/FCH.0b013e3181fded12
6. Vaughn LM. Group level assessment: a large group method for identifying primary issues and needs within a community. Sage Journals. 2014;38:336-355. https://doi.org/10.4135/978144627305014541626
7. Vaughn LM. Psychology and culture: thinking, feeling and behaving in a global context. 2nd ed. New York, NY: Taylor & Francis; 2019.
8. Choe A, Unaka N, Schondelmeyer AC, Bignall, RW, Vilvens H, Thomson J. Inpatient communication barriers and drivers when caring for children with limited English proficiency [published online ahead of print July 24, 2019]. J Hosp Med. https://doi.org/10.12788/jhm.3240.

References

1. Vaughn LM, Lohmueller M. Calling all stakeholders: group-level assessment (GLA)—a qualitative and participatory method for large groups. Eval Rev. 2014;38(4):336-355. https:// doi.org/10.1177/0193841X14544903.
2. Gosdin CH, Vaughn L. Perceptions of physician bedside handoff with nurse and family involvement. Hosp Pediatr. 2012;2(1):34-38. https://doi.org/10.1542/hpeds.2011-0008-2
3. Graham KE, Schellinger AR, Vaughn LM. Developing strategies for positive change: transitioning foster youth to adulthood. Child Youth Serv Rev. 2015;54:71-79. https://doi.org/10.1016/j.childyouth.2015.04.014
4. Schondelmeyer AC, Jenkins AM, Allison B, et al. Factors influencing use of continuous physiologic monitors for hospitalized pediatric patients. Hosp Pediatr. 2019;9(6):423-428. https://doi.org/10.1542/hpeds.2019-0007
5. Vaughn LM, Jacquez F, Zhao J, Lang M. Partnering with students to explore the health needs of an ethnically diverse, low-resource school: an innovative large group assessment approach. Fam Community Health. 2011;34(1):72-84. https://doi.org/10.1097/FCH.0b013e3181fded12
6. Vaughn LM. Group level assessment: a large group method for identifying primary issues and needs within a community. Sage Journals. 2014;38:336-355. https://doi.org/10.4135/978144627305014541626
7. Vaughn LM. Psychology and culture: thinking, feeling and behaving in a global context. 2nd ed. New York, NY: Taylor & Francis; 2019.
8. Choe A, Unaka N, Schondelmeyer AC, Bignall, RW, Vilvens H, Thomson J. Inpatient communication barriers and drivers when caring for children with limited English proficiency [published online ahead of print July 24, 2019]. J Hosp Med. https://doi.org/10.12788/jhm.3240.

Issue
Journal of Hospital Medicine 14(10)
Issue
Journal of Hospital Medicine 14(10)
Page Number
627-629. Published online first August 21, 2019.
Page Number
627-629. Published online first August 21, 2019.
Topics
Article Type
Sections
Article Source

© 2019 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Lisa M. Vaughn, PhD; E-mail: [email protected]; Telephone: 513-636-9424
Content Gating
Gated (full article locked unless allowed per User)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Gating Strategy
First Peek Free
Article PDF Media
Media Files

Clinical Progress Note: Pediatric Acute Kidney Injury

Article Type
Changed
Tue, 09/17/2019 - 23:27

Acute kidney injury (AKI) occurs in 5%-30% of noncritically ill hospitalized children.1 Initially thought to be simply a symptom of more severe pathologies, it is now recognized that AKI independently increases mortality and is associated with the development of chronic kidney disease (CKD), even in children.2 The wide acceptance of the Kidney Disease Improving Global Outcome (KDIGO) diagnostic criteria has enabled a more uniform definition of AKI from both clinical and research perspectives.2 A better understanding of the pathophysiology and risk factors for AKI has led to new methods for early detection and prevention efforts. While serum creatinine (SCr) was historically one of the sole markers of AKI, novel biomarkers can facilitate earlier diagnosis of AKI, identify subclinical AKI, and guide clinical management. This clinical practice update addresses the latest clinical advances in risk assessment, diagnosis, and prevention of pediatric AKI, with a focus on AKI biomarkers.

DIAGNOSIS, BIOMARKERS, AND DEFINITION

Several sets of criteria have been used to diagnose AKI. The KDIGO classification, based on a systematic review of the literature and developed through expert consensus, is the current recommended definition.3 Increasing AKI stage, as defined by the KDIGO classification, is associated with increased mortality, the need for renal replacement therapy, length of stay, and CKD, thus underscoring the importance of accurate classification.3 Stage 1 AKI is defined by a rise in SCr of ≥0.3 mg/dL,1.5-1.9 times the baseline SCr, or urine output <0.5 ml/kg/h for six to 12 hours; stage 2 by a rise of ≥2.0-2.9 times the baseline SCr or urine output <0.5 ml/kg/h for >12 hours; and stage 3 by a rise of ≥4.0 mg/dL, ≥three times the baseline SCr, initiation of renal replacement therapy, urine output <0.3 ml/kg/h for ≥24 hours, or anuria ≥12 hours. However, these criteria rely on SCr, which is a suboptimal marker of renal dysfunction, as it rises only once the glomerular filtration rate (GFR) has already decreased, in some cases by as much as 50%. Additionally, interpretation of SCr in the diagnosis of AKI requires a prior Scr measurement to determine the magnitude of change from the baseline value, which is often lacking in children. To mitigate this limitation, different formulas exist to estimate a baseline SCr value based on height or age, an approach that assumes patients have preexisting normal renal function.

The limitations of SCr have led to interest in identifying more accurate biomarkers of AKI. Although many candidates have been identified, we will limit our discussion to those currently available for clinical use: serum cystatin C, urine neutrophil gelatinase-associated lipocalin (NGAL), urine TIMP-2, and urine IGFBP7 (Table).4-8 While urine NGAL and cystatin C are measured individually, TIMP-2 and IGFBP7 are measured on the same panel and the product of their multiplied values is used for clinical guidance. While each of these biomarkers have good predictive accuracy for AKI when used independently, their combined use increases the accuracy of AKI diagnosis. These biomarkers can be divided into broad categories based on their utility as either functional markers or markers of injury.6 Serum cystatin C is a functional marker and as such can be used to estimate GFR more accurately than SCr.9 Comparatively, urine NGAL is a marker of renal injury, while TIMP2 and IGFBP7 are markers of renal stress. These markers are not useful in estimating GFR, but rather aid in the prediction and diagnosis of AKI (Figure). Despite the limitations of SCr, these biomarkers have yet to be incorporated into the diagnostic criteria. They have, however, helped to refine our understanding of the pathophysiology of AKI.



AKI has classically been divided into three categories based on the etiology of injury, namely prerenal azotemia, intrinsic renal disease, and postrenal causes. The discovery of new biomarkers adds nuance to the classification of AKI. Two groups of biomarkers are particularly helpful in this regard: markers of structural injury (eg, NGAL) and functional markers (eg, cystatin C). The combination of these biomarkers with SCr has refined the categories of AKI (Figure). For example, NGAL can accurately distinguish between a rise in SCr due to functional AKI, previously referred to as prerenal azotemia, and a rise in SCr due to intrinsic kidney injury. An elevation of structural injury biomarkers in the absence of a significant rise in SCr is referred to as subclinical AKI. Patients with subclinical AKI have worse outcomes than those without AKI but better outcomes than patients with AKI with elevation of both SCr and NGAL (Figure).2,6 Time to resolution of AKI further refines our ability to predict prognosis and outcomes. Transient AKI, defined as resolution within 48 hours, is associated with a better prognosis than persistent AKI. Renal dysfunction lasting more than seven days but less than 90 days is referred to as acute kidney disease (AKD). While both transient AKI and AKD represent different entities on the continuum between AKI and CKD, further research is needed to better elucidate these classifications.2

 

 

RISK STRATIFICATION

The renal angina index (RAI) identifies critically ill children at high risk for AKI. The RAI combines traditional markers of AKI, such as a change in estimated creatinine clearance and fluid overload, with patient factors, including need for ventilation, inotropic support, and history of transplantation (solid organ or bone marrow) to identify those patients who are at high risk for severe AKI. Patients identified as high risk by the patient factors component of the RAI have a much lower threshold for both a decrease in creatinine clearance and fluid overload to be considered at risk for severe AKI, as these early signs are more likely to reflect an early impending severe AKI in this high-risk group. Conversely, patients that do not meet these patient factors are more likely to simply have a transient or functional AKI, and therefore have a higher threshold for both a change in creatinine clearance and fluid overload in order to be considered at high risk for severe AKI.

The RAI has been validated in the critical care setting as a method to predict severe AKI at day three of admission to the pediatric intensive care unit, with a negative predictive value of 92%-99% when the score is negative in the first 12 hours.10 In selected high-risk patients (RAI ≥ 8), biomarkers become even more reliable for AKI prediction (eg, injury markers have an excellent area under the receiver operating characteristic curve (AUC) of 0.97 for severe AKI prediction in this high-risk group).11 While only validated for critically ill patients, the concept of renal angina is still applicable in the complex populations managed by hospitalists who practice outside of the intensive care unit setting. Early signs of renal dysfunction (eg, rising SCr, fluid overload ≥5%) in patients with risk factors (see below) should prompt a thorough evaluation, including urinalysis, daily SCr, nephrotoxin avoidance, and tissue injury biomarkers, if available.

The risk factors for AKI are numerous and tend to potentiate one another. The most frequent predisposing comorbidities include CKD, heart failure or congenital heart diseases, transplantation (bone marrow or solid organs), and diabetes. Disease-related factors include sepsis, cardiac surgery, cardio-pulmonary bypass, mechanical ventilation, and vasopressor use. Potentially modifiable factors include hypovolemia and multiple nephrotoxic exposures. 2,3

Nephrotoxic medications are now among the most common causes of AKI in hospitalized children.12 Approximately 80% of children are exposed to at least one nephrotoxin during an inpatient admission.12 Exposure to a single nephrotoxic medication is sufficient to place a child at risk of AKI, and each additional nephrotoxin further increases the risk.12 While some drugs are routinely recognized to be nephrotoxic (eg, ibuprofen), others are commonly overlooked, notably certain antibiotics (eg, cefotaxime, ceftazidime, cefuroxime, nafcillin, and piperacillin) and anticonvulsants (eg, zonisamide).12 Furthermore, the combination of multiple nephrotoxins can potentiate the risk of AKI. For example, the combination of vancomycin and piperacillin/tazobactam increases the risk of AKI by 3.4 times compared with the combination of vancomycin with another antipseudomonal beta-lactam antibiotic.13

Adequate monitoring, including daily SCr measurements and risk awareness, are critical as nephrotoxin-associated AKI can be easily missed in the absence of routine SCr monitoring, especially since these children are typically nonoliguric12. Quality improvement efforts focused on obtaining daily SCr in patients exposed to either three or more nephrotoxins or three days of either aminoglycoside or vancomycin, even without concomitant exposure to other nephrotoxins, have shown success in decreasing both the number of nephrotoxins and the rate of nephrotoxin-associated AKI.12

While a significant injury cannot always be avoided, a mindful clinical approach and management can help to prevent some complications of AKI. An awareness of fluid status is critical, as fluid overload greater than 10% of the patient’s weight independently increases the risk of mortality in both adults and children.14 To assess the risk of AKI progression and potential failure of conservative management with diuretics, a furosemide stress test (FST) is an easy, safe, and accessible functional assessment of tubular reserve in a patient without intravascular depletion.15 A growing body of literature in adults shows that FST-responders are less likely to progress to stage 3 AKI or need renal replacement therapy than nonresponders.15 The FST is currently being investigated and standardized in children.

 

 

CONCLUSION

Research in AKI has made significant strides over the last few years. Nevertheless, many areas of research remain to be explored (eg, the impact of IV fluid type in the pediatric population, AKD characterization and impact on CKD development). AKI is common, associated with significant morbidity and mortality and, in some instances, preventable. While no targeted therapeutic options are currently under investigation, recent advances allow for better identification of high-risk patients and offer opportunities for impactful preventive approaches. Thoughtful use of nephrotoxic medications, early identification of patients at high risk for AKI, and accurate diagnosis and appropriate management of AKI are the recommended best practice.

Disclosures

The authors have nothing to disclose.

References

1. McGregor TL, Jones DP, Wang L, et al. Acute kidney injury incidence in noncritically ill hospitalized children, adolescents, and young adults: a retrospective observational study. Am J Kidney Dis. 2016;67(3):384-390. https://doi.org/10.1053/j.ajkd.2015.07.019.
2. Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241-257. https://doi.org/10.1038/nrneph.2017.2.
3. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):179-184. https://doi.org/10.1159/000339789.
4. Filho LT, Grande AJ, Colonetti T, Della ÉSP, da Rosa MI. Accuracy of neutrophil gelatinase-associated lipocalin for acute kidney injury diagnosis in children: systematic review and meta-analysis. Pediatr Nephrol. 2017;32(10):1979-1988. https://doi.org/10.1007/s00467-017-3704-6.
5. Levey AS, Inker LA. Assessment of glomerular filtration rate in health and disease: a state of the art review. Clin Pharmacol Ther. 2017;102(3):405-419. https://doi.org/10.1002/cpt.729.
6. Endre ZH, Kellum JA, Di Somma S, et al. Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol. 2013;182:30-44. https://doi.org/10.1159/000349964.
7. Su LJ, Li YM, Kellum JA, Peng ZY. Predictive value of cell cycle arrest biomarkers for cardiac surgery-associated acute kidney injury: a meta-analysis. Br J Anaesth. 2018;121(2):350-357. https://doi.org/10.1016/j.bja.2018.02.069.
8. Westhoff JH, Tönshoff B, Waldherr S, et al. Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) · insulin-like growth factor-binding protein 7 (IGFBP7) predicts adverse outcome in pediatric acute kidney injury. PLoS One. 2015;10(11):1-16. https://doi.org/10.1371/journal.pone.0143628.
9. Berg UB, Nyman U, Bäck R, et al. New standardized cystatin C and creatinine GFR equations in children validated with inulin clearance. Pediatr Nephrol. 2015;30(8):1317-1326. https://doi.org/10.1007/s00467-015-3060-3.
10. Chawla LS, Goldstein SL, Kellum JA, Ronco C. Renal angina: concept and development of pretest probability assessment in acute kidney injury. Crit Care. 2015;19(1):93. https://doi.org/10.1186/s13054-015-0779-y.
11. Menon S, Goldstein SL, Mottes T, et al. Urinary biomarker incorporation into the renal angina index early in intensive care unit admission optimizes acute kidney injury prediction in critically ill children: a prospective cohort study. Nephrol Dial Transplant. 2016;31(4):586-594. https://doi.org/10.1093/ndt/gfv457.
12. Goldstein SL, Mottes T, Simpson K, et al. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int. 2016;90(1):212-221. https://doi.org/10.1016/j.kint.2016.03.031.
13. Downes KJ, Cowden C, Laskin BL, et al. Association of acute kidney injury with concomitant vancomycin and piperacillin/tazobactam treatment among hospitalized children. JAMA Pediatr. 2017;19146:e173219-e173219. https://doi.org/10.1001/JAMAPEDIATRICS.2017.3219.
14. Naipaul A, Jefferson LS, Goldstein SL, Loftis LL, Zappitelli M, Arikan AA. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children*. Pediatr Crit Care Med. 2011;13(3):253-258. https://doi.org/10.1097/pcc.0b013e31822882a3.
15. Lumlertgul N, Peerapornratana S, Trakarnvanich T, et al. Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care. 2018;22(1):1-9. https://doi.org/10.1186/s13054-018-2021-1.

Article PDF
Issue
Journal of Hospital Medicine 14(9)
Topics
Page Number
552-554. Published online first August 21, 2019.
Sections
Article PDF
Article PDF

Acute kidney injury (AKI) occurs in 5%-30% of noncritically ill hospitalized children.1 Initially thought to be simply a symptom of more severe pathologies, it is now recognized that AKI independently increases mortality and is associated with the development of chronic kidney disease (CKD), even in children.2 The wide acceptance of the Kidney Disease Improving Global Outcome (KDIGO) diagnostic criteria has enabled a more uniform definition of AKI from both clinical and research perspectives.2 A better understanding of the pathophysiology and risk factors for AKI has led to new methods for early detection and prevention efforts. While serum creatinine (SCr) was historically one of the sole markers of AKI, novel biomarkers can facilitate earlier diagnosis of AKI, identify subclinical AKI, and guide clinical management. This clinical practice update addresses the latest clinical advances in risk assessment, diagnosis, and prevention of pediatric AKI, with a focus on AKI biomarkers.

DIAGNOSIS, BIOMARKERS, AND DEFINITION

Several sets of criteria have been used to diagnose AKI. The KDIGO classification, based on a systematic review of the literature and developed through expert consensus, is the current recommended definition.3 Increasing AKI stage, as defined by the KDIGO classification, is associated with increased mortality, the need for renal replacement therapy, length of stay, and CKD, thus underscoring the importance of accurate classification.3 Stage 1 AKI is defined by a rise in SCr of ≥0.3 mg/dL,1.5-1.9 times the baseline SCr, or urine output <0.5 ml/kg/h for six to 12 hours; stage 2 by a rise of ≥2.0-2.9 times the baseline SCr or urine output <0.5 ml/kg/h for >12 hours; and stage 3 by a rise of ≥4.0 mg/dL, ≥three times the baseline SCr, initiation of renal replacement therapy, urine output <0.3 ml/kg/h for ≥24 hours, or anuria ≥12 hours. However, these criteria rely on SCr, which is a suboptimal marker of renal dysfunction, as it rises only once the glomerular filtration rate (GFR) has already decreased, in some cases by as much as 50%. Additionally, interpretation of SCr in the diagnosis of AKI requires a prior Scr measurement to determine the magnitude of change from the baseline value, which is often lacking in children. To mitigate this limitation, different formulas exist to estimate a baseline SCr value based on height or age, an approach that assumes patients have preexisting normal renal function.

The limitations of SCr have led to interest in identifying more accurate biomarkers of AKI. Although many candidates have been identified, we will limit our discussion to those currently available for clinical use: serum cystatin C, urine neutrophil gelatinase-associated lipocalin (NGAL), urine TIMP-2, and urine IGFBP7 (Table).4-8 While urine NGAL and cystatin C are measured individually, TIMP-2 and IGFBP7 are measured on the same panel and the product of their multiplied values is used for clinical guidance. While each of these biomarkers have good predictive accuracy for AKI when used independently, their combined use increases the accuracy of AKI diagnosis. These biomarkers can be divided into broad categories based on their utility as either functional markers or markers of injury.6 Serum cystatin C is a functional marker and as such can be used to estimate GFR more accurately than SCr.9 Comparatively, urine NGAL is a marker of renal injury, while TIMP2 and IGFBP7 are markers of renal stress. These markers are not useful in estimating GFR, but rather aid in the prediction and diagnosis of AKI (Figure). Despite the limitations of SCr, these biomarkers have yet to be incorporated into the diagnostic criteria. They have, however, helped to refine our understanding of the pathophysiology of AKI.



AKI has classically been divided into three categories based on the etiology of injury, namely prerenal azotemia, intrinsic renal disease, and postrenal causes. The discovery of new biomarkers adds nuance to the classification of AKI. Two groups of biomarkers are particularly helpful in this regard: markers of structural injury (eg, NGAL) and functional markers (eg, cystatin C). The combination of these biomarkers with SCr has refined the categories of AKI (Figure). For example, NGAL can accurately distinguish between a rise in SCr due to functional AKI, previously referred to as prerenal azotemia, and a rise in SCr due to intrinsic kidney injury. An elevation of structural injury biomarkers in the absence of a significant rise in SCr is referred to as subclinical AKI. Patients with subclinical AKI have worse outcomes than those without AKI but better outcomes than patients with AKI with elevation of both SCr and NGAL (Figure).2,6 Time to resolution of AKI further refines our ability to predict prognosis and outcomes. Transient AKI, defined as resolution within 48 hours, is associated with a better prognosis than persistent AKI. Renal dysfunction lasting more than seven days but less than 90 days is referred to as acute kidney disease (AKD). While both transient AKI and AKD represent different entities on the continuum between AKI and CKD, further research is needed to better elucidate these classifications.2

 

 

RISK STRATIFICATION

The renal angina index (RAI) identifies critically ill children at high risk for AKI. The RAI combines traditional markers of AKI, such as a change in estimated creatinine clearance and fluid overload, with patient factors, including need for ventilation, inotropic support, and history of transplantation (solid organ or bone marrow) to identify those patients who are at high risk for severe AKI. Patients identified as high risk by the patient factors component of the RAI have a much lower threshold for both a decrease in creatinine clearance and fluid overload to be considered at risk for severe AKI, as these early signs are more likely to reflect an early impending severe AKI in this high-risk group. Conversely, patients that do not meet these patient factors are more likely to simply have a transient or functional AKI, and therefore have a higher threshold for both a change in creatinine clearance and fluid overload in order to be considered at high risk for severe AKI.

The RAI has been validated in the critical care setting as a method to predict severe AKI at day three of admission to the pediatric intensive care unit, with a negative predictive value of 92%-99% when the score is negative in the first 12 hours.10 In selected high-risk patients (RAI ≥ 8), biomarkers become even more reliable for AKI prediction (eg, injury markers have an excellent area under the receiver operating characteristic curve (AUC) of 0.97 for severe AKI prediction in this high-risk group).11 While only validated for critically ill patients, the concept of renal angina is still applicable in the complex populations managed by hospitalists who practice outside of the intensive care unit setting. Early signs of renal dysfunction (eg, rising SCr, fluid overload ≥5%) in patients with risk factors (see below) should prompt a thorough evaluation, including urinalysis, daily SCr, nephrotoxin avoidance, and tissue injury biomarkers, if available.

The risk factors for AKI are numerous and tend to potentiate one another. The most frequent predisposing comorbidities include CKD, heart failure or congenital heart diseases, transplantation (bone marrow or solid organs), and diabetes. Disease-related factors include sepsis, cardiac surgery, cardio-pulmonary bypass, mechanical ventilation, and vasopressor use. Potentially modifiable factors include hypovolemia and multiple nephrotoxic exposures. 2,3

Nephrotoxic medications are now among the most common causes of AKI in hospitalized children.12 Approximately 80% of children are exposed to at least one nephrotoxin during an inpatient admission.12 Exposure to a single nephrotoxic medication is sufficient to place a child at risk of AKI, and each additional nephrotoxin further increases the risk.12 While some drugs are routinely recognized to be nephrotoxic (eg, ibuprofen), others are commonly overlooked, notably certain antibiotics (eg, cefotaxime, ceftazidime, cefuroxime, nafcillin, and piperacillin) and anticonvulsants (eg, zonisamide).12 Furthermore, the combination of multiple nephrotoxins can potentiate the risk of AKI. For example, the combination of vancomycin and piperacillin/tazobactam increases the risk of AKI by 3.4 times compared with the combination of vancomycin with another antipseudomonal beta-lactam antibiotic.13

Adequate monitoring, including daily SCr measurements and risk awareness, are critical as nephrotoxin-associated AKI can be easily missed in the absence of routine SCr monitoring, especially since these children are typically nonoliguric12. Quality improvement efforts focused on obtaining daily SCr in patients exposed to either three or more nephrotoxins or three days of either aminoglycoside or vancomycin, even without concomitant exposure to other nephrotoxins, have shown success in decreasing both the number of nephrotoxins and the rate of nephrotoxin-associated AKI.12

While a significant injury cannot always be avoided, a mindful clinical approach and management can help to prevent some complications of AKI. An awareness of fluid status is critical, as fluid overload greater than 10% of the patient’s weight independently increases the risk of mortality in both adults and children.14 To assess the risk of AKI progression and potential failure of conservative management with diuretics, a furosemide stress test (FST) is an easy, safe, and accessible functional assessment of tubular reserve in a patient without intravascular depletion.15 A growing body of literature in adults shows that FST-responders are less likely to progress to stage 3 AKI or need renal replacement therapy than nonresponders.15 The FST is currently being investigated and standardized in children.

 

 

CONCLUSION

Research in AKI has made significant strides over the last few years. Nevertheless, many areas of research remain to be explored (eg, the impact of IV fluid type in the pediatric population, AKD characterization and impact on CKD development). AKI is common, associated with significant morbidity and mortality and, in some instances, preventable. While no targeted therapeutic options are currently under investigation, recent advances allow for better identification of high-risk patients and offer opportunities for impactful preventive approaches. Thoughtful use of nephrotoxic medications, early identification of patients at high risk for AKI, and accurate diagnosis and appropriate management of AKI are the recommended best practice.

Disclosures

The authors have nothing to disclose.

Acute kidney injury (AKI) occurs in 5%-30% of noncritically ill hospitalized children.1 Initially thought to be simply a symptom of more severe pathologies, it is now recognized that AKI independently increases mortality and is associated with the development of chronic kidney disease (CKD), even in children.2 The wide acceptance of the Kidney Disease Improving Global Outcome (KDIGO) diagnostic criteria has enabled a more uniform definition of AKI from both clinical and research perspectives.2 A better understanding of the pathophysiology and risk factors for AKI has led to new methods for early detection and prevention efforts. While serum creatinine (SCr) was historically one of the sole markers of AKI, novel biomarkers can facilitate earlier diagnosis of AKI, identify subclinical AKI, and guide clinical management. This clinical practice update addresses the latest clinical advances in risk assessment, diagnosis, and prevention of pediatric AKI, with a focus on AKI biomarkers.

DIAGNOSIS, BIOMARKERS, AND DEFINITION

Several sets of criteria have been used to diagnose AKI. The KDIGO classification, based on a systematic review of the literature and developed through expert consensus, is the current recommended definition.3 Increasing AKI stage, as defined by the KDIGO classification, is associated with increased mortality, the need for renal replacement therapy, length of stay, and CKD, thus underscoring the importance of accurate classification.3 Stage 1 AKI is defined by a rise in SCr of ≥0.3 mg/dL,1.5-1.9 times the baseline SCr, or urine output <0.5 ml/kg/h for six to 12 hours; stage 2 by a rise of ≥2.0-2.9 times the baseline SCr or urine output <0.5 ml/kg/h for >12 hours; and stage 3 by a rise of ≥4.0 mg/dL, ≥three times the baseline SCr, initiation of renal replacement therapy, urine output <0.3 ml/kg/h for ≥24 hours, or anuria ≥12 hours. However, these criteria rely on SCr, which is a suboptimal marker of renal dysfunction, as it rises only once the glomerular filtration rate (GFR) has already decreased, in some cases by as much as 50%. Additionally, interpretation of SCr in the diagnosis of AKI requires a prior Scr measurement to determine the magnitude of change from the baseline value, which is often lacking in children. To mitigate this limitation, different formulas exist to estimate a baseline SCr value based on height or age, an approach that assumes patients have preexisting normal renal function.

The limitations of SCr have led to interest in identifying more accurate biomarkers of AKI. Although many candidates have been identified, we will limit our discussion to those currently available for clinical use: serum cystatin C, urine neutrophil gelatinase-associated lipocalin (NGAL), urine TIMP-2, and urine IGFBP7 (Table).4-8 While urine NGAL and cystatin C are measured individually, TIMP-2 and IGFBP7 are measured on the same panel and the product of their multiplied values is used for clinical guidance. While each of these biomarkers have good predictive accuracy for AKI when used independently, their combined use increases the accuracy of AKI diagnosis. These biomarkers can be divided into broad categories based on their utility as either functional markers or markers of injury.6 Serum cystatin C is a functional marker and as such can be used to estimate GFR more accurately than SCr.9 Comparatively, urine NGAL is a marker of renal injury, while TIMP2 and IGFBP7 are markers of renal stress. These markers are not useful in estimating GFR, but rather aid in the prediction and diagnosis of AKI (Figure). Despite the limitations of SCr, these biomarkers have yet to be incorporated into the diagnostic criteria. They have, however, helped to refine our understanding of the pathophysiology of AKI.



AKI has classically been divided into three categories based on the etiology of injury, namely prerenal azotemia, intrinsic renal disease, and postrenal causes. The discovery of new biomarkers adds nuance to the classification of AKI. Two groups of biomarkers are particularly helpful in this regard: markers of structural injury (eg, NGAL) and functional markers (eg, cystatin C). The combination of these biomarkers with SCr has refined the categories of AKI (Figure). For example, NGAL can accurately distinguish between a rise in SCr due to functional AKI, previously referred to as prerenal azotemia, and a rise in SCr due to intrinsic kidney injury. An elevation of structural injury biomarkers in the absence of a significant rise in SCr is referred to as subclinical AKI. Patients with subclinical AKI have worse outcomes than those without AKI but better outcomes than patients with AKI with elevation of both SCr and NGAL (Figure).2,6 Time to resolution of AKI further refines our ability to predict prognosis and outcomes. Transient AKI, defined as resolution within 48 hours, is associated with a better prognosis than persistent AKI. Renal dysfunction lasting more than seven days but less than 90 days is referred to as acute kidney disease (AKD). While both transient AKI and AKD represent different entities on the continuum between AKI and CKD, further research is needed to better elucidate these classifications.2

 

 

RISK STRATIFICATION

The renal angina index (RAI) identifies critically ill children at high risk for AKI. The RAI combines traditional markers of AKI, such as a change in estimated creatinine clearance and fluid overload, with patient factors, including need for ventilation, inotropic support, and history of transplantation (solid organ or bone marrow) to identify those patients who are at high risk for severe AKI. Patients identified as high risk by the patient factors component of the RAI have a much lower threshold for both a decrease in creatinine clearance and fluid overload to be considered at risk for severe AKI, as these early signs are more likely to reflect an early impending severe AKI in this high-risk group. Conversely, patients that do not meet these patient factors are more likely to simply have a transient or functional AKI, and therefore have a higher threshold for both a change in creatinine clearance and fluid overload in order to be considered at high risk for severe AKI.

The RAI has been validated in the critical care setting as a method to predict severe AKI at day three of admission to the pediatric intensive care unit, with a negative predictive value of 92%-99% when the score is negative in the first 12 hours.10 In selected high-risk patients (RAI ≥ 8), biomarkers become even more reliable for AKI prediction (eg, injury markers have an excellent area under the receiver operating characteristic curve (AUC) of 0.97 for severe AKI prediction in this high-risk group).11 While only validated for critically ill patients, the concept of renal angina is still applicable in the complex populations managed by hospitalists who practice outside of the intensive care unit setting. Early signs of renal dysfunction (eg, rising SCr, fluid overload ≥5%) in patients with risk factors (see below) should prompt a thorough evaluation, including urinalysis, daily SCr, nephrotoxin avoidance, and tissue injury biomarkers, if available.

The risk factors for AKI are numerous and tend to potentiate one another. The most frequent predisposing comorbidities include CKD, heart failure or congenital heart diseases, transplantation (bone marrow or solid organs), and diabetes. Disease-related factors include sepsis, cardiac surgery, cardio-pulmonary bypass, mechanical ventilation, and vasopressor use. Potentially modifiable factors include hypovolemia and multiple nephrotoxic exposures. 2,3

Nephrotoxic medications are now among the most common causes of AKI in hospitalized children.12 Approximately 80% of children are exposed to at least one nephrotoxin during an inpatient admission.12 Exposure to a single nephrotoxic medication is sufficient to place a child at risk of AKI, and each additional nephrotoxin further increases the risk.12 While some drugs are routinely recognized to be nephrotoxic (eg, ibuprofen), others are commonly overlooked, notably certain antibiotics (eg, cefotaxime, ceftazidime, cefuroxime, nafcillin, and piperacillin) and anticonvulsants (eg, zonisamide).12 Furthermore, the combination of multiple nephrotoxins can potentiate the risk of AKI. For example, the combination of vancomycin and piperacillin/tazobactam increases the risk of AKI by 3.4 times compared with the combination of vancomycin with another antipseudomonal beta-lactam antibiotic.13

Adequate monitoring, including daily SCr measurements and risk awareness, are critical as nephrotoxin-associated AKI can be easily missed in the absence of routine SCr monitoring, especially since these children are typically nonoliguric12. Quality improvement efforts focused on obtaining daily SCr in patients exposed to either three or more nephrotoxins or three days of either aminoglycoside or vancomycin, even without concomitant exposure to other nephrotoxins, have shown success in decreasing both the number of nephrotoxins and the rate of nephrotoxin-associated AKI.12

While a significant injury cannot always be avoided, a mindful clinical approach and management can help to prevent some complications of AKI. An awareness of fluid status is critical, as fluid overload greater than 10% of the patient’s weight independently increases the risk of mortality in both adults and children.14 To assess the risk of AKI progression and potential failure of conservative management with diuretics, a furosemide stress test (FST) is an easy, safe, and accessible functional assessment of tubular reserve in a patient without intravascular depletion.15 A growing body of literature in adults shows that FST-responders are less likely to progress to stage 3 AKI or need renal replacement therapy than nonresponders.15 The FST is currently being investigated and standardized in children.

 

 

CONCLUSION

Research in AKI has made significant strides over the last few years. Nevertheless, many areas of research remain to be explored (eg, the impact of IV fluid type in the pediatric population, AKD characterization and impact on CKD development). AKI is common, associated with significant morbidity and mortality and, in some instances, preventable. While no targeted therapeutic options are currently under investigation, recent advances allow for better identification of high-risk patients and offer opportunities for impactful preventive approaches. Thoughtful use of nephrotoxic medications, early identification of patients at high risk for AKI, and accurate diagnosis and appropriate management of AKI are the recommended best practice.

Disclosures

The authors have nothing to disclose.

References

1. McGregor TL, Jones DP, Wang L, et al. Acute kidney injury incidence in noncritically ill hospitalized children, adolescents, and young adults: a retrospective observational study. Am J Kidney Dis. 2016;67(3):384-390. https://doi.org/10.1053/j.ajkd.2015.07.019.
2. Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241-257. https://doi.org/10.1038/nrneph.2017.2.
3. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):179-184. https://doi.org/10.1159/000339789.
4. Filho LT, Grande AJ, Colonetti T, Della ÉSP, da Rosa MI. Accuracy of neutrophil gelatinase-associated lipocalin for acute kidney injury diagnosis in children: systematic review and meta-analysis. Pediatr Nephrol. 2017;32(10):1979-1988. https://doi.org/10.1007/s00467-017-3704-6.
5. Levey AS, Inker LA. Assessment of glomerular filtration rate in health and disease: a state of the art review. Clin Pharmacol Ther. 2017;102(3):405-419. https://doi.org/10.1002/cpt.729.
6. Endre ZH, Kellum JA, Di Somma S, et al. Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol. 2013;182:30-44. https://doi.org/10.1159/000349964.
7. Su LJ, Li YM, Kellum JA, Peng ZY. Predictive value of cell cycle arrest biomarkers for cardiac surgery-associated acute kidney injury: a meta-analysis. Br J Anaesth. 2018;121(2):350-357. https://doi.org/10.1016/j.bja.2018.02.069.
8. Westhoff JH, Tönshoff B, Waldherr S, et al. Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) · insulin-like growth factor-binding protein 7 (IGFBP7) predicts adverse outcome in pediatric acute kidney injury. PLoS One. 2015;10(11):1-16. https://doi.org/10.1371/journal.pone.0143628.
9. Berg UB, Nyman U, Bäck R, et al. New standardized cystatin C and creatinine GFR equations in children validated with inulin clearance. Pediatr Nephrol. 2015;30(8):1317-1326. https://doi.org/10.1007/s00467-015-3060-3.
10. Chawla LS, Goldstein SL, Kellum JA, Ronco C. Renal angina: concept and development of pretest probability assessment in acute kidney injury. Crit Care. 2015;19(1):93. https://doi.org/10.1186/s13054-015-0779-y.
11. Menon S, Goldstein SL, Mottes T, et al. Urinary biomarker incorporation into the renal angina index early in intensive care unit admission optimizes acute kidney injury prediction in critically ill children: a prospective cohort study. Nephrol Dial Transplant. 2016;31(4):586-594. https://doi.org/10.1093/ndt/gfv457.
12. Goldstein SL, Mottes T, Simpson K, et al. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int. 2016;90(1):212-221. https://doi.org/10.1016/j.kint.2016.03.031.
13. Downes KJ, Cowden C, Laskin BL, et al. Association of acute kidney injury with concomitant vancomycin and piperacillin/tazobactam treatment among hospitalized children. JAMA Pediatr. 2017;19146:e173219-e173219. https://doi.org/10.1001/JAMAPEDIATRICS.2017.3219.
14. Naipaul A, Jefferson LS, Goldstein SL, Loftis LL, Zappitelli M, Arikan AA. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children*. Pediatr Crit Care Med. 2011;13(3):253-258. https://doi.org/10.1097/pcc.0b013e31822882a3.
15. Lumlertgul N, Peerapornratana S, Trakarnvanich T, et al. Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care. 2018;22(1):1-9. https://doi.org/10.1186/s13054-018-2021-1.

References

1. McGregor TL, Jones DP, Wang L, et al. Acute kidney injury incidence in noncritically ill hospitalized children, adolescents, and young adults: a retrospective observational study. Am J Kidney Dis. 2016;67(3):384-390. https://doi.org/10.1053/j.ajkd.2015.07.019.
2. Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241-257. https://doi.org/10.1038/nrneph.2017.2.
3. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):179-184. https://doi.org/10.1159/000339789.
4. Filho LT, Grande AJ, Colonetti T, Della ÉSP, da Rosa MI. Accuracy of neutrophil gelatinase-associated lipocalin for acute kidney injury diagnosis in children: systematic review and meta-analysis. Pediatr Nephrol. 2017;32(10):1979-1988. https://doi.org/10.1007/s00467-017-3704-6.
5. Levey AS, Inker LA. Assessment of glomerular filtration rate in health and disease: a state of the art review. Clin Pharmacol Ther. 2017;102(3):405-419. https://doi.org/10.1002/cpt.729.
6. Endre ZH, Kellum JA, Di Somma S, et al. Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol. 2013;182:30-44. https://doi.org/10.1159/000349964.
7. Su LJ, Li YM, Kellum JA, Peng ZY. Predictive value of cell cycle arrest biomarkers for cardiac surgery-associated acute kidney injury: a meta-analysis. Br J Anaesth. 2018;121(2):350-357. https://doi.org/10.1016/j.bja.2018.02.069.
8. Westhoff JH, Tönshoff B, Waldherr S, et al. Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) · insulin-like growth factor-binding protein 7 (IGFBP7) predicts adverse outcome in pediatric acute kidney injury. PLoS One. 2015;10(11):1-16. https://doi.org/10.1371/journal.pone.0143628.
9. Berg UB, Nyman U, Bäck R, et al. New standardized cystatin C and creatinine GFR equations in children validated with inulin clearance. Pediatr Nephrol. 2015;30(8):1317-1326. https://doi.org/10.1007/s00467-015-3060-3.
10. Chawla LS, Goldstein SL, Kellum JA, Ronco C. Renal angina: concept and development of pretest probability assessment in acute kidney injury. Crit Care. 2015;19(1):93. https://doi.org/10.1186/s13054-015-0779-y.
11. Menon S, Goldstein SL, Mottes T, et al. Urinary biomarker incorporation into the renal angina index early in intensive care unit admission optimizes acute kidney injury prediction in critically ill children: a prospective cohort study. Nephrol Dial Transplant. 2016;31(4):586-594. https://doi.org/10.1093/ndt/gfv457.
12. Goldstein SL, Mottes T, Simpson K, et al. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int. 2016;90(1):212-221. https://doi.org/10.1016/j.kint.2016.03.031.
13. Downes KJ, Cowden C, Laskin BL, et al. Association of acute kidney injury with concomitant vancomycin and piperacillin/tazobactam treatment among hospitalized children. JAMA Pediatr. 2017;19146:e173219-e173219. https://doi.org/10.1001/JAMAPEDIATRICS.2017.3219.
14. Naipaul A, Jefferson LS, Goldstein SL, Loftis LL, Zappitelli M, Arikan AA. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children*. Pediatr Crit Care Med. 2011;13(3):253-258. https://doi.org/10.1097/pcc.0b013e31822882a3.
15. Lumlertgul N, Peerapornratana S, Trakarnvanich T, et al. Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care. 2018;22(1):1-9. https://doi.org/10.1186/s13054-018-2021-1.

Issue
Journal of Hospital Medicine 14(9)
Issue
Journal of Hospital Medicine 14(9)
Page Number
552-554. Published online first August 21, 2019.
Page Number
552-554. Published online first August 21, 2019.
Topics
Article Type
Sections
Article Source

© 2019 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Jean-Philippe Roy, MD; E-mail: [email protected]; Telephone: 514-622-8331.
Content Gating
Gated (full article locked unless allowed per User)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Gating Strategy
First Peek Free
Article PDF Media

Nurturing Sustainability in a Growing Community Pediatric Hospital Medicine Workforce

Article Type
Changed
Wed, 10/30/2019 - 14:29

Systematic efforts to measure and compare work hours emerged in the 19th century as laborers shifted from artisanal shops to factories, sparking debate over the appropriate length and intensity of work.1 Two centuries of unionization and regulation defined work hours for many United States employees, including graduate medical trainees, but left attending physicians largely untouched. Instead, the medical workforce has long relied on survey data to shape jobs that balance professional norms with local market demands. Leaders in young, dynamic specialties, such as pediatric hospital medicine (PHM), particularly require such data to recruit and retain talent.

PHM progressed swiftly from acknowledgment as a “distinct area of practice” in 1999 to a subspecialty recognition.2 Currently, at least 3,000 pediatric hospitalists3 practice in more than 800 US sites (Snow C, Personal communication regarding community PHM workforce survey). Approximately half of them work at community hospitals, where PHM groups often comprise fewer than five full-time equivalents (FTEs) and face unique challenges. Community PHM practices may assume broader responsibilities than university/children’s hospital colleagues, including advocacy for the needs of children in predominantly adult-oriented hospitals.4 Although data regarding academic PHM work demands are available,5 there is little information pertaining to community hospitalists regarding typical workloads or other characteristics of thriving practices.

In this issue of the Journal of Hospital Medicine, Alvarez et al. present the findings of structured interviews with 70 community PHM group leaders.6 Each participant answered 12 questions about their group, addressing the definition of a full-time workload and hours, the design of backup systems, and the respondent’s perception of the program’s sustainability. The sample is robust, with the caveats that it disproportionately represents the Midwest and West (34.3% each) and more than half of the groups were employed by an academic institution. The authors found a median work expectation per FTE of 1,882 hours/year and 21 weekends per year, although they noted significant variability in employers’ demands and services provided. The majority of hospitalist groups lacked census caps, formal backup systems, or processes to expand coverage during busy seasons. Among the site leaders, 63% perceived their program as sustainable, but no program design or employer characteristic was clearly associated with this perception.

The importance of this study derives from aggregating data about the largest cross section of community PHM groups yet reported. For many PHM group leaders, this will offer a new point of reference for key practice characteristics. Furthermore, the authors should be commended for attempting to distinguish how program sustainability manifests in community PHM, where hospitalists shoulder longer patient care hours and many of them sustain academic endeavors. It is concerning that more than a third of leaders do not perceive their program as sustainable, but the implications for the field are unclear. Perhaps part of this uncertainty arises from the terminology, as sustainability lacks a technical or a consensus definition and the authors purposefully did not define the term for the respondents. While many respondents probably worried about physician burnout, others might have channeled fears about group finances or competition with adult service lines for beds. In addition, leaders’ fears about sustainability may not exactly represent the concerns of front-line employees.

Sustainable work environments are complex constructs with several inputs. For example, supportive leaders, efficient delivery systems, optimized EHRs, competitive pay, and confidence about service line stability might all mitigate higher workloads. Ultimately, this complexity underscores an important caution about all workplace surveys in medicine; ie, average values can inform practice design, but hospitalists and administrators should always consider the local context. Blindly applying medians as benchmarks and ignoring the myriad other contributors to sustainable practice risk disrupting successful PHM programs. In other words, surveys describe how the world is, not how it should be. The spectrum of academic work and norms permeating community PHM groups instead call for a nuanced approach.

How does the field build upon this useful paper? First, the Society of Hospital Medicine (SHM) should engage PHM leaders to increase participation in regular remeasurement, a critical endeavor for this dynamic field. SHM’s State of Hospital Medicine Report queries about a wider variety of practice characteristics, but it has a smaller sample size that must grow to fill this void.7 As the work of repeated surveys transitions from academic inquiry to professional society service, SHM’s Practice Analysis Committee can meet the needs of PHM through relevant questions and efforts to foster adequate participation. Second, all practice leaders should follow the ballooning bodies of literature about burnout and healthcare value. Just as labor leaders had discovered in the industrial revolution, sustainable careers require not only measuring work hours but also advocating for safe, meaningful, and engaging work conditions. By continuously creating value for patients, families, and hospitals, we can strengthen our claim to the resources needed to optimize the work environment.

 

 

Disclosure

Andrew White is Chair of the Society of Hospital Medicine’s Practice Analysis Committee, an unpaid position. Dr. Marek serves on the American Academy of Pediatrics Section on Hospital Medicine Executive Committee which is a voluntary, unpaid, elected position.

 

References

1. Whaples R. Hours of Work in U.S. History. EH Net Encyclopedia. 2001. http://eh.net/encyclopedia/hours-of-work-in-u-s-history/. Accessed June 25, 2019.
2. Pediatric Hospital Medicine Certification. The American Board of Pediatrics.
https://www.abp.org/content/pediatric-hospital-medicine-certification.
Accessed 28 February, 2018.
3. Harbuck SM, Follmer AD, Dill MJ, Erikson C. Estimating the number and characteristics
of hospitalist physicians in the United States and their possible workforce
implications. Association of Medical Colleges. 2012. www.aamc.org/download/
300620/data/aibvol12_no3-hospitalist.pdf. Accessed June 25, 2019.
4. Roberts KB, Brown J, Quinonez RA, Percelay JM. Institutions and individuals:
what makes a hospitalist “academic”? Hosp Pediatr. 2014;4(5);326-327.
https://doi.org/10.1542/hpeds.2014-00.
5. Fromme HB, Chen CO, Fine BR, Gosdin C, Shaughnessy EE. Pediatric hospitalist
workload and sustainability in university-based programs: results from a
national interview-based survey. J Hosp Med. 2018;13(10):702-705. https://doi.
org/10.12788/jhm.2977.
6. Alvarez, F, McDaniel CE, Birnie K, et al. Community pediatric hospitalist
workload: results from a national survey. J Hosp Med. 2019; 14(11):682-685. https://
doi.org/10.12788/jhm.3263.
7. 2018 State of Hospital Medicine Report. Society of Hospital Medicine: Philadelphia,
Pennsylvania; 2019. https://www.hospitalmedicine.org/practice-management/
shms-state-of-hospital-medicine/. Accessed July 27, 2019.

Article PDF
Issue
Journal of Hospital Medicine 14(11)
Topics
Page Number
721-722. Published online first August 21, 2019
Sections
Article PDF
Article PDF
Related Articles

Systematic efforts to measure and compare work hours emerged in the 19th century as laborers shifted from artisanal shops to factories, sparking debate over the appropriate length and intensity of work.1 Two centuries of unionization and regulation defined work hours for many United States employees, including graduate medical trainees, but left attending physicians largely untouched. Instead, the medical workforce has long relied on survey data to shape jobs that balance professional norms with local market demands. Leaders in young, dynamic specialties, such as pediatric hospital medicine (PHM), particularly require such data to recruit and retain talent.

PHM progressed swiftly from acknowledgment as a “distinct area of practice” in 1999 to a subspecialty recognition.2 Currently, at least 3,000 pediatric hospitalists3 practice in more than 800 US sites (Snow C, Personal communication regarding community PHM workforce survey). Approximately half of them work at community hospitals, where PHM groups often comprise fewer than five full-time equivalents (FTEs) and face unique challenges. Community PHM practices may assume broader responsibilities than university/children’s hospital colleagues, including advocacy for the needs of children in predominantly adult-oriented hospitals.4 Although data regarding academic PHM work demands are available,5 there is little information pertaining to community hospitalists regarding typical workloads or other characteristics of thriving practices.

In this issue of the Journal of Hospital Medicine, Alvarez et al. present the findings of structured interviews with 70 community PHM group leaders.6 Each participant answered 12 questions about their group, addressing the definition of a full-time workload and hours, the design of backup systems, and the respondent’s perception of the program’s sustainability. The sample is robust, with the caveats that it disproportionately represents the Midwest and West (34.3% each) and more than half of the groups were employed by an academic institution. The authors found a median work expectation per FTE of 1,882 hours/year and 21 weekends per year, although they noted significant variability in employers’ demands and services provided. The majority of hospitalist groups lacked census caps, formal backup systems, or processes to expand coverage during busy seasons. Among the site leaders, 63% perceived their program as sustainable, but no program design or employer characteristic was clearly associated with this perception.

The importance of this study derives from aggregating data about the largest cross section of community PHM groups yet reported. For many PHM group leaders, this will offer a new point of reference for key practice characteristics. Furthermore, the authors should be commended for attempting to distinguish how program sustainability manifests in community PHM, where hospitalists shoulder longer patient care hours and many of them sustain academic endeavors. It is concerning that more than a third of leaders do not perceive their program as sustainable, but the implications for the field are unclear. Perhaps part of this uncertainty arises from the terminology, as sustainability lacks a technical or a consensus definition and the authors purposefully did not define the term for the respondents. While many respondents probably worried about physician burnout, others might have channeled fears about group finances or competition with adult service lines for beds. In addition, leaders’ fears about sustainability may not exactly represent the concerns of front-line employees.

Sustainable work environments are complex constructs with several inputs. For example, supportive leaders, efficient delivery systems, optimized EHRs, competitive pay, and confidence about service line stability might all mitigate higher workloads. Ultimately, this complexity underscores an important caution about all workplace surveys in medicine; ie, average values can inform practice design, but hospitalists and administrators should always consider the local context. Blindly applying medians as benchmarks and ignoring the myriad other contributors to sustainable practice risk disrupting successful PHM programs. In other words, surveys describe how the world is, not how it should be. The spectrum of academic work and norms permeating community PHM groups instead call for a nuanced approach.

How does the field build upon this useful paper? First, the Society of Hospital Medicine (SHM) should engage PHM leaders to increase participation in regular remeasurement, a critical endeavor for this dynamic field. SHM’s State of Hospital Medicine Report queries about a wider variety of practice characteristics, but it has a smaller sample size that must grow to fill this void.7 As the work of repeated surveys transitions from academic inquiry to professional society service, SHM’s Practice Analysis Committee can meet the needs of PHM through relevant questions and efforts to foster adequate participation. Second, all practice leaders should follow the ballooning bodies of literature about burnout and healthcare value. Just as labor leaders had discovered in the industrial revolution, sustainable careers require not only measuring work hours but also advocating for safe, meaningful, and engaging work conditions. By continuously creating value for patients, families, and hospitals, we can strengthen our claim to the resources needed to optimize the work environment.

 

 

Disclosure

Andrew White is Chair of the Society of Hospital Medicine’s Practice Analysis Committee, an unpaid position. Dr. Marek serves on the American Academy of Pediatrics Section on Hospital Medicine Executive Committee which is a voluntary, unpaid, elected position.

 

Systematic efforts to measure and compare work hours emerged in the 19th century as laborers shifted from artisanal shops to factories, sparking debate over the appropriate length and intensity of work.1 Two centuries of unionization and regulation defined work hours for many United States employees, including graduate medical trainees, but left attending physicians largely untouched. Instead, the medical workforce has long relied on survey data to shape jobs that balance professional norms with local market demands. Leaders in young, dynamic specialties, such as pediatric hospital medicine (PHM), particularly require such data to recruit and retain talent.

PHM progressed swiftly from acknowledgment as a “distinct area of practice” in 1999 to a subspecialty recognition.2 Currently, at least 3,000 pediatric hospitalists3 practice in more than 800 US sites (Snow C, Personal communication regarding community PHM workforce survey). Approximately half of them work at community hospitals, where PHM groups often comprise fewer than five full-time equivalents (FTEs) and face unique challenges. Community PHM practices may assume broader responsibilities than university/children’s hospital colleagues, including advocacy for the needs of children in predominantly adult-oriented hospitals.4 Although data regarding academic PHM work demands are available,5 there is little information pertaining to community hospitalists regarding typical workloads or other characteristics of thriving practices.

In this issue of the Journal of Hospital Medicine, Alvarez et al. present the findings of structured interviews with 70 community PHM group leaders.6 Each participant answered 12 questions about their group, addressing the definition of a full-time workload and hours, the design of backup systems, and the respondent’s perception of the program’s sustainability. The sample is robust, with the caveats that it disproportionately represents the Midwest and West (34.3% each) and more than half of the groups were employed by an academic institution. The authors found a median work expectation per FTE of 1,882 hours/year and 21 weekends per year, although they noted significant variability in employers’ demands and services provided. The majority of hospitalist groups lacked census caps, formal backup systems, or processes to expand coverage during busy seasons. Among the site leaders, 63% perceived their program as sustainable, but no program design or employer characteristic was clearly associated with this perception.

The importance of this study derives from aggregating data about the largest cross section of community PHM groups yet reported. For many PHM group leaders, this will offer a new point of reference for key practice characteristics. Furthermore, the authors should be commended for attempting to distinguish how program sustainability manifests in community PHM, where hospitalists shoulder longer patient care hours and many of them sustain academic endeavors. It is concerning that more than a third of leaders do not perceive their program as sustainable, but the implications for the field are unclear. Perhaps part of this uncertainty arises from the terminology, as sustainability lacks a technical or a consensus definition and the authors purposefully did not define the term for the respondents. While many respondents probably worried about physician burnout, others might have channeled fears about group finances or competition with adult service lines for beds. In addition, leaders’ fears about sustainability may not exactly represent the concerns of front-line employees.

Sustainable work environments are complex constructs with several inputs. For example, supportive leaders, efficient delivery systems, optimized EHRs, competitive pay, and confidence about service line stability might all mitigate higher workloads. Ultimately, this complexity underscores an important caution about all workplace surveys in medicine; ie, average values can inform practice design, but hospitalists and administrators should always consider the local context. Blindly applying medians as benchmarks and ignoring the myriad other contributors to sustainable practice risk disrupting successful PHM programs. In other words, surveys describe how the world is, not how it should be. The spectrum of academic work and norms permeating community PHM groups instead call for a nuanced approach.

How does the field build upon this useful paper? First, the Society of Hospital Medicine (SHM) should engage PHM leaders to increase participation in regular remeasurement, a critical endeavor for this dynamic field. SHM’s State of Hospital Medicine Report queries about a wider variety of practice characteristics, but it has a smaller sample size that must grow to fill this void.7 As the work of repeated surveys transitions from academic inquiry to professional society service, SHM’s Practice Analysis Committee can meet the needs of PHM through relevant questions and efforts to foster adequate participation. Second, all practice leaders should follow the ballooning bodies of literature about burnout and healthcare value. Just as labor leaders had discovered in the industrial revolution, sustainable careers require not only measuring work hours but also advocating for safe, meaningful, and engaging work conditions. By continuously creating value for patients, families, and hospitals, we can strengthen our claim to the resources needed to optimize the work environment.

 

 

Disclosure

Andrew White is Chair of the Society of Hospital Medicine’s Practice Analysis Committee, an unpaid position. Dr. Marek serves on the American Academy of Pediatrics Section on Hospital Medicine Executive Committee which is a voluntary, unpaid, elected position.

 

References

1. Whaples R. Hours of Work in U.S. History. EH Net Encyclopedia. 2001. http://eh.net/encyclopedia/hours-of-work-in-u-s-history/. Accessed June 25, 2019.
2. Pediatric Hospital Medicine Certification. The American Board of Pediatrics.
https://www.abp.org/content/pediatric-hospital-medicine-certification.
Accessed 28 February, 2018.
3. Harbuck SM, Follmer AD, Dill MJ, Erikson C. Estimating the number and characteristics
of hospitalist physicians in the United States and their possible workforce
implications. Association of Medical Colleges. 2012. www.aamc.org/download/
300620/data/aibvol12_no3-hospitalist.pdf. Accessed June 25, 2019.
4. Roberts KB, Brown J, Quinonez RA, Percelay JM. Institutions and individuals:
what makes a hospitalist “academic”? Hosp Pediatr. 2014;4(5);326-327.
https://doi.org/10.1542/hpeds.2014-00.
5. Fromme HB, Chen CO, Fine BR, Gosdin C, Shaughnessy EE. Pediatric hospitalist
workload and sustainability in university-based programs: results from a
national interview-based survey. J Hosp Med. 2018;13(10):702-705. https://doi.
org/10.12788/jhm.2977.
6. Alvarez, F, McDaniel CE, Birnie K, et al. Community pediatric hospitalist
workload: results from a national survey. J Hosp Med. 2019; 14(11):682-685. https://
doi.org/10.12788/jhm.3263.
7. 2018 State of Hospital Medicine Report. Society of Hospital Medicine: Philadelphia,
Pennsylvania; 2019. https://www.hospitalmedicine.org/practice-management/
shms-state-of-hospital-medicine/. Accessed July 27, 2019.

References

1. Whaples R. Hours of Work in U.S. History. EH Net Encyclopedia. 2001. http://eh.net/encyclopedia/hours-of-work-in-u-s-history/. Accessed June 25, 2019.
2. Pediatric Hospital Medicine Certification. The American Board of Pediatrics.
https://www.abp.org/content/pediatric-hospital-medicine-certification.
Accessed 28 February, 2018.
3. Harbuck SM, Follmer AD, Dill MJ, Erikson C. Estimating the number and characteristics
of hospitalist physicians in the United States and their possible workforce
implications. Association of Medical Colleges. 2012. www.aamc.org/download/
300620/data/aibvol12_no3-hospitalist.pdf. Accessed June 25, 2019.
4. Roberts KB, Brown J, Quinonez RA, Percelay JM. Institutions and individuals:
what makes a hospitalist “academic”? Hosp Pediatr. 2014;4(5);326-327.
https://doi.org/10.1542/hpeds.2014-00.
5. Fromme HB, Chen CO, Fine BR, Gosdin C, Shaughnessy EE. Pediatric hospitalist
workload and sustainability in university-based programs: results from a
national interview-based survey. J Hosp Med. 2018;13(10):702-705. https://doi.
org/10.12788/jhm.2977.
6. Alvarez, F, McDaniel CE, Birnie K, et al. Community pediatric hospitalist
workload: results from a national survey. J Hosp Med. 2019; 14(11):682-685. https://
doi.org/10.12788/jhm.3263.
7. 2018 State of Hospital Medicine Report. Society of Hospital Medicine: Philadelphia,
Pennsylvania; 2019. https://www.hospitalmedicine.org/practice-management/
shms-state-of-hospital-medicine/. Accessed July 27, 2019.

Issue
Journal of Hospital Medicine 14(11)
Issue
Journal of Hospital Medicine 14(11)
Page Number
721-722. Published online first August 21, 2019
Page Number
721-722. Published online first August 21, 2019
Topics
Article Type
Sections
Article Source

© 2019 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Rachel L. Marek, MD; E-mail: [email protected]; Telephone: 936-267-5476.
Content Gating
Gated (full article locked unless allowed per User)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Gating Strategy
First Peek Free
Article PDF Media

Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man (FULL)

Article Type
Changed
Thu, 12/15/2022 - 14:41
Display Headline
Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man
Immune status, severity or burden of disease, appropriate dosing of medication, and drug resistance are important considerations when treating immunosuppressed patients.

Historically, aspergillosis in patients with hematopoietic stem cell transplantation (HSCT) has carried a high mortality rate. However, recent data demonstrate a dramatic improvement in outcomes for patients with HSCT: 90-day survival increased from 22% before 2000 to 45% over the past 15 years.1 Improved outcomes coincide with changes in transplant immunosuppression practices, use of cross-sectional imaging for early disease identification, galactomannan screening, and the development of novel treatment options.

Voriconazole is an azole drug that blocks the synthesis of ergosterol, a vital component of the cellular membrane of fungi. Voriconazole was approved in 2002 after a clinical trial demonstrated an improvement in 50% of patients with invasive aspergillosis in the voriconazole arm vs 30% in the amphotericin B arm at 12 weeks.2 Amphotericin B is a polyene antifungal drug that binds with ergosterol, creating leaks in the cell membrane that lead to cellular demise. Voriconazole quickly became the first-line therapy for invasive aspergillosis and is recommended by both the Infectious Disease Society of American (IDSA) and the European Conference on Infections in Leukemia.3

Case Presentation

A 55-year-old man with high-risk chronic myelogenous leukemia (CML) underwent a 10 of 10 human leukocyte antigen allele and antigen-matched peripheral blood allogeneic HSCT with a myeloablative-conditioning regimen of busulfan and cyclophosphamide, along with prophylactic voriconazole, sulfamethoxazole/trimethoprim, and acyclovir. After successful engraftment (without significant neutropenia), his posttransplant course was complicated by grade 2 graft vs host disease (GVHD) of the skin, eyes, and liver, which responded well to steroids and tacrolimus. Voriconazole was continued for 5 months until immunosuppression was minimized (tacrolimus 1 mg twice daily). Two months later, the patient’s GVHD worsened, necessitating treatment at an outside hospital with high-dose prednisone (2 mg/kg/d) and cyclosporine (300 mg twice daily). Voriconazole prophylaxis was not reinitiated at that time.

One year later, at a routine follow-up appointment, the patient endorsed several weeks of malaise, weight loss, and nonproductive cough. The patient’s immunosuppression recently had been reduced to 1 mg/kg/d of prednisone and 100 mg of cyclosporine twice daily. A chest X-ray demonstrated multiple pulmonary nodules; follow-up chest computed tomography (CT) confirmed multiple nodular infiltrates with surrounding ground-glass opacities suspicious with a fungal infection (Figure 1). 

Bronchoscopy with bronchoalveolar lavage (BAL) was significant for a positive Aspergillus fumigatus (A fumigatus) DNA polymerase chain reaction (PCR) assay and a BAL galactomannan level of > 5.3 optical density index (ODI) (normal, < 0.5). Bacterial and fungal cultures were negative, and serum galactomannan testing was not performed.

Treatment with oral voriconazole (300 mg twice daily) was initiated for probable pulmonary aspergillosis. Cyclosporine (150 mg twice daily) and prednisone (1 mg/kg/d) were continued throughout treatment out of concern for hepatic GVHD. The patient’s symptoms improved over the next 10 days, and follow-up chest imaging demonstrated improvement.

Two weeks after initiation of voriconazole treatment, the patient developed a new productive cough and dyspnea, associated with fevers and chills. Repeat imaging revealed right lower-lobe pneumonia. The serum voriconazole trough level was checked and was 3.1 mg/L, suggesting therapeutic dosing. The patient subsequently developed acute respiratory distress syndrome and required intubation and mechanical ventilation. Repeat BAL sampling demonstrated multidrug-resistant Escherichia coli, a BAL galactomannan level of 2.0 ODI, and negative fungal cultures. The patient’s hospital course was complicated by profound hypoxemia, requiring prone positioning and neuromuscular blockade. He was treated with meropenem and voriconazole. His immunosuppression was reduced, but he rapidly developed acute liver injury from hepatic GVHD that resolved after reinitiation of cyclosporine and prednisone at 0.75 mg/kg/d.

The patient improved over the next 3 weeks and was successfully extubated. Repeat chest CT imaging demonstrated numerous pneumatoceles in the location of previous nodules, consistent with healing necrotic fungal disease, and a new right lower-lobe cavitary mass (Figure 2). Two days after transferring out of the intensive care unit, the patient again developed hypoxemia and fevers to 39° C. Bronchoscopy with BAL of the right lower lobe revealed positive A fumigatus and Rhizopus sp polymerase chain reaction (PCR) assays, although fungal cultures were positive only for A fumigatus. Liposomal amphotericin B (5 mg/kg) was added to voriconazole therapy to treat mucormycosis and to provide a second active agent against A fumigatus.

Unfortunately, the patient’s clinical status continued to deteriorate with signs of progressive respiratory failure and infection despite empiric, broad-spectrum antibiotics and dual antifungal therapy. His serum voriconazole level continued to be therapeutic at 1.9 mg/L. The patient declined reintubation and invasive mechanical ventilation, and he ultimately transitioned to comfort measures and died with his family at the bedside.

Autopsy demonstrated widely disseminated Aspergillus infection as the cause of death, with evidence of myocardial, neural, and vascular invasion of A fumigatus (Figures 3 and 4). 

Rhizopus sp was identified in the large right lower lobe cavity without signs of angioinvasion, suggestive of cavity colonization. Follow-up sensitivity data (University of Texas, San Antonio, CLSI M38 A2, broth microdilution) of the A fumigatus demonstrated voriconazole sensitivity (MIC 0.25 µg/dL) but surprisingly, amphotericin B resistance (MIC > 2 µg/dL).

 

 

Discussion

This case of fatal, progressive, invasive, pulmonary aspergillosis demonstrates several important factors in the treatment of patients with this disease. Treatment failure usually relates to any of 4 possible factors: host immune status, severity or burden of disease, appropriate dosing of antifungal agents, and drug resistance. This patient’s immune system was heavily suppressed for a prolonged period. Attempts at reducing immunosuppression to the minimal required dosage to prevent a GVHD flare were unsuccessful and became an unmodifiable risk factor, a major contributor to his demise.

The risks of continuous high-dose immunosuppression in steroid-refractory GVHD is well understood and has been previously demonstrated to have up to 50% 4-year nonrelapse mortality, mainly due to overwhelming bacterial, viral, and fungal infections.4 All attempts should be made to cease or reduce immunosuppression in the setting of a severe infection, although this is sometimes impossible as in this case.

The patient’s disease burden was significant as evidenced by the bilateral, multifocal pulmonary nodules seen on chest imaging and the disseminated disease found at postmortem examination. His initial improvement in symptoms with voriconazole and the evolution of his images (with many of his initial pulmonary nodules becoming pneumatoceles) suggested a temporary positive immune response. The authors believe that the Rhizopus in his sputum represents noninvasive colonization of one of his pneumatoceles, because postmortem examination failed to reveal Rhizopus at any other location.

Voriconazole has excellent pulmonary and central nervous system penetration: In this patient serum levels were well within the therapeutic range. His peculiar drug resistance pattern (sensitivity to azoles and resistance to amphotericin) is unusual. Azole resistance in leukemia and patients with HSCT is more common than is amphotericin resistance, with current estimates of azole resistance close to 5%, ranging between 1% and 30%.5,6 Widespread use of antifungal prophylaxis with azoles likely selects for azole resistance.6

Despite this concern of azole resistance, current IDSA guidelines recommend against routine susceptibility testing of Aspergillus to azole therapy because of the current lack of consensus between the European Committee on Antibiotic Susceptibility Testing and Clinical and Laboratory Standards Institute on break points for resistance patterns.3,7 This is an area of emerging research, and proposed cut points for declaration of resistance do exist in the literature even if not globally agreed on.8

Combination antifungal therapy is an option for treatment in cases of possible drug resistance. Nonetheless, a recent randomized, double-blind, placebo-controlled, multicenter trial comparing voriconazole monotherapy with the combination of voriconazole and anidulafungin failed to demonstrate an overall mortality benefit in the primary analysis, although secondary analysis showed a mortality benefit with combination therapy in patients at highest risk for death.9

Despite the lack of unified standards with susceptibility testing, it may be reasonable to perform such tests in patients with demonstrating progressive disease. In this patient’s case, amphotericin B was added to treat the Rhizopus species found in his sputum, and while not the combination studied in the previously mentioned study, the drug should have provided an additional active agent for Aspergillus should this patient have had azole resistance.

Surprisingly, subsequent testing demonstrated the Aspergillus species to be resistant to amphotericin B. De novo amphotericin B-resistant A fumigates is extremely rare, with an expected incidence of 1% or less.10 The authors believe the patient may have demonstrated induction of amphotericin-B resistance through activation of fungal stress pathways by prior treatment with voriconazole. This has been demonstrated in vitro and should be considered should combination salvage therapy be required for the treatment of a refractory Aspergillus infection especially if patients have received prior treatment with voriconazole.11

 

 

Conclusion

This fatal case of invasive pulmonary aspergillosis illustrates the importance of considering the 4 main causes of treatment failure in an infection. Although the patient had a high burden of disease with a rare resistance pattern, he was treated with appropriate and well-dosed therapy. Ultimately, his unmodifiable immunosuppression was likely the driving factor leading to treatment failure and death. The indication for and number of bone marrow transplants continues to increase, thus exposure to and treatment of invasive fungal infections will increase accordingly. As such, providers should ensure that all causes of treatment failure are considered and addressed.

References

1. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis. 2007;44(4):531-540.

2. Herbrecht R, Denning DW, Patterson TF, et al; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408-415.

3. Patterson TF, Thompson GR III, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Disease Society of America. Clin Infect Dis. 2016;63(4):e1-e60.

4. García-Cadenas I, Rivera I, Martino R, et al. Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease. Bone Marrow Transplant. 2017;52(1):107-113.

5. Vermeulen E, Maertens J, De Bel A, et al. Nationwide surveillance of azole resistance in Aspergillus diseases. Antimicrob Agents Chemother. 2015;59(8):4569-4576.

6. Wiederhold NP, Patterson TF. Emergence of azole resistance in Aspergillus. Semin Respir Crit Care Med. 2015;36(5):673-680.

7. Cuenca-Estrella M, Moore CB, Barchiesi F, et al; AFST Subcommittee of the European Committee on Antimicrobial Susceptibility Testing. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect. 2003;9(6):467-474.

8. Pfaller MA, Diekema DJ, Ghannoum MA, et al; Clinical and Laboratory Standards Institute Antifungal Testing Subcommittee. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by Clinical and Laboratory Standards Institute for broth microdilution methods. J Clin Microbiol. 2009;47(10):3142-3146.

9. Marr KA, Schlamm HT, Herbrecht R, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015;162(2):81-89.

10. Tashiro M, Izumikawa K, Minematsu A, et al. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan. Antimicrob Agents Chemother. 2012;56(1):584-587.

11. Rajendran R, Mowat E, Jones B, Williams C, Ramage G. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms. Int J Antimicrob Agents. 2015;46(3):342-345.

Article PDF
Author and Disclosure Information

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Dr. Albert is a Physician at the Veterans Affairs Puget Sound Healthcare System in Seattle, Washington. Dr. Seaburg is a Senior Fellow in the Division of Pulmonary and Critical Care Medicine, Dr. Hill is an Acting Assistant Professor in the Division of Allergy and Infectious Disease, and Dr. Albert is a Clinical Instructor in the Division of General Internal Medicine, all in the Department of Medicine at the University of Washington School of Medicine.
Correspondence:Dr. Albert ([email protected])

Issue
Federal Practitioner - 35(5)s
Publications
Topics
Page Number
S58-S61
Sections
Author and Disclosure Information

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Dr. Albert is a Physician at the Veterans Affairs Puget Sound Healthcare System in Seattle, Washington. Dr. Seaburg is a Senior Fellow in the Division of Pulmonary and Critical Care Medicine, Dr. Hill is an Acting Assistant Professor in the Division of Allergy and Infectious Disease, and Dr. Albert is a Clinical Instructor in the Division of General Internal Medicine, all in the Department of Medicine at the University of Washington School of Medicine.
Correspondence:Dr. Albert ([email protected])

Author and Disclosure Information

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Dr. Albert is a Physician at the Veterans Affairs Puget Sound Healthcare System in Seattle, Washington. Dr. Seaburg is a Senior Fellow in the Division of Pulmonary and Critical Care Medicine, Dr. Hill is an Acting Assistant Professor in the Division of Allergy and Infectious Disease, and Dr. Albert is a Clinical Instructor in the Division of General Internal Medicine, all in the Department of Medicine at the University of Washington School of Medicine.
Correspondence:Dr. Albert ([email protected])

Article PDF
Article PDF
Immune status, severity or burden of disease, appropriate dosing of medication, and drug resistance are important considerations when treating immunosuppressed patients.
Immune status, severity or burden of disease, appropriate dosing of medication, and drug resistance are important considerations when treating immunosuppressed patients.

Historically, aspergillosis in patients with hematopoietic stem cell transplantation (HSCT) has carried a high mortality rate. However, recent data demonstrate a dramatic improvement in outcomes for patients with HSCT: 90-day survival increased from 22% before 2000 to 45% over the past 15 years.1 Improved outcomes coincide with changes in transplant immunosuppression practices, use of cross-sectional imaging for early disease identification, galactomannan screening, and the development of novel treatment options.

Voriconazole is an azole drug that blocks the synthesis of ergosterol, a vital component of the cellular membrane of fungi. Voriconazole was approved in 2002 after a clinical trial demonstrated an improvement in 50% of patients with invasive aspergillosis in the voriconazole arm vs 30% in the amphotericin B arm at 12 weeks.2 Amphotericin B is a polyene antifungal drug that binds with ergosterol, creating leaks in the cell membrane that lead to cellular demise. Voriconazole quickly became the first-line therapy for invasive aspergillosis and is recommended by both the Infectious Disease Society of American (IDSA) and the European Conference on Infections in Leukemia.3

Case Presentation

A 55-year-old man with high-risk chronic myelogenous leukemia (CML) underwent a 10 of 10 human leukocyte antigen allele and antigen-matched peripheral blood allogeneic HSCT with a myeloablative-conditioning regimen of busulfan and cyclophosphamide, along with prophylactic voriconazole, sulfamethoxazole/trimethoprim, and acyclovir. After successful engraftment (without significant neutropenia), his posttransplant course was complicated by grade 2 graft vs host disease (GVHD) of the skin, eyes, and liver, which responded well to steroids and tacrolimus. Voriconazole was continued for 5 months until immunosuppression was minimized (tacrolimus 1 mg twice daily). Two months later, the patient’s GVHD worsened, necessitating treatment at an outside hospital with high-dose prednisone (2 mg/kg/d) and cyclosporine (300 mg twice daily). Voriconazole prophylaxis was not reinitiated at that time.

One year later, at a routine follow-up appointment, the patient endorsed several weeks of malaise, weight loss, and nonproductive cough. The patient’s immunosuppression recently had been reduced to 1 mg/kg/d of prednisone and 100 mg of cyclosporine twice daily. A chest X-ray demonstrated multiple pulmonary nodules; follow-up chest computed tomography (CT) confirmed multiple nodular infiltrates with surrounding ground-glass opacities suspicious with a fungal infection (Figure 1). 

Bronchoscopy with bronchoalveolar lavage (BAL) was significant for a positive Aspergillus fumigatus (A fumigatus) DNA polymerase chain reaction (PCR) assay and a BAL galactomannan level of > 5.3 optical density index (ODI) (normal, < 0.5). Bacterial and fungal cultures were negative, and serum galactomannan testing was not performed.

Treatment with oral voriconazole (300 mg twice daily) was initiated for probable pulmonary aspergillosis. Cyclosporine (150 mg twice daily) and prednisone (1 mg/kg/d) were continued throughout treatment out of concern for hepatic GVHD. The patient’s symptoms improved over the next 10 days, and follow-up chest imaging demonstrated improvement.

Two weeks after initiation of voriconazole treatment, the patient developed a new productive cough and dyspnea, associated with fevers and chills. Repeat imaging revealed right lower-lobe pneumonia. The serum voriconazole trough level was checked and was 3.1 mg/L, suggesting therapeutic dosing. The patient subsequently developed acute respiratory distress syndrome and required intubation and mechanical ventilation. Repeat BAL sampling demonstrated multidrug-resistant Escherichia coli, a BAL galactomannan level of 2.0 ODI, and negative fungal cultures. The patient’s hospital course was complicated by profound hypoxemia, requiring prone positioning and neuromuscular blockade. He was treated with meropenem and voriconazole. His immunosuppression was reduced, but he rapidly developed acute liver injury from hepatic GVHD that resolved after reinitiation of cyclosporine and prednisone at 0.75 mg/kg/d.

The patient improved over the next 3 weeks and was successfully extubated. Repeat chest CT imaging demonstrated numerous pneumatoceles in the location of previous nodules, consistent with healing necrotic fungal disease, and a new right lower-lobe cavitary mass (Figure 2). Two days after transferring out of the intensive care unit, the patient again developed hypoxemia and fevers to 39° C. Bronchoscopy with BAL of the right lower lobe revealed positive A fumigatus and Rhizopus sp polymerase chain reaction (PCR) assays, although fungal cultures were positive only for A fumigatus. Liposomal amphotericin B (5 mg/kg) was added to voriconazole therapy to treat mucormycosis and to provide a second active agent against A fumigatus.

Unfortunately, the patient’s clinical status continued to deteriorate with signs of progressive respiratory failure and infection despite empiric, broad-spectrum antibiotics and dual antifungal therapy. His serum voriconazole level continued to be therapeutic at 1.9 mg/L. The patient declined reintubation and invasive mechanical ventilation, and he ultimately transitioned to comfort measures and died with his family at the bedside.

Autopsy demonstrated widely disseminated Aspergillus infection as the cause of death, with evidence of myocardial, neural, and vascular invasion of A fumigatus (Figures 3 and 4). 

Rhizopus sp was identified in the large right lower lobe cavity without signs of angioinvasion, suggestive of cavity colonization. Follow-up sensitivity data (University of Texas, San Antonio, CLSI M38 A2, broth microdilution) of the A fumigatus demonstrated voriconazole sensitivity (MIC 0.25 µg/dL) but surprisingly, amphotericin B resistance (MIC > 2 µg/dL).

 

 

Discussion

This case of fatal, progressive, invasive, pulmonary aspergillosis demonstrates several important factors in the treatment of patients with this disease. Treatment failure usually relates to any of 4 possible factors: host immune status, severity or burden of disease, appropriate dosing of antifungal agents, and drug resistance. This patient’s immune system was heavily suppressed for a prolonged period. Attempts at reducing immunosuppression to the minimal required dosage to prevent a GVHD flare were unsuccessful and became an unmodifiable risk factor, a major contributor to his demise.

The risks of continuous high-dose immunosuppression in steroid-refractory GVHD is well understood and has been previously demonstrated to have up to 50% 4-year nonrelapse mortality, mainly due to overwhelming bacterial, viral, and fungal infections.4 All attempts should be made to cease or reduce immunosuppression in the setting of a severe infection, although this is sometimes impossible as in this case.

The patient’s disease burden was significant as evidenced by the bilateral, multifocal pulmonary nodules seen on chest imaging and the disseminated disease found at postmortem examination. His initial improvement in symptoms with voriconazole and the evolution of his images (with many of his initial pulmonary nodules becoming pneumatoceles) suggested a temporary positive immune response. The authors believe that the Rhizopus in his sputum represents noninvasive colonization of one of his pneumatoceles, because postmortem examination failed to reveal Rhizopus at any other location.

Voriconazole has excellent pulmonary and central nervous system penetration: In this patient serum levels were well within the therapeutic range. His peculiar drug resistance pattern (sensitivity to azoles and resistance to amphotericin) is unusual. Azole resistance in leukemia and patients with HSCT is more common than is amphotericin resistance, with current estimates of azole resistance close to 5%, ranging between 1% and 30%.5,6 Widespread use of antifungal prophylaxis with azoles likely selects for azole resistance.6

Despite this concern of azole resistance, current IDSA guidelines recommend against routine susceptibility testing of Aspergillus to azole therapy because of the current lack of consensus between the European Committee on Antibiotic Susceptibility Testing and Clinical and Laboratory Standards Institute on break points for resistance patterns.3,7 This is an area of emerging research, and proposed cut points for declaration of resistance do exist in the literature even if not globally agreed on.8

Combination antifungal therapy is an option for treatment in cases of possible drug resistance. Nonetheless, a recent randomized, double-blind, placebo-controlled, multicenter trial comparing voriconazole monotherapy with the combination of voriconazole and anidulafungin failed to demonstrate an overall mortality benefit in the primary analysis, although secondary analysis showed a mortality benefit with combination therapy in patients at highest risk for death.9

Despite the lack of unified standards with susceptibility testing, it may be reasonable to perform such tests in patients with demonstrating progressive disease. In this patient’s case, amphotericin B was added to treat the Rhizopus species found in his sputum, and while not the combination studied in the previously mentioned study, the drug should have provided an additional active agent for Aspergillus should this patient have had azole resistance.

Surprisingly, subsequent testing demonstrated the Aspergillus species to be resistant to amphotericin B. De novo amphotericin B-resistant A fumigates is extremely rare, with an expected incidence of 1% or less.10 The authors believe the patient may have demonstrated induction of amphotericin-B resistance through activation of fungal stress pathways by prior treatment with voriconazole. This has been demonstrated in vitro and should be considered should combination salvage therapy be required for the treatment of a refractory Aspergillus infection especially if patients have received prior treatment with voriconazole.11

 

 

Conclusion

This fatal case of invasive pulmonary aspergillosis illustrates the importance of considering the 4 main causes of treatment failure in an infection. Although the patient had a high burden of disease with a rare resistance pattern, he was treated with appropriate and well-dosed therapy. Ultimately, his unmodifiable immunosuppression was likely the driving factor leading to treatment failure and death. The indication for and number of bone marrow transplants continues to increase, thus exposure to and treatment of invasive fungal infections will increase accordingly. As such, providers should ensure that all causes of treatment failure are considered and addressed.

Historically, aspergillosis in patients with hematopoietic stem cell transplantation (HSCT) has carried a high mortality rate. However, recent data demonstrate a dramatic improvement in outcomes for patients with HSCT: 90-day survival increased from 22% before 2000 to 45% over the past 15 years.1 Improved outcomes coincide with changes in transplant immunosuppression practices, use of cross-sectional imaging for early disease identification, galactomannan screening, and the development of novel treatment options.

Voriconazole is an azole drug that blocks the synthesis of ergosterol, a vital component of the cellular membrane of fungi. Voriconazole was approved in 2002 after a clinical trial demonstrated an improvement in 50% of patients with invasive aspergillosis in the voriconazole arm vs 30% in the amphotericin B arm at 12 weeks.2 Amphotericin B is a polyene antifungal drug that binds with ergosterol, creating leaks in the cell membrane that lead to cellular demise. Voriconazole quickly became the first-line therapy for invasive aspergillosis and is recommended by both the Infectious Disease Society of American (IDSA) and the European Conference on Infections in Leukemia.3

Case Presentation

A 55-year-old man with high-risk chronic myelogenous leukemia (CML) underwent a 10 of 10 human leukocyte antigen allele and antigen-matched peripheral blood allogeneic HSCT with a myeloablative-conditioning regimen of busulfan and cyclophosphamide, along with prophylactic voriconazole, sulfamethoxazole/trimethoprim, and acyclovir. After successful engraftment (without significant neutropenia), his posttransplant course was complicated by grade 2 graft vs host disease (GVHD) of the skin, eyes, and liver, which responded well to steroids and tacrolimus. Voriconazole was continued for 5 months until immunosuppression was minimized (tacrolimus 1 mg twice daily). Two months later, the patient’s GVHD worsened, necessitating treatment at an outside hospital with high-dose prednisone (2 mg/kg/d) and cyclosporine (300 mg twice daily). Voriconazole prophylaxis was not reinitiated at that time.

One year later, at a routine follow-up appointment, the patient endorsed several weeks of malaise, weight loss, and nonproductive cough. The patient’s immunosuppression recently had been reduced to 1 mg/kg/d of prednisone and 100 mg of cyclosporine twice daily. A chest X-ray demonstrated multiple pulmonary nodules; follow-up chest computed tomography (CT) confirmed multiple nodular infiltrates with surrounding ground-glass opacities suspicious with a fungal infection (Figure 1). 

Bronchoscopy with bronchoalveolar lavage (BAL) was significant for a positive Aspergillus fumigatus (A fumigatus) DNA polymerase chain reaction (PCR) assay and a BAL galactomannan level of > 5.3 optical density index (ODI) (normal, < 0.5). Bacterial and fungal cultures were negative, and serum galactomannan testing was not performed.

Treatment with oral voriconazole (300 mg twice daily) was initiated for probable pulmonary aspergillosis. Cyclosporine (150 mg twice daily) and prednisone (1 mg/kg/d) were continued throughout treatment out of concern for hepatic GVHD. The patient’s symptoms improved over the next 10 days, and follow-up chest imaging demonstrated improvement.

Two weeks after initiation of voriconazole treatment, the patient developed a new productive cough and dyspnea, associated with fevers and chills. Repeat imaging revealed right lower-lobe pneumonia. The serum voriconazole trough level was checked and was 3.1 mg/L, suggesting therapeutic dosing. The patient subsequently developed acute respiratory distress syndrome and required intubation and mechanical ventilation. Repeat BAL sampling demonstrated multidrug-resistant Escherichia coli, a BAL galactomannan level of 2.0 ODI, and negative fungal cultures. The patient’s hospital course was complicated by profound hypoxemia, requiring prone positioning and neuromuscular blockade. He was treated with meropenem and voriconazole. His immunosuppression was reduced, but he rapidly developed acute liver injury from hepatic GVHD that resolved after reinitiation of cyclosporine and prednisone at 0.75 mg/kg/d.

The patient improved over the next 3 weeks and was successfully extubated. Repeat chest CT imaging demonstrated numerous pneumatoceles in the location of previous nodules, consistent with healing necrotic fungal disease, and a new right lower-lobe cavitary mass (Figure 2). Two days after transferring out of the intensive care unit, the patient again developed hypoxemia and fevers to 39° C. Bronchoscopy with BAL of the right lower lobe revealed positive A fumigatus and Rhizopus sp polymerase chain reaction (PCR) assays, although fungal cultures were positive only for A fumigatus. Liposomal amphotericin B (5 mg/kg) was added to voriconazole therapy to treat mucormycosis and to provide a second active agent against A fumigatus.

Unfortunately, the patient’s clinical status continued to deteriorate with signs of progressive respiratory failure and infection despite empiric, broad-spectrum antibiotics and dual antifungal therapy. His serum voriconazole level continued to be therapeutic at 1.9 mg/L. The patient declined reintubation and invasive mechanical ventilation, and he ultimately transitioned to comfort measures and died with his family at the bedside.

Autopsy demonstrated widely disseminated Aspergillus infection as the cause of death, with evidence of myocardial, neural, and vascular invasion of A fumigatus (Figures 3 and 4). 

Rhizopus sp was identified in the large right lower lobe cavity without signs of angioinvasion, suggestive of cavity colonization. Follow-up sensitivity data (University of Texas, San Antonio, CLSI M38 A2, broth microdilution) of the A fumigatus demonstrated voriconazole sensitivity (MIC 0.25 µg/dL) but surprisingly, amphotericin B resistance (MIC > 2 µg/dL).

 

 

Discussion

This case of fatal, progressive, invasive, pulmonary aspergillosis demonstrates several important factors in the treatment of patients with this disease. Treatment failure usually relates to any of 4 possible factors: host immune status, severity or burden of disease, appropriate dosing of antifungal agents, and drug resistance. This patient’s immune system was heavily suppressed for a prolonged period. Attempts at reducing immunosuppression to the minimal required dosage to prevent a GVHD flare were unsuccessful and became an unmodifiable risk factor, a major contributor to his demise.

The risks of continuous high-dose immunosuppression in steroid-refractory GVHD is well understood and has been previously demonstrated to have up to 50% 4-year nonrelapse mortality, mainly due to overwhelming bacterial, viral, and fungal infections.4 All attempts should be made to cease or reduce immunosuppression in the setting of a severe infection, although this is sometimes impossible as in this case.

The patient’s disease burden was significant as evidenced by the bilateral, multifocal pulmonary nodules seen on chest imaging and the disseminated disease found at postmortem examination. His initial improvement in symptoms with voriconazole and the evolution of his images (with many of his initial pulmonary nodules becoming pneumatoceles) suggested a temporary positive immune response. The authors believe that the Rhizopus in his sputum represents noninvasive colonization of one of his pneumatoceles, because postmortem examination failed to reveal Rhizopus at any other location.

Voriconazole has excellent pulmonary and central nervous system penetration: In this patient serum levels were well within the therapeutic range. His peculiar drug resistance pattern (sensitivity to azoles and resistance to amphotericin) is unusual. Azole resistance in leukemia and patients with HSCT is more common than is amphotericin resistance, with current estimates of azole resistance close to 5%, ranging between 1% and 30%.5,6 Widespread use of antifungal prophylaxis with azoles likely selects for azole resistance.6

Despite this concern of azole resistance, current IDSA guidelines recommend against routine susceptibility testing of Aspergillus to azole therapy because of the current lack of consensus between the European Committee on Antibiotic Susceptibility Testing and Clinical and Laboratory Standards Institute on break points for resistance patterns.3,7 This is an area of emerging research, and proposed cut points for declaration of resistance do exist in the literature even if not globally agreed on.8

Combination antifungal therapy is an option for treatment in cases of possible drug resistance. Nonetheless, a recent randomized, double-blind, placebo-controlled, multicenter trial comparing voriconazole monotherapy with the combination of voriconazole and anidulafungin failed to demonstrate an overall mortality benefit in the primary analysis, although secondary analysis showed a mortality benefit with combination therapy in patients at highest risk for death.9

Despite the lack of unified standards with susceptibility testing, it may be reasonable to perform such tests in patients with demonstrating progressive disease. In this patient’s case, amphotericin B was added to treat the Rhizopus species found in his sputum, and while not the combination studied in the previously mentioned study, the drug should have provided an additional active agent for Aspergillus should this patient have had azole resistance.

Surprisingly, subsequent testing demonstrated the Aspergillus species to be resistant to amphotericin B. De novo amphotericin B-resistant A fumigates is extremely rare, with an expected incidence of 1% or less.10 The authors believe the patient may have demonstrated induction of amphotericin-B resistance through activation of fungal stress pathways by prior treatment with voriconazole. This has been demonstrated in vitro and should be considered should combination salvage therapy be required for the treatment of a refractory Aspergillus infection especially if patients have received prior treatment with voriconazole.11

 

 

Conclusion

This fatal case of invasive pulmonary aspergillosis illustrates the importance of considering the 4 main causes of treatment failure in an infection. Although the patient had a high burden of disease with a rare resistance pattern, he was treated with appropriate and well-dosed therapy. Ultimately, his unmodifiable immunosuppression was likely the driving factor leading to treatment failure and death. The indication for and number of bone marrow transplants continues to increase, thus exposure to and treatment of invasive fungal infections will increase accordingly. As such, providers should ensure that all causes of treatment failure are considered and addressed.

References

1. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis. 2007;44(4):531-540.

2. Herbrecht R, Denning DW, Patterson TF, et al; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408-415.

3. Patterson TF, Thompson GR III, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Disease Society of America. Clin Infect Dis. 2016;63(4):e1-e60.

4. García-Cadenas I, Rivera I, Martino R, et al. Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease. Bone Marrow Transplant. 2017;52(1):107-113.

5. Vermeulen E, Maertens J, De Bel A, et al. Nationwide surveillance of azole resistance in Aspergillus diseases. Antimicrob Agents Chemother. 2015;59(8):4569-4576.

6. Wiederhold NP, Patterson TF. Emergence of azole resistance in Aspergillus. Semin Respir Crit Care Med. 2015;36(5):673-680.

7. Cuenca-Estrella M, Moore CB, Barchiesi F, et al; AFST Subcommittee of the European Committee on Antimicrobial Susceptibility Testing. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect. 2003;9(6):467-474.

8. Pfaller MA, Diekema DJ, Ghannoum MA, et al; Clinical and Laboratory Standards Institute Antifungal Testing Subcommittee. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by Clinical and Laboratory Standards Institute for broth microdilution methods. J Clin Microbiol. 2009;47(10):3142-3146.

9. Marr KA, Schlamm HT, Herbrecht R, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015;162(2):81-89.

10. Tashiro M, Izumikawa K, Minematsu A, et al. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan. Antimicrob Agents Chemother. 2012;56(1):584-587.

11. Rajendran R, Mowat E, Jones B, Williams C, Ramage G. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms. Int J Antimicrob Agents. 2015;46(3):342-345.

References

1. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis. 2007;44(4):531-540.

2. Herbrecht R, Denning DW, Patterson TF, et al; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408-415.

3. Patterson TF, Thompson GR III, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Disease Society of America. Clin Infect Dis. 2016;63(4):e1-e60.

4. García-Cadenas I, Rivera I, Martino R, et al. Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease. Bone Marrow Transplant. 2017;52(1):107-113.

5. Vermeulen E, Maertens J, De Bel A, et al. Nationwide surveillance of azole resistance in Aspergillus diseases. Antimicrob Agents Chemother. 2015;59(8):4569-4576.

6. Wiederhold NP, Patterson TF. Emergence of azole resistance in Aspergillus. Semin Respir Crit Care Med. 2015;36(5):673-680.

7. Cuenca-Estrella M, Moore CB, Barchiesi F, et al; AFST Subcommittee of the European Committee on Antimicrobial Susceptibility Testing. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect. 2003;9(6):467-474.

8. Pfaller MA, Diekema DJ, Ghannoum MA, et al; Clinical and Laboratory Standards Institute Antifungal Testing Subcommittee. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by Clinical and Laboratory Standards Institute for broth microdilution methods. J Clin Microbiol. 2009;47(10):3142-3146.

9. Marr KA, Schlamm HT, Herbrecht R, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015;162(2):81-89.

10. Tashiro M, Izumikawa K, Minematsu A, et al. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan. Antimicrob Agents Chemother. 2012;56(1):584-587.

11. Rajendran R, Mowat E, Jones B, Williams C, Ramage G. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms. Int J Antimicrob Agents. 2015;46(3):342-345.

Issue
Federal Practitioner - 35(5)s
Issue
Federal Practitioner - 35(5)s
Page Number
S58-S61
Page Number
S58-S61
Publications
Publications
Topics
Article Type
Display Headline
Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man
Display Headline
Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Article PDF Media

Tales From VA Anesthesiology

Article Type
Changed
Thu, 08/08/2019 - 16:05
A 99-year-old veteran, his family, and an anesthesiologist practice shared decision making to ensure patient-centered care before a procedure.

The patient grabbed my attention as I glanced through our clinic schedule. It was his age: He was 99 years old and scheduled for eye surgery. The plastic surgery resident’s note read: “Patient understands that this would involve surgery under general anesthesia and is agreeable to moving forward...Extremely high risk of anesthesia emphasized.”

I reviewed the patient’s history. At baseline, he had severe pulmonary hypertension, severe aortic stenosis (AS), diastolic heart failure, chronic atrial fibrillation, chronic kidney disease (estimated glomerular filtration rate of 26 mL/min [normal is > 60 mL/min]), anemia (hematocrit 26%), and a standing do not resuscitate (DNR) order. His maximal daily exercise was walking slowly across a room, primarily limited by joint pain. Recent geropsychiatry notes indicated mild cognitive impairment. The anesthesia record from an urgent hip fracture repair 7 months before under general anesthesia was unremarkable.

I phoned the attending plastic surgeon. Our conversation was as follows:

“Hi, I’m about to see a 99-year-old patient with a DNR who is scheduled for resection of an eyelid tumor. His medical history makes me nervous. Are you sure this is a good idea?”“Hmmm, 99-year-old…okay, that’s right,” he responded. “He has an invasive squamous that could become a big problem. The actual procedure is under 10 minutes. Waiting for the pathology report will be the longest part of the procedure.”

“Can it be done under local?” I asked.

“Yes,” he replied.

“Okay, I’ll talk to him and call you back.”

I found the patient in the waiting room, flanked by his 2 daughters and invited them into the clinic room. After introductions, I began asking whether they had any questions about the anesthesia. By midsentence a daughter was prompting him to discuss what happened “last time.” He described a history of posttraumatic stress disorder (PTSD) stemming from his hip surgery, which he blamed squarely on the anesthesia. His emotion was evident in the gathering pauses. “I hate that I am so emotional since they kept me awake during my surgery.”

Through the fog of multiple accounts, it became clear that he was traumatized by the loss of control during the administration of and emergence from the anesthesia.

“They told me it was only oxygen,” he said. “They lied. There was a taste to it…I was awake and skinned alive…They said I was a monster when I woke up thrashing.” He went on, explaining that in the recovery room “there were 2 people bothering me, man-handling me, asking me questions.”

One of his daughters showed me pictures of bruises on his face from ripping off the mask and pulling out the breathing tube. They were visibly upset by the memory of his postoperative combativeness and paranoia. The note written by the orthopedic surgery resident on the day after surgery stated succinctly, “Doing well, had some delirium from anesthesia overnight.” Subsequent geropsychiatry home visits attested to intrusive thoughts, flashbacks, and nightmares from his time as a combat soldier in World War II, 65 years in the past.

“It took me months…months to recover,” he said.

He was in the mood to reminisce, however, perhaps a willful distraction. He had the floor for at least 30 minutes, during which I spoke about 5 sentences. With every sad story he told there was a happy, humorous one, such as meeting his future wife while on leave in New Zealand during the war, recalled down to exact dates. And another story:
 

 

 

There we were in New Caledonia. All our supplies went out to replace what sank on [USS] Coolidge, including a lot of food. Well, there were deer on the island. So we took out a truck and a rifle and wouldn’t you know we came upon a roadblock in the form of a big steer. We figured it looked enough like a deer. My buddy shot it dead with one shot. We dressed it and loaded it into the jeep. Hardly before we even got back to the mess hall, the officers’ cook came sniffing around. He and our captain agreed it was easily the biggest deer they’d ever seen and appropriated it to the officers’ mess. Next day the CO [commanding officer] of the whole outfit came by and announced it was the best tasting ‘venison’ he’d ever had. I heard the farmer got paid a pretty penny for that steer. I didn’t get a damn bite.

He delivered this last bit with relish.

When the conversation returned to anesthesia, I read them the record of his hip fracture repair. I explained that on the face of it, the report seemed uneventful. One daughter asked astute questions about his awareness. I explained that although awareness during general anesthesia is possible, it seemed from the record, he’d had plenty of anesthesia during the case and that there is always less at the beginning and end, the periods that apparently had caused him distress. I also explained that most studies report the incidence of true awareness as at most 1 out of thousands of events and that he had none of the established risk factors for it, such as female gender, young age, chronic substance abuse, cardiac and obstetric surgery, and history of awareness.1

The other daughter wondered why he was so agitated afterward. I recited data on the frequency of postoperative delirium in elderly patients but explained that the range is wide, depending on the study and population, from about 1% in elderly patients undergoing ambulatory surgery to 65% for open aortic surgery.2,3 I added that their father had 2 of the strongest risk factors for delirium, advanced age and cognitive impairment.3 Only after airing each question about the hip surgery in detail were they ready to discuss the eye surgery.

He started that conversation with the right question: “Do I really need it?”

I quoted my surgical colleague’s concern. I told him that, should he opt to undergo the surgery, I was confident that this time around his experience would be different from the last.

“If you’re okay with it, all you need is some numbing medicine from the surgeon; you won’t need any anesthesia from me.”

I walked step-by-step through what they could expect on the day of surgery. Maintaining control was of obvious importance to him. He felt comfortable going forward. His daughters intuited that less would be more for a quick recovery.

We then addressed the DNR directive. I acknowledged his absolute right to self-determination and explained that the need for resuscitation is, at times, a consequence of the surgery and anesthesia. I reassured them that our plan made resuscitation and intubation highly unlikely. They also asked to use any interventions necessary to restart his heart if it should stop beating. I documented their decision in my notes and communicated it to the surgical team. We had talked for 90 minutes.

I met the patient and his daughters on the day of surgery in the preoperative holding area. I inserted an IV, applied electrocardiography leads, and affixed a pulse oximeter and a noninvasive blood pressure cuff. In the operating room (OR) we took time to place his 99-year-old joints into, as he said, the “least worst” position. He tolerated the injection of the local by the surgeon perfectly well. We were in the OR for 3 hours, during which he taught me a fair amount about boating and outboard engines among other things. Pathology reported clean margins. He was discharged home soon after and had an uneventful recovery.

 

 

Patient-First Approach

A core competency of the Accreditation Council for Graduate Medical Education for an anesthesia residency is the Interpersonal and Communication Skills program. A comprehensive discussion of communication is far beyond the scope here. But not surprisingly, deficient communication between physicians and patients can cause emotional distress, significant dissatisfaction among family members, and negative patient judgment of how well we communicate.4-6 These observations are particularly true in our increasingly elderly surgical population, in which both surgeons and anesthesiologists often feel unequal to the task of discussing concepts such as code status.7,8

In our practice and in residency training, the preoperative clinic often is the location where patient/provider communication occurs. Here we consider the latest American College of Cardiology/American Heart Association guidelines, examine airways, review electrocardiograms, and formulate plans agreeable to and understood by our anxious patients and their families. The potent anxiolytic effect of a preoperative visit by an anesthesiologist is well established.9 Anxiety about surgery is a risk factor for impaired decision making before surgery.10 And surgery is traumatic—as many as 7.6% of postoperative patients experience symptoms consistent with PTSD attributable to the surgery, placing it on a par with being mugged (8.0%).11,12

The patient in this case presented several communication challenges even absent his revelation of prior traumatic experience with anesthesia. He was elderly, anxious, and had multiple comorbidities. He had mild cognitive impairment and required a code status discussion. There also were the clinical challenges—navigating a 99-year-old with severe aortic stenosis and a right ventricular systolic pressure > 90 mm Hg through a general anesthetic gave me a sinking feeling.

He was fortunate that the procedure could be done with local anesthesia, mitigating his risk of cognitive dysfunction, including delirium. He also was fortunate in that his anesthesiologist and surgeon had created a collaborative, patient-first approach and that his US Department of Veterans Affairs (VA) clinic had the time, space, and staffing to accommodate an unexpected 90-minute visit. A big investment in communication, mainly my keeping quiet, made the intraoperative management simple. Such is life in an integrated health care system without financial incentives for high-volume care—and another reminder that VA physicians are blessed to guide patients through some of the most vulnerable and distressing moments of their lives.

Postscript

During the preparation of this manuscript, the patient passed away at the age of 100. His obituary was consistent with what I had learned about him and his family during our 2 encounters: a long successful career in local industry; extensive involvement in his community; an avid sportsman; and nearly 30 grandchildren, great-grandchildren, and great-great grandchildren. But there was one more detail that never came up during my extensive discussion with him and his daughters: He was awarded the Purple Heart for his service in World War II.

References

1. Ghoneim MM, Block RI, Haffarnan M, Mathews MJ. Awareness during anesthesia: risk factors, causes and sequelae: a review of reported cases in the literature. Anesth Analg. 2009;108(2):527-535.

2. Aya AGM, Pouchain PH, Thomas H, Ripart J, Cuvillon P. Incidence of postoperative delirium in elderly ambulatory patients: a prospective evaluation using the FAM-CAM instrument. J Clin Anesth. 2019;53:35-38.

3. Raats JW, Steunenberg SL, de Lange DC, van der Laan L. Risk factors of post-operative delirium after elective vascular surgery in the elderly: a systematic review. Int J Surg. 2016;35:1-6.

4. Roter DL, Hall JA, Kern DE, Barker LR, Cole KA, Roca RP. Improving physicians’ interviewing skills and reducing patients’ emotional distress: a randomized clinical trial. Arch Intern Med. 1995;155(17):1877-1884.

5. Wright AA, Keating NL, Ayanian JZ, et al. Family perspectives on aggressive cancer care near the end of life. JAMA. 2016;315(3):284-292.

6. Hall JA, Roter DL, Rand CS. Communication of affect between patient and physician. J Health Soc Behav. 1981;22(1):18-30.

7. Cooper Z, Meyers M, Keating NL, Gu X, Lipsitz SR, Rogers SO. Resident education and management of end-of-life care: the resident’s perspective. J Surg Educ. 2010;67(2):79-84.

8. Hickey TR, Cooper Z, Urman RD, Hepner DL, Bader AM. An agenda for improving perioperative code status discussion. A A Case Rep. 2016;6(12):411-415.

9. Egbert LD, Battit GE, Turndorf H, Beecher HK. The value of the preoperative visit by an anesthetist. JAMA. 1963;185(7):553-555.

10. Ankuda CK, Block SD, Cooper Z, et al. Measuring critical deficits in shared decision making before elective surgery. Patient Educ Couns. 2014;94(3):328-333.

11. Whitlock EL, Rodebaugh TL, Hassett AL, et al. Psychological sequelae of surgery in a prospective cohort of patients from three intraoperative awareness prevention trials. Anesth Analg. 2015;120(1):87-95.

12. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry. 1998;55(7):626-632.

Article PDF
Author and Disclosure Information

Thomas Hickey is a Staff Anesthesiologist at VA Connecticut Healthcare System and an Assistant Professor at Yale University School of Medicine in New Haven, Connecticut. Correspondence: Thomas Hickey ([email protected])

Author disclosures
The patient and his daughters consented to the publication of this manuscript. The author reports no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the author and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Issue
Federal Practitioner - 36(8)a
Publications
Topics
Page Number
352-354
Sections
Author and Disclosure Information

Thomas Hickey is a Staff Anesthesiologist at VA Connecticut Healthcare System and an Assistant Professor at Yale University School of Medicine in New Haven, Connecticut. Correspondence: Thomas Hickey ([email protected])

Author disclosures
The patient and his daughters consented to the publication of this manuscript. The author reports no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the author and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Author and Disclosure Information

Thomas Hickey is a Staff Anesthesiologist at VA Connecticut Healthcare System and an Assistant Professor at Yale University School of Medicine in New Haven, Connecticut. Correspondence: Thomas Hickey ([email protected])

Author disclosures
The patient and his daughters consented to the publication of this manuscript. The author reports no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the author and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Article PDF
Article PDF
Related Articles
A 99-year-old veteran, his family, and an anesthesiologist practice shared decision making to ensure patient-centered care before a procedure.
A 99-year-old veteran, his family, and an anesthesiologist practice shared decision making to ensure patient-centered care before a procedure.

The patient grabbed my attention as I glanced through our clinic schedule. It was his age: He was 99 years old and scheduled for eye surgery. The plastic surgery resident’s note read: “Patient understands that this would involve surgery under general anesthesia and is agreeable to moving forward...Extremely high risk of anesthesia emphasized.”

I reviewed the patient’s history. At baseline, he had severe pulmonary hypertension, severe aortic stenosis (AS), diastolic heart failure, chronic atrial fibrillation, chronic kidney disease (estimated glomerular filtration rate of 26 mL/min [normal is > 60 mL/min]), anemia (hematocrit 26%), and a standing do not resuscitate (DNR) order. His maximal daily exercise was walking slowly across a room, primarily limited by joint pain. Recent geropsychiatry notes indicated mild cognitive impairment. The anesthesia record from an urgent hip fracture repair 7 months before under general anesthesia was unremarkable.

I phoned the attending plastic surgeon. Our conversation was as follows:

“Hi, I’m about to see a 99-year-old patient with a DNR who is scheduled for resection of an eyelid tumor. His medical history makes me nervous. Are you sure this is a good idea?”“Hmmm, 99-year-old…okay, that’s right,” he responded. “He has an invasive squamous that could become a big problem. The actual procedure is under 10 minutes. Waiting for the pathology report will be the longest part of the procedure.”

“Can it be done under local?” I asked.

“Yes,” he replied.

“Okay, I’ll talk to him and call you back.”

I found the patient in the waiting room, flanked by his 2 daughters and invited them into the clinic room. After introductions, I began asking whether they had any questions about the anesthesia. By midsentence a daughter was prompting him to discuss what happened “last time.” He described a history of posttraumatic stress disorder (PTSD) stemming from his hip surgery, which he blamed squarely on the anesthesia. His emotion was evident in the gathering pauses. “I hate that I am so emotional since they kept me awake during my surgery.”

Through the fog of multiple accounts, it became clear that he was traumatized by the loss of control during the administration of and emergence from the anesthesia.

“They told me it was only oxygen,” he said. “They lied. There was a taste to it…I was awake and skinned alive…They said I was a monster when I woke up thrashing.” He went on, explaining that in the recovery room “there were 2 people bothering me, man-handling me, asking me questions.”

One of his daughters showed me pictures of bruises on his face from ripping off the mask and pulling out the breathing tube. They were visibly upset by the memory of his postoperative combativeness and paranoia. The note written by the orthopedic surgery resident on the day after surgery stated succinctly, “Doing well, had some delirium from anesthesia overnight.” Subsequent geropsychiatry home visits attested to intrusive thoughts, flashbacks, and nightmares from his time as a combat soldier in World War II, 65 years in the past.

“It took me months…months to recover,” he said.

He was in the mood to reminisce, however, perhaps a willful distraction. He had the floor for at least 30 minutes, during which I spoke about 5 sentences. With every sad story he told there was a happy, humorous one, such as meeting his future wife while on leave in New Zealand during the war, recalled down to exact dates. And another story:
 

 

 

There we were in New Caledonia. All our supplies went out to replace what sank on [USS] Coolidge, including a lot of food. Well, there were deer on the island. So we took out a truck and a rifle and wouldn’t you know we came upon a roadblock in the form of a big steer. We figured it looked enough like a deer. My buddy shot it dead with one shot. We dressed it and loaded it into the jeep. Hardly before we even got back to the mess hall, the officers’ cook came sniffing around. He and our captain agreed it was easily the biggest deer they’d ever seen and appropriated it to the officers’ mess. Next day the CO [commanding officer] of the whole outfit came by and announced it was the best tasting ‘venison’ he’d ever had. I heard the farmer got paid a pretty penny for that steer. I didn’t get a damn bite.

He delivered this last bit with relish.

When the conversation returned to anesthesia, I read them the record of his hip fracture repair. I explained that on the face of it, the report seemed uneventful. One daughter asked astute questions about his awareness. I explained that although awareness during general anesthesia is possible, it seemed from the record, he’d had plenty of anesthesia during the case and that there is always less at the beginning and end, the periods that apparently had caused him distress. I also explained that most studies report the incidence of true awareness as at most 1 out of thousands of events and that he had none of the established risk factors for it, such as female gender, young age, chronic substance abuse, cardiac and obstetric surgery, and history of awareness.1

The other daughter wondered why he was so agitated afterward. I recited data on the frequency of postoperative delirium in elderly patients but explained that the range is wide, depending on the study and population, from about 1% in elderly patients undergoing ambulatory surgery to 65% for open aortic surgery.2,3 I added that their father had 2 of the strongest risk factors for delirium, advanced age and cognitive impairment.3 Only after airing each question about the hip surgery in detail were they ready to discuss the eye surgery.

He started that conversation with the right question: “Do I really need it?”

I quoted my surgical colleague’s concern. I told him that, should he opt to undergo the surgery, I was confident that this time around his experience would be different from the last.

“If you’re okay with it, all you need is some numbing medicine from the surgeon; you won’t need any anesthesia from me.”

I walked step-by-step through what they could expect on the day of surgery. Maintaining control was of obvious importance to him. He felt comfortable going forward. His daughters intuited that less would be more for a quick recovery.

We then addressed the DNR directive. I acknowledged his absolute right to self-determination and explained that the need for resuscitation is, at times, a consequence of the surgery and anesthesia. I reassured them that our plan made resuscitation and intubation highly unlikely. They also asked to use any interventions necessary to restart his heart if it should stop beating. I documented their decision in my notes and communicated it to the surgical team. We had talked for 90 minutes.

I met the patient and his daughters on the day of surgery in the preoperative holding area. I inserted an IV, applied electrocardiography leads, and affixed a pulse oximeter and a noninvasive blood pressure cuff. In the operating room (OR) we took time to place his 99-year-old joints into, as he said, the “least worst” position. He tolerated the injection of the local by the surgeon perfectly well. We were in the OR for 3 hours, during which he taught me a fair amount about boating and outboard engines among other things. Pathology reported clean margins. He was discharged home soon after and had an uneventful recovery.

 

 

Patient-First Approach

A core competency of the Accreditation Council for Graduate Medical Education for an anesthesia residency is the Interpersonal and Communication Skills program. A comprehensive discussion of communication is far beyond the scope here. But not surprisingly, deficient communication between physicians and patients can cause emotional distress, significant dissatisfaction among family members, and negative patient judgment of how well we communicate.4-6 These observations are particularly true in our increasingly elderly surgical population, in which both surgeons and anesthesiologists often feel unequal to the task of discussing concepts such as code status.7,8

In our practice and in residency training, the preoperative clinic often is the location where patient/provider communication occurs. Here we consider the latest American College of Cardiology/American Heart Association guidelines, examine airways, review electrocardiograms, and formulate plans agreeable to and understood by our anxious patients and their families. The potent anxiolytic effect of a preoperative visit by an anesthesiologist is well established.9 Anxiety about surgery is a risk factor for impaired decision making before surgery.10 And surgery is traumatic—as many as 7.6% of postoperative patients experience symptoms consistent with PTSD attributable to the surgery, placing it on a par with being mugged (8.0%).11,12

The patient in this case presented several communication challenges even absent his revelation of prior traumatic experience with anesthesia. He was elderly, anxious, and had multiple comorbidities. He had mild cognitive impairment and required a code status discussion. There also were the clinical challenges—navigating a 99-year-old with severe aortic stenosis and a right ventricular systolic pressure > 90 mm Hg through a general anesthetic gave me a sinking feeling.

He was fortunate that the procedure could be done with local anesthesia, mitigating his risk of cognitive dysfunction, including delirium. He also was fortunate in that his anesthesiologist and surgeon had created a collaborative, patient-first approach and that his US Department of Veterans Affairs (VA) clinic had the time, space, and staffing to accommodate an unexpected 90-minute visit. A big investment in communication, mainly my keeping quiet, made the intraoperative management simple. Such is life in an integrated health care system without financial incentives for high-volume care—and another reminder that VA physicians are blessed to guide patients through some of the most vulnerable and distressing moments of their lives.

Postscript

During the preparation of this manuscript, the patient passed away at the age of 100. His obituary was consistent with what I had learned about him and his family during our 2 encounters: a long successful career in local industry; extensive involvement in his community; an avid sportsman; and nearly 30 grandchildren, great-grandchildren, and great-great grandchildren. But there was one more detail that never came up during my extensive discussion with him and his daughters: He was awarded the Purple Heart for his service in World War II.

The patient grabbed my attention as I glanced through our clinic schedule. It was his age: He was 99 years old and scheduled for eye surgery. The plastic surgery resident’s note read: “Patient understands that this would involve surgery under general anesthesia and is agreeable to moving forward...Extremely high risk of anesthesia emphasized.”

I reviewed the patient’s history. At baseline, he had severe pulmonary hypertension, severe aortic stenosis (AS), diastolic heart failure, chronic atrial fibrillation, chronic kidney disease (estimated glomerular filtration rate of 26 mL/min [normal is > 60 mL/min]), anemia (hematocrit 26%), and a standing do not resuscitate (DNR) order. His maximal daily exercise was walking slowly across a room, primarily limited by joint pain. Recent geropsychiatry notes indicated mild cognitive impairment. The anesthesia record from an urgent hip fracture repair 7 months before under general anesthesia was unremarkable.

I phoned the attending plastic surgeon. Our conversation was as follows:

“Hi, I’m about to see a 99-year-old patient with a DNR who is scheduled for resection of an eyelid tumor. His medical history makes me nervous. Are you sure this is a good idea?”“Hmmm, 99-year-old…okay, that’s right,” he responded. “He has an invasive squamous that could become a big problem. The actual procedure is under 10 minutes. Waiting for the pathology report will be the longest part of the procedure.”

“Can it be done under local?” I asked.

“Yes,” he replied.

“Okay, I’ll talk to him and call you back.”

I found the patient in the waiting room, flanked by his 2 daughters and invited them into the clinic room. After introductions, I began asking whether they had any questions about the anesthesia. By midsentence a daughter was prompting him to discuss what happened “last time.” He described a history of posttraumatic stress disorder (PTSD) stemming from his hip surgery, which he blamed squarely on the anesthesia. His emotion was evident in the gathering pauses. “I hate that I am so emotional since they kept me awake during my surgery.”

Through the fog of multiple accounts, it became clear that he was traumatized by the loss of control during the administration of and emergence from the anesthesia.

“They told me it was only oxygen,” he said. “They lied. There was a taste to it…I was awake and skinned alive…They said I was a monster when I woke up thrashing.” He went on, explaining that in the recovery room “there were 2 people bothering me, man-handling me, asking me questions.”

One of his daughters showed me pictures of bruises on his face from ripping off the mask and pulling out the breathing tube. They were visibly upset by the memory of his postoperative combativeness and paranoia. The note written by the orthopedic surgery resident on the day after surgery stated succinctly, “Doing well, had some delirium from anesthesia overnight.” Subsequent geropsychiatry home visits attested to intrusive thoughts, flashbacks, and nightmares from his time as a combat soldier in World War II, 65 years in the past.

“It took me months…months to recover,” he said.

He was in the mood to reminisce, however, perhaps a willful distraction. He had the floor for at least 30 minutes, during which I spoke about 5 sentences. With every sad story he told there was a happy, humorous one, such as meeting his future wife while on leave in New Zealand during the war, recalled down to exact dates. And another story:
 

 

 

There we were in New Caledonia. All our supplies went out to replace what sank on [USS] Coolidge, including a lot of food. Well, there were deer on the island. So we took out a truck and a rifle and wouldn’t you know we came upon a roadblock in the form of a big steer. We figured it looked enough like a deer. My buddy shot it dead with one shot. We dressed it and loaded it into the jeep. Hardly before we even got back to the mess hall, the officers’ cook came sniffing around. He and our captain agreed it was easily the biggest deer they’d ever seen and appropriated it to the officers’ mess. Next day the CO [commanding officer] of the whole outfit came by and announced it was the best tasting ‘venison’ he’d ever had. I heard the farmer got paid a pretty penny for that steer. I didn’t get a damn bite.

He delivered this last bit with relish.

When the conversation returned to anesthesia, I read them the record of his hip fracture repair. I explained that on the face of it, the report seemed uneventful. One daughter asked astute questions about his awareness. I explained that although awareness during general anesthesia is possible, it seemed from the record, he’d had plenty of anesthesia during the case and that there is always less at the beginning and end, the periods that apparently had caused him distress. I also explained that most studies report the incidence of true awareness as at most 1 out of thousands of events and that he had none of the established risk factors for it, such as female gender, young age, chronic substance abuse, cardiac and obstetric surgery, and history of awareness.1

The other daughter wondered why he was so agitated afterward. I recited data on the frequency of postoperative delirium in elderly patients but explained that the range is wide, depending on the study and population, from about 1% in elderly patients undergoing ambulatory surgery to 65% for open aortic surgery.2,3 I added that their father had 2 of the strongest risk factors for delirium, advanced age and cognitive impairment.3 Only after airing each question about the hip surgery in detail were they ready to discuss the eye surgery.

He started that conversation with the right question: “Do I really need it?”

I quoted my surgical colleague’s concern. I told him that, should he opt to undergo the surgery, I was confident that this time around his experience would be different from the last.

“If you’re okay with it, all you need is some numbing medicine from the surgeon; you won’t need any anesthesia from me.”

I walked step-by-step through what they could expect on the day of surgery. Maintaining control was of obvious importance to him. He felt comfortable going forward. His daughters intuited that less would be more for a quick recovery.

We then addressed the DNR directive. I acknowledged his absolute right to self-determination and explained that the need for resuscitation is, at times, a consequence of the surgery and anesthesia. I reassured them that our plan made resuscitation and intubation highly unlikely. They also asked to use any interventions necessary to restart his heart if it should stop beating. I documented their decision in my notes and communicated it to the surgical team. We had talked for 90 minutes.

I met the patient and his daughters on the day of surgery in the preoperative holding area. I inserted an IV, applied electrocardiography leads, and affixed a pulse oximeter and a noninvasive blood pressure cuff. In the operating room (OR) we took time to place his 99-year-old joints into, as he said, the “least worst” position. He tolerated the injection of the local by the surgeon perfectly well. We were in the OR for 3 hours, during which he taught me a fair amount about boating and outboard engines among other things. Pathology reported clean margins. He was discharged home soon after and had an uneventful recovery.

 

 

Patient-First Approach

A core competency of the Accreditation Council for Graduate Medical Education for an anesthesia residency is the Interpersonal and Communication Skills program. A comprehensive discussion of communication is far beyond the scope here. But not surprisingly, deficient communication between physicians and patients can cause emotional distress, significant dissatisfaction among family members, and negative patient judgment of how well we communicate.4-6 These observations are particularly true in our increasingly elderly surgical population, in which both surgeons and anesthesiologists often feel unequal to the task of discussing concepts such as code status.7,8

In our practice and in residency training, the preoperative clinic often is the location where patient/provider communication occurs. Here we consider the latest American College of Cardiology/American Heart Association guidelines, examine airways, review electrocardiograms, and formulate plans agreeable to and understood by our anxious patients and their families. The potent anxiolytic effect of a preoperative visit by an anesthesiologist is well established.9 Anxiety about surgery is a risk factor for impaired decision making before surgery.10 And surgery is traumatic—as many as 7.6% of postoperative patients experience symptoms consistent with PTSD attributable to the surgery, placing it on a par with being mugged (8.0%).11,12

The patient in this case presented several communication challenges even absent his revelation of prior traumatic experience with anesthesia. He was elderly, anxious, and had multiple comorbidities. He had mild cognitive impairment and required a code status discussion. There also were the clinical challenges—navigating a 99-year-old with severe aortic stenosis and a right ventricular systolic pressure > 90 mm Hg through a general anesthetic gave me a sinking feeling.

He was fortunate that the procedure could be done with local anesthesia, mitigating his risk of cognitive dysfunction, including delirium. He also was fortunate in that his anesthesiologist and surgeon had created a collaborative, patient-first approach and that his US Department of Veterans Affairs (VA) clinic had the time, space, and staffing to accommodate an unexpected 90-minute visit. A big investment in communication, mainly my keeping quiet, made the intraoperative management simple. Such is life in an integrated health care system without financial incentives for high-volume care—and another reminder that VA physicians are blessed to guide patients through some of the most vulnerable and distressing moments of their lives.

Postscript

During the preparation of this manuscript, the patient passed away at the age of 100. His obituary was consistent with what I had learned about him and his family during our 2 encounters: a long successful career in local industry; extensive involvement in his community; an avid sportsman; and nearly 30 grandchildren, great-grandchildren, and great-great grandchildren. But there was one more detail that never came up during my extensive discussion with him and his daughters: He was awarded the Purple Heart for his service in World War II.

References

1. Ghoneim MM, Block RI, Haffarnan M, Mathews MJ. Awareness during anesthesia: risk factors, causes and sequelae: a review of reported cases in the literature. Anesth Analg. 2009;108(2):527-535.

2. Aya AGM, Pouchain PH, Thomas H, Ripart J, Cuvillon P. Incidence of postoperative delirium in elderly ambulatory patients: a prospective evaluation using the FAM-CAM instrument. J Clin Anesth. 2019;53:35-38.

3. Raats JW, Steunenberg SL, de Lange DC, van der Laan L. Risk factors of post-operative delirium after elective vascular surgery in the elderly: a systematic review. Int J Surg. 2016;35:1-6.

4. Roter DL, Hall JA, Kern DE, Barker LR, Cole KA, Roca RP. Improving physicians’ interviewing skills and reducing patients’ emotional distress: a randomized clinical trial. Arch Intern Med. 1995;155(17):1877-1884.

5. Wright AA, Keating NL, Ayanian JZ, et al. Family perspectives on aggressive cancer care near the end of life. JAMA. 2016;315(3):284-292.

6. Hall JA, Roter DL, Rand CS. Communication of affect between patient and physician. J Health Soc Behav. 1981;22(1):18-30.

7. Cooper Z, Meyers M, Keating NL, Gu X, Lipsitz SR, Rogers SO. Resident education and management of end-of-life care: the resident’s perspective. J Surg Educ. 2010;67(2):79-84.

8. Hickey TR, Cooper Z, Urman RD, Hepner DL, Bader AM. An agenda for improving perioperative code status discussion. A A Case Rep. 2016;6(12):411-415.

9. Egbert LD, Battit GE, Turndorf H, Beecher HK. The value of the preoperative visit by an anesthetist. JAMA. 1963;185(7):553-555.

10. Ankuda CK, Block SD, Cooper Z, et al. Measuring critical deficits in shared decision making before elective surgery. Patient Educ Couns. 2014;94(3):328-333.

11. Whitlock EL, Rodebaugh TL, Hassett AL, et al. Psychological sequelae of surgery in a prospective cohort of patients from three intraoperative awareness prevention trials. Anesth Analg. 2015;120(1):87-95.

12. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry. 1998;55(7):626-632.

References

1. Ghoneim MM, Block RI, Haffarnan M, Mathews MJ. Awareness during anesthesia: risk factors, causes and sequelae: a review of reported cases in the literature. Anesth Analg. 2009;108(2):527-535.

2. Aya AGM, Pouchain PH, Thomas H, Ripart J, Cuvillon P. Incidence of postoperative delirium in elderly ambulatory patients: a prospective evaluation using the FAM-CAM instrument. J Clin Anesth. 2019;53:35-38.

3. Raats JW, Steunenberg SL, de Lange DC, van der Laan L. Risk factors of post-operative delirium after elective vascular surgery in the elderly: a systematic review. Int J Surg. 2016;35:1-6.

4. Roter DL, Hall JA, Kern DE, Barker LR, Cole KA, Roca RP. Improving physicians’ interviewing skills and reducing patients’ emotional distress: a randomized clinical trial. Arch Intern Med. 1995;155(17):1877-1884.

5. Wright AA, Keating NL, Ayanian JZ, et al. Family perspectives on aggressive cancer care near the end of life. JAMA. 2016;315(3):284-292.

6. Hall JA, Roter DL, Rand CS. Communication of affect between patient and physician. J Health Soc Behav. 1981;22(1):18-30.

7. Cooper Z, Meyers M, Keating NL, Gu X, Lipsitz SR, Rogers SO. Resident education and management of end-of-life care: the resident’s perspective. J Surg Educ. 2010;67(2):79-84.

8. Hickey TR, Cooper Z, Urman RD, Hepner DL, Bader AM. An agenda for improving perioperative code status discussion. A A Case Rep. 2016;6(12):411-415.

9. Egbert LD, Battit GE, Turndorf H, Beecher HK. The value of the preoperative visit by an anesthetist. JAMA. 1963;185(7):553-555.

10. Ankuda CK, Block SD, Cooper Z, et al. Measuring critical deficits in shared decision making before elective surgery. Patient Educ Couns. 2014;94(3):328-333.

11. Whitlock EL, Rodebaugh TL, Hassett AL, et al. Psychological sequelae of surgery in a prospective cohort of patients from three intraoperative awareness prevention trials. Anesth Analg. 2015;120(1):87-95.

12. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry. 1998;55(7):626-632.

Issue
Federal Practitioner - 36(8)a
Issue
Federal Practitioner - 36(8)a
Page Number
352-354
Page Number
352-354
Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media